Sign in Start for free

San Diego Union-Tribune

signonsandiego.com JSON

Sandiegouniontribune.com covers local news in San Diego County, CA, California and national news, sports, things to do and the best places to eat, business and the San Diego housing market.

Sources & updates

How this name was decided

the site's published name — stated on sandiegouniontribune.com, signonsandiego.com, facebook.com

Profile sources

Facebookdeclared on sandiegouniontribune.com
Instagramdeclared on sandiegouniontribune.com

Last observed: Oct 23, 2026, 10:59 AM UTCCurrent
Record last changed: Oct 23, 2026, 10:59 AM UTC
Observations: 7,617
Sources read: 26 of 27

This collection is not finished: 1 source (declared_live) could not be read.

Legal Entities & Relationships

What other sites’ records say

al.com links the same ga4 measurement id, ua property id and gtm container id

A shared account is a relationship between the sites, not by itself a common owner.

bradenton.com links the same ga4 measurement id, ua property id, gtm container id and meta pixel id

A shared account is a relationship between the sites, not by itself a common owner.

charlotteobserver.com links the same ga4 measurement id, ua property id, gtm container id and meta pixel id

A shared account is a relationship between the sites, not by itself a common owner.

chron.com links the same ga4 measurement id and ua property id

A shared account is a relationship between the sites, not by itself a common owner.

cleveland.com links the same ga4 measurement id, ua property id and gtm container id

A shared account is a relationship between the sites, not by itself a common owner.

dailybreeze.com links the same ga4 measurement id, ua property id, gtm container id, bing site verification and workday tenant

A shared account is a relationship between the sites, not by itself a common owner.

dailybulletin.com links the same ga4 measurement id, ua property id, gtm container id, bing site verification and workday tenant

A shared account is a relationship between the sites, not by itself a common owner.

dailyherald.com links the same gtm container id

A shared account is a relationship between the sites, not by itself a common owner.

dailynews.com links the same ga4 measurement id, ua property id, gtm container id, bing site verification and workday tenant

A shared account is a relationship between the sites, not by itself a common owner.

dallasnews.com links the same ga4 measurement id, ua property id, gtm container id and meta pixel id

A shared account is a relationship between the sites, not by itself a common owner.

denverpost.com links the same ga4 measurement id, ua property id, gtm container id, meta pixel id, bing site verification and workday tenant

A shared account is a relationship between the sites, not by itself a common owner.

fresnobee.com links the same ga4 measurement id, ua property id, gtm container id and meta pixel id

A shared account is a relationship between the sites, not by itself a common owner.

idahostatesman.com links the same ga4 measurement id, ua property id, gtm container id and meta pixel id

A shared account is a relationship between the sites, not by itself a common owner.

madison.com links the same ga4 measurement id, ua property id, gtm container id and meta pixel id

A shared account is a relationship between the sites, not by itself a common owner.

mlive.com links the same ga4 measurement id, ua property id and gtm container id

A shared account is a relationship between the sites, not by itself a common owner.

montereyherald.com links the same gtm container id, bing site verification and workday tenant

A shared account is a relationship between the sites, not by itself a common owner.

myrtlebeachonline.com links the same ga4 measurement id, ua property id, gtm container id and meta pixel id

A shared account is a relationship between the sites, not by itself a common owner.

mysanantonio.com links the same ga4 measurement id and ua property id

A shared account is a relationship between the sites, not by itself a common owner.

nola.com links the same ga4 measurement id, gtm container id and meta pixel id

A shared account is a relationship between the sites, not by itself a common owner.

ocregister.com links the same ga4 measurement id, ua property id, gtm container id, bing site verification and workday tenant

A shared account is a relationship between the sites, not by itself a common owner.

oregonlive.com links the same ga4 measurement id, ua property id and gtm container id

A shared account is a relationship between the sites, not by itself a common owner.

orlandosentinel.com links the same ga4 measurement id, ua property id, gtm container id, meta pixel id and bing site verification

A shared account is a relationship between the sites, not by itself a common owner.

pasadenastarnews.com links the same gtm container id, bing site verification and workday tenant

A shared account is a relationship between the sites, not by itself a common owner.

patch.com links the same ga4 measurement id, ua property id, gtm container id and meta pixel id

A shared account is a relationship between the sites, not by itself a common owner.

pilotonline.com links the same ga4 measurement id, ua property id, gtm container id, meta pixel id and bing site verification

A shared account is a relationship between the sites, not by itself a common owner.

presstelegram.com links the same ga4 measurement id, ua property id, gtm container id, bing site verification and workday tenant

A shared account is a relationship between the sites, not by itself a common owner.

restaurantlilo.com links the same instagram account

A shared account is a relationship between the sites, not by itself a common owner.

reviewjournal.com links the same ga4 measurement id and meta pixel id

A shared account is a relationship between the sites, not by itself a common owner.

sacbee.com links the same ga4 measurement id, ua property id, gtm container id and meta pixel id

A shared account is a relationship between the sites, not by itself a common owner.

sbsun.com links the same ga4 measurement id, ua property id, gtm container id, bing site verification and workday tenant

A shared account is a relationship between the sites, not by itself a common owner.

sgvtribune.com links the same ga4 measurement id, ua property id, gtm container id, bing site verification and workday tenant

A shared account is a relationship between the sites, not by itself a common owner.

silive.com links the same ga4 measurement id, ua property id and gtm container id

A shared account is a relationship between the sites, not by itself a common owner.

stltoday.com links the same ga4 measurement id, ua property id, gtm container id and meta pixel id

A shared account is a relationship between the sites, not by itself a common owner.

sun-news.com links the same ga4 measurement id, gtm container id and meta pixel id

A shared account is a relationship between the sites, not by itself a common owner.

syracuse.com links the same ga4 measurement id, ua property id and gtm container id

A shared account is a relationship between the sites, not by itself a common owner.

tampabay.com links the same ga4 measurement id, ua property id, gtm container id and meta pixel id

A shared account is a relationship between the sites, not by itself a common owner.

thenewstribune.com links the same ga4 measurement id, ua property id, gtm container id and meta pixel id

A shared account is a relationship between the sites, not by itself a common owner.

theolympian.com links the same ga4 measurement id, ua property id, gtm container id and meta pixel id

A shared account is a relationship between the sites, not by itself a common owner.

triblive.com links the same ga4 measurement id, ua property id, gtm container id and meta pixel id

A shared account is a relationship between the sites, not by itself a common owner.

tri-cityherald.com links the same ga4 measurement id, ua property id, gtm container id and meta pixel id

A shared account is a relationship between the sites, not by itself a common owner.

twincities.com links the same ga4 measurement id, ua property id, gtm container id, meta pixel id, bing site verification and workday tenant

A shared account is a relationship between the sites, not by itself a common owner.

whittierdailynews.com links the same gtm container id, bing site verification and workday tenant

A shared account is a relationship between the sites, not by itself a common owner.

Relationship evidence

Identity revision 1, last changed 2026-10-23

a declared affiliated site is a relationship the publisher states, not common ownership
a declared provider account (gift cards, hiring, ordering) is a service relationship, not an affiliation
a register party at the business's premises is a candidate operator until the Place and legal resolvers bind it
a licensed operator of the business's premises operates those locations; it is not thereby the brand's owner
an employer a job board names on the openings posts them; it is not thereby the owner or the operator
an app's store seller or developer publishes the app; neither is thereby the restaurant's owner
a menu that names a producer names it; it is not a supply contract, a volume or an exclusivity
a mail or DMARC service domain in DNS is a technical service relationship, not an affiliation
a group the site says it is part of is a public affiliation; the equity chain and buying rights are separate questions
an organization that posts the openings, sells the app or holds a program account shares services with the business; that is not affiliation or ownership
a supplier or charitable partner the site's own page names and links is the publisher's statement; it is not a contract, a volume, an exclusivity or a gift amount

Published nameSan Diego Union-Tribune
Published by the company · confirmed Oct 23, 2026, 10:55 AM UTC
Observed via
https://www.sandiegouniontribune.com/ → declared og:site_name
First observed
Oct 23, 2026, 10:55 AM UTC
Read from
https://www.sandiegouniontribune.com
Published descriptionSandiegouniontribune.com covers local news in San Diego County, CA, California and national news, sports, things to do and the best places to eat, business and the San Diego housing market.
Published by the company · confirmed Oct 23, 2026, 10:55 AM UTC
Observed via
https://www.sandiegouniontribune.com/
First observed
Oct 23, 2026, 10:55 AM UTC
Read from
https://www.sandiegouniontribune.com
Declared languageen-US
Published by the company · confirmed Oct 23, 2026, 10:55 AM UTC
Observed via
https://www.sandiegouniontribune.com/
First observed
Oct 23, 2026, 10:55 AM UTC
Read from
https://www.sandiegouniontribune.com
Canonical URLhttps://www.sandiegouniontribune.com
Published by the company · confirmed Oct 23, 2026, 10:55 AM UTC
Observed via
https://www.sandiegouniontribune.com/
First observed
Oct 23, 2026, 10:55 AM UTC
Read from
https://www.sandiegouniontribune.com
Copyright lineCopyright 2026 San Diego Union-Tribune
Directly observed · confirmed Oct 23, 2026, 10:55 AM UTC
Observed via
https://www.sandiegouniontribune.com/
First observed
Oct 23, 2026, 10:55 AM UTC
Read from
https://www.sandiegouniontribune.com
San Diego Union Tribune Media Kit
San Diego Union Tribune Media Kit
https://mediakit.sandiegouniontribune.com/
Published by the company · confirmed Oct 23, 2026, 10:58 AM UTC
Observed via
https://mediakit.sandiegouniontribune.com/team/
First observed
Oct 23, 2026, 10:58 AM UTC
Read from
https://mediakit.sandiegouniontribune.com
San Diego Union-TribuneSan Diego Union-Tribune · url: https://www.sandiegouniontribune.com/ · logo: https://www.sandiegouniontribune.com/wp-content/uploads/2024/06/SDUT_logo_black_horizontal.png · foundingDate: 02/02/1992 · numberOfEmployees: 350
Published by the company · confirmed Oct 23, 2026, 10:55 AM UTC
Observed via
https://www.sandiegouniontribune.com/
First observed
Oct 23, 2026, 10:55 AM UTC
Read from
https://www.sandiegouniontribune.com
Logo
Published by the company · confirmed Oct 23, 2026, 10:55 AM UTC
Observed via
https://www.sandiegouniontribune.com/ → declared Organization logo → declared asset on another registrable domain (sandiegouniontribune.com) — not the subject's own host
First observed
Oct 23, 2026, 10:55 AM UTC
Read from
https://www.sandiegouniontribune.com
Legal entity
ILLUMINA, INC. · C/O THE CORPORATION TRUST COMPANY, CORPORATION TRUST CENTER, 1209 ORANGE ST, WILMINGTON, US-DE, 19801, US · since 2000-05-16
lei
SQ95QG8SR5Q56LSNF682
registrationAuthorityFileNumber
3228889
registrationAuthority
RA000602
entityStatus
ACTIVE
registrationStatus
ISSUED
jurisdiction
US-DE
legalForm
XTIQ
entityCategory
GENERAL
headquartersAddress
5200 ILLUMINA WAY, SAN DIEGO, US-CA, 92122, US
leiInitialRegistration
2012-11-13
leiLastUpdate
2026-04-06
leiNextRenewal
2027-04-14
managingLOU
5493001KJTIIGC8Y1R12
subOrganization
ILLUMINA CAMBRIDGE LIMITED (LEI 254900KW7GYMUW1LWK43), Illumina Singapore Pte. Ltd. (LEI 254900IWFG3HM348L331)
About a party this site's own evidence does not bind to the business
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://api.gleif.org/api/v1/lei-records/SQ95QG8SR5Q56LSNF682 → printed as ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm → confirmed by the only GLEIF record under this legal name
First observed
Oct 23, 2026, 10:59 AM UTC
About
a party this site's own evidence does not bind to the business
Read from
https://api.gleif.org
Interpreted by rule
gleif-lei-v2

Trademarks

OLIGATOR no longer live · ABANDONED - NO STATEMENT OF USE FILED · Serial 75716667
Filed
May 28, 1999
Classes
IC 009
Attorney
Karen S. Smith
Goods & services
(ABANDONED) IC 009: scientific equipment and instruments for synthesizing oligonucleotides, namely, oligonucleotide synthesizers and DNA synthesizers.
Owners as filed
- Illumina, Inc. (OWNER AT PUBLICATION)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:5a369f01e7c1c6a86ef6a49a
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=75716667&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
No
Owners as filed
City
San Diego
Name
Illumina, Inc.
Role
OWNER AT PUBLICATION
Region
CALIFORNIA 921211975, UNITED STATES
Entity Type
CORPORATION
As Published
Illumina, Inc. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
ABANDONED - NO STATEMENT OF USE FILED
Attorney
Karen S. Smith
Wordmark
OLIGATOR
Filed Date
1999-05-28
Mark Types
TRADEMARK
Us Classes
021 026 038 036 023.
Registered
No
Status Code
606
Abandon Date
2002-10-11
Serial Number
75716667
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
Goods And Services
(ABANDONED) IC 009: scientific equipment and instruments for synthesizing oligonucleotides, namely, oligonucleotide synthesizers and DNA synthesizers.
Queried Legal Name
ILLUMINA, INC.
International Classes
IC 009
Matching Owner Entries
Illumina, Inc. (CORPORATION; DELAWARE, USA)
ARRAY OF ARRAYS no longer live · CANCELLED - SECTION 8 · Serial 75827652
Registration
2976385
Filed
Oct 20, 1999
Registered
Jul 26, 2005
Cancelled
Mar 2, 2012
Classes
IC 042
Attorney
DAVID J BRCZNER
Goods & services
(CANCELLED) IC 042: [ Scientific and medical research, namely, analysis of cells, proteins, nucleic acids and other molecules of 50 to 10,000 daltons, sequencing DNA, genotyping, gene expression profiling and high through-put screening ].
Owners as filed
- Illumina, Inc. (ORIGINAL REGISTRANT)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:94a3bce902b7b740f4f9c58c
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=75827652&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
No
Owners as filed
City
San Diego
Name
Illumina, Inc.
Role
ORIGINAL REGISTRANT
Region
CALIFORNIA 92121, UNITED STATES
Entity Type
CORPORATION
As Published
Illumina, Inc. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
CANCELLED - SECTION 8
Attorney
DAVID J BRCZNER
Wordmark
ARRAY OF ARRAYS
Filed Date
1999-10-20
Mark Types
SERVICE MARK
Us Classes
100 101.
Cancel Date
2012-03-02
Registered
No
Status Code
710
Serial Number
75827652
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
First Use Any Date
2001-10-12
Goods And Services
(CANCELLED) IC 042: [ Scientific and medical research, namely, analysis of cells, proteins, nucleic acids and other molecules of 50 to 10,000 daltons, sequencing DNA, genotyping, gene expression profiling and high through-put screening ].
Queried Legal Name
ILLUMINA, INC.
Registration Date
2005-07-26
Registration Number
2976385
First Use Commerce Date
2001-10-12
International Classes
IC 042
Matching Owner Entries
Illumina, Inc. (CORPORATION; DELAWARE, USA)
PET OLIGATOR no longer live · ABANDONED - NO STATEMENT OF USE FILED · Serial 75907797
Filed
Feb 1, 2000
Classes
IC 001, IC 009
Attorney
David J. Brezner
Goods & services
(ABANDONED) IC 001: Oligonucleotide synthesizer reagents for synthesizing oligonucleotides and nucleic acids for use in research and diagnostics. (ABANDONED) IC 009: Oligonucleotide synthesizer for synthesizing oligonucleotides and nucleic acids for use in research and diagnostics.
Owners as filed
- Illumina, Inc. (OWNER AT PUBLICATION)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:693e85bfaa5a389e770921b0
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=75907797&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
No
Owners as filed
City
San Diego
Name
Illumina, Inc.
Role
OWNER AT PUBLICATION
Region
CALIFORNIA 92121, UNITED STATES
Entity Type
CORPORATION
As Published
Illumina, Inc. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
ABANDONED - NO STATEMENT OF USE FILED
Attorney
David J. Brezner
Wordmark
PET OLIGATOR
Filed Date
2000-02-01
Mark Types
TRADEMARK
Us Classes
001 010 026 046 006 005., 026 038 036 021 023.
Registered
No
Status Code
606
Abandon Date
2003-09-12
Serial Number
75907797
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
Goods And Services
(ABANDONED) IC 001: Oligonucleotide synthesizer reagents for synthesizing oligonucleotides and nucleic acids for use in research and diagnostics., (ABANDONED) IC 009: Oligonucleotide synthesizer for synthesizing oligonucleotides and nucleic acids for use in research and diagnostics.
Queried Legal Name
ILLUMINA, INC.
International Classes
IC 001, IC 009
Matching Owner Entries
Illumina, Inc. (CORPORATION; DELAWARE, USA)
BEADARRAY no longer live · ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE · Serial 75908005
Filed
Feb 1, 2000
Classes
IC 001, IC 009
Attorney
Karen S Smith
Goods & services
(ABANDONED) IC 001: optical array sensor reagents for scientific or medical research for use. (ABANDONED) IC 009: optical array sensor with microbeads on a solid substrate for, either separately or simultaneously, identifying nucleic acids and/or proteins, screening molecules for pharmaceutical activity and characterizing the molecular composition of a gas or liquid.
Owners as filed
- Illumina, Inc. (ORIGINAL APPLICANT)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:579817e7ee5541417d5f6e3f
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=75908005&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
No
Owners as filed
City
San Diego
Name
Illumina, Inc.
Role
ORIGINAL APPLICANT
Region
CALIFORNIA 92121, UNITED STATES
Entity Type
CORPORATION
As Published
Illumina, Inc. (CORPORATION; CALIFORNIA, USA)
Citizenship
CALIFORNIA, USA
Status
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
Attorney
Karen S Smith
Wordmark
BEADARRAY
Filed Date
2000-02-01
Mark Types
TRADEMARK
Us Classes
001 010 026 046 006 005., 026 038 036 021 023.
Registered
No
Status Code
602
Abandon Date
2001-12-28
Serial Number
75908005
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
Goods And Services
(ABANDONED) IC 001: optical array sensor reagents for scientific or medical research for use., (ABANDONED) IC 009: optical array sensor with microbeads on a solid substrate for, either separately or simultaneously, identifying nucleic acids and/or proteins, screening molecules for pharmaceutical activity and characterizing the molecular composition of a gas or liquid.
Queried Legal Name
ILLUMINA, INC.
International Classes
IC 001, IC 009
Matching Owner Entries
Illumina, Inc. (CORPORATION; CALIFORNIA, USA)
OLIGATOR FARM no longer live · CANCELLED - SECTION 8 · Serial 75908025
Registration
2656904
Filed
Feb 1, 2000
Registered
Dec 3, 2002
Cancelled
Jul 11, 2009
Classes
IC 040
Attorney
Gabrielle A. Holley
Goods & services
(CANCELLED) IC 040: [ custom synthesis of oligonucleotides to the order and specification of others ].
Owners as filed
- Illumina, Inc. (ORIGINAL REGISTRANT)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:599fddb7ef6500007d215d24
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=75908025&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
No
Owners as filed
City
San Diego
Name
Illumina, Inc.
Role
ORIGINAL REGISTRANT
Region
CALIFORNIA 92121, UNITED STATES
Entity Type
CORPORATION
As Published
Illumina, Inc. (CORPORATION; CALIFORNIA, USA)
Citizenship
CALIFORNIA, USA
Status
CANCELLED - SECTION 8
Attorney
Gabrielle A. Holley
Wordmark
OLIGATOR FARM
Filed Date
2000-02-01
Mark Types
SERVICE MARK
Us Classes
106 100 103.
Cancel Date
2009-07-11
Registered
No
Status Code
710
Serial Number
75908025
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
First Use Any Date
2001-11-30
Goods And Services
(CANCELLED) IC 040: [ custom synthesis of oligonucleotides to the order and specification of others ].
Queried Legal Name
ILLUMINA, INC.
Registration Date
2002-12-03
Registration Number
2656904
First Use Commerce Date
2001-11-30
International Classes
IC 040
Matching Owner Entries
Illumina, Inc. (CORPORATION; CALIFORNIA, USA)
PATTERN VISUALIZATION SYSTEM REGISTERED AND RENEWED · Serial 75942610
Registration
2516548
Filed
Mar 13, 2000
Registered
Dec 11, 2001
Classes
IC 009
Attorney
William D. O'Neill
Goods & services
IC 009: Computer software for database interaction and analysis for transforming, extrapolating and presenting data, and user manuals distributed as a unit therewith.
Owners as filed
- Partek Incorporated (ORIGINAL REGISTRANT)
- ILLUMINA, INC. (SUBSEQUENT OWNER AFTER REGISTRATION)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:3dc84634b1df3d4ed1bc455b
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=75942610&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
Yes
Owners as filed
City
Chesterfield
Name
Partek Incorporated
Role
ORIGINAL REGISTRANT
Region
MISSOURI 63005, UNITED STATES
Entity Type
CORPORATION
As Published
Partek Incorporated (CORPORATION; MISSOURI, USA)
Citizenship
MISSOURI, USA
City
SAN DIEGO
Name
ILLUMINA, INC.
Role
SUBSEQUENT OWNER AFTER REGISTRATION
Region
CALIFORNIA 92122, UNITED STATES
Entity Type
CORPORATION
As Published
ILLUMINA, INC. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
REGISTERED AND RENEWED
Attorney
William D. O'Neill
Wordmark
PATTERN VISUALIZATION SYSTEM
Filed Date
2000-03-13
Mark Types
TRADEMARK
Us Classes
021 023 026 036 038.
Registered
Yes
Status Code
800
Serial Number
75942610
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
First Use Any Date
1993-12-31
Goods And Services
IC 009: Computer software for database interaction and analysis for transforming, extrapolating and presenting data, and user manuals distributed as a unit therewith.
Queried Legal Name
ILLUMINA, INC.
Registration Date
2001-12-11
Registration Number
2516548
First Use Commerce Date
1993-12-31
International Classes
IC 009
Matching Owner Entries
ILLUMINA, INC. (CORPORATION; DELAWARE, USA)
THE ANALYTICAL SPREADSHEET REGISTERED AND RENEWED · Serial 75942611
Registration
2524258
Filed
Mar 13, 2000
Registered
Jan 1, 2002
Classes
IC 009
Attorney
William D. O'Neill
Goods & services
IC 009: Computer software for database interaction and analysis for transforming, extrapolating and presenting data, and user manuals distributed as a unit therewith.
Owners as filed
- Partek Incorporated (ORIGINAL REGISTRANT)
- ILLUMINA, INC. (SUBSEQUENT OWNER AFTER REGISTRATION)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:0bacab3fc946edd09774dbbc
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=75942611&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
Yes
Owners as filed
City
Chesterfield
Name
Partek Incorporated
Role
ORIGINAL REGISTRANT
Region
MISSOURI 63005, UNITED STATES
Entity Type
CORPORATION
As Published
Partek Incorporated (CORPORATION; MISSOURI, USA)
Citizenship
MISSOURI, USA
City
SAN DIEGO
Name
ILLUMINA, INC.
Role
SUBSEQUENT OWNER AFTER REGISTRATION
Region
CALIFORNIA 92122, UNITED STATES
Entity Type
CORPORATION
As Published
ILLUMINA, INC. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
REGISTERED AND RENEWED
Attorney
William D. O'Neill
Wordmark
THE ANALYTICAL SPREADSHEET
Filed Date
2000-03-13
Mark Types
TRADEMARK
Us Classes
021 023 026 036 038.
Registered
Yes
Status Code
800
Serial Number
75942611
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
First Use Any Date
1993-12-31
Goods And Services
IC 009: Computer software for database interaction and analysis for transforming, extrapolating and presenting data, and user manuals distributed as a unit therewith.
Queried Legal Name
ILLUMINA, INC.
Registration Date
2002-01-01
Registration Number
2524258
First Use Commerce Date
1993-12-31
International Classes
IC 009
Matching Owner Entries
ILLUMINA, INC. (CORPORATION; DELAWARE, USA)
PARTEK REGISTERED AND RENEWED · Serial 75942612
Registration
2516549
Filed
Mar 13, 2000
Registered
Dec 11, 2001
Classes
IC 009
Attorney
Susan M. Natland
Goods & services
IC 009: Computer software for database interaction and analysis for transforming, extrapolating and presenting data, and user manuals distributed as a unit therewith.
Owners as filed
- Partek Incorporated (ORIGINAL REGISTRANT)
- ILLUMINA, INC. (SUBSEQUENT OWNER AFTER REGISTRATION)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:d69197edb81ae94abcf94d82
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=75942612&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
Yes
Owners as filed
City
Chesterfield
Name
Partek Incorporated
Role
ORIGINAL REGISTRANT
Region
MISSOURI 63005, UNITED STATES
Entity Type
CORPORATION
As Published
Partek Incorporated (CORPORATION; MISSOURI, USA)
Citizenship
MISSOURI, USA
City
SAN DIEGO
Name
ILLUMINA, INC.
Role
SUBSEQUENT OWNER AFTER REGISTRATION
Region
CALIFORNIA 92122, UNITED STATES
Entity Type
CORPORATION
As Published
ILLUMINA, INC. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
REGISTERED AND RENEWED
Attorney
Susan M. Natland
Wordmark
PARTEK
Filed Date
2000-03-13
Mark Types
TRADEMARK
Us Classes
021 023 026 036 038.
Registered
Yes
Status Code
800
Serial Number
75942612
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
First Use Any Date
1993-12-31
Goods And Services
IC 009: Computer software for database interaction and analysis for transforming, extrapolating and presenting data, and user manuals distributed as a unit therewith.
Queried Legal Name
ILLUMINA, INC.
Registration Date
2001-12-11
Registration Number
2516549
First Use Commerce Date
1993-12-31
International Classes
IC 009
Matching Owner Entries
ILLUMINA, INC. (CORPORATION; DELAWARE, USA)
PARTEK REGISTERED AND RENEWED · Serial 75943295
Registration
2603467
Filed
Mar 13, 2000
Registered
Aug 6, 2002
Classes
IC 009
Attorney
Susan M. Natland
Goods & services
IC 009: Computer software for database interaction and analysis for transforming, extrapolating and presenting data, and user manuals distributed as a unit therewith.
Owners as filed
- Partek Incorporated (ORIGINAL REGISTRANT)
- ILLUMINA, INC. (SUBSEQUENT OWNER AFTER REGISTRATION)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:9bc2c7c4fb108fa7c13a6dd6
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=75943295&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
Yes
Owners as filed
City
Chesterfield
Name
Partek Incorporated
Role
ORIGINAL REGISTRANT
Region
MISSOURI 63005, UNITED STATES
Entity Type
CORPORATION
As Published
Partek Incorporated (CORPORATION; MISSOURI, USA)
Citizenship
MISSOURI, USA
City
SAN DIEGO
Name
ILLUMINA, INC.
Role
SUBSEQUENT OWNER AFTER REGISTRATION
Region
CALIFORNIA 92122, UNITED STATES
Entity Type
CORPORATION
As Published
ILLUMINA, INC. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
REGISTERED AND RENEWED
Attorney
Susan M. Natland
Wordmark
PARTEK
Filed Date
2000-03-13
Mark Types
TRADEMARK
Us Classes
021 023 026 036 038.
Registered
Yes
Status Code
800
Serial Number
75943295
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
First Use Any Date
2001-10-09
Goods And Services
IC 009: Computer software for database interaction and analysis for transforming, extrapolating and presenting data, and user manuals distributed as a unit therewith.
Queried Legal Name
ILLUMINA, INC.
Registration Date
2002-08-06
Registration Number
2603467
First Use Commerce Date
2001-10-09
International Classes
IC 009
Matching Owner Entries
ILLUMINA, INC. (CORPORATION; DELAWARE, USA)
ILLUMINA REGISTERED AND RENEWED · Serial 75982227
Registration
2632507
Filed
Aug 18, 2000
Registered
Oct 8, 2002
Classes
IC 001, IC 042
Attorney
Susan M. Natland
Goods & services
IC 001: chemicals, namely reagents for scientific or medical research use for analyzing cells, proteins, nucleic acids and other molecules of 50 to 10,000 daltons, sequencing DNA, genotyping, gene expression profiling and high through-put screening. IC 042: scientific and medical research, namely, analysis of cells, proteins, nucleic acids and other molecules of 50 to 10,000 daltons, sequencing DNA, genotyping, gene expression profiling and high through-put screening.
Owners as filed
- Illumina, Inc. (ORIGINAL REGISTRANT)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:9764682091acbc823f4e396d
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=75982227&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
Yes
Owners as filed
City
San Diego
Name
Illumina, Inc.
Role
ORIGINAL REGISTRANT
Region
California 92122, UNITED STATES
Entity Type
CORPORATION
As Published
Illumina, Inc. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
REGISTERED AND RENEWED
Attorney
Susan M. Natland
Wordmark
ILLUMINA
Filed Date
2000-08-18
Mark Types
TRADEMARK, SERVICE MARK
Us Classes
001 005 006 010 026 046., 100 101.
Registered
Yes
Status Code
800
Serial Number
75982227
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
First Use Any Date
2001-10-12
Goods And Services
IC 001: chemicals, namely reagents for scientific or medical research use for analyzing cells, proteins, nucleic acids and other molecules of 50 to 10,000 daltons, sequencing DNA, genotyping, gene expression profiling and high through-put screening., IC 042: scientific and medical research, namely, analysis of cells, proteins, nucleic acids and other molecules of 50 to 10,000 daltons, sequencing DNA, genotyping, gene expression profiling and high through-put screening.
Queried Legal Name
ILLUMINA, INC.
Registration Date
2002-10-08
Registration Number
2632507
First Use Commerce Date
2001-10-12
International Classes
IC 001, IC 042
Matching Owner Entries
Illumina, Inc. (CORPORATION; DELAWARE, USA)
OLIGATOR no longer live · CANCELLED - SECTION 8 · Serial 75982486
Registration
2640345
Filed
May 28, 1999
Registered
Oct 22, 2002
Cancelled
May 30, 2009
Classes
IC 040
Attorney
Gabrielle A. Holley
Goods & services
(CANCELLED) IC 040: [ custom synthesis of oligonucleotides to the order and specification of others ].
Owners as filed
- Illumina, Inc. (ORIGINAL REGISTRANT)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:adedbccf2bd2b4ad07d776a0
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=75982486&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
No
Owners as filed
City
San Diego
Name
Illumina, Inc.
Role
ORIGINAL REGISTRANT
Region
CALIFORNIA 921211975, UNITED STATES
Entity Type
CORPORATION
As Published
Illumina, Inc. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
CANCELLED - SECTION 8
Attorney
Gabrielle A. Holley
Wordmark
OLIGATOR
Filed Date
1999-05-28
Mark Types
SERVICE MARK
Us Classes
100 103 106.
Cancel Date
2009-05-30
Registered
No
Status Code
710
Serial Number
75982486
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
First Use Any Date
2001-05-11
Goods And Services
(CANCELLED) IC 040: [ custom synthesis of oligonucleotides to the order and specification of others ].
Queried Legal Name
ILLUMINA, INC.
Registration Date
2002-10-22
Registration Number
2640345
First Use Commerce Date
2001-05-11
International Classes
IC 040
Matching Owner Entries
Illumina, Inc. (CORPORATION; DELAWARE, USA)
ILLUMINA REGISTERED AND RENEWED · Serial 76072152
Registration
2471539
Filed
Jun 15, 2000
Registered
Jul 24, 2001
Classes
IC 040
Attorney
Susan M. Natland
Goods & services
IC 040: Developing, to the order and specification of others, biological and/or chemical sensing systems which use random array technology to identify [ inorganic and ] organic molecules, compounds and substances.
Owners as filed
- Illumina, Inc. (ORIGINAL REGISTRANT)
- Illumina, Inc. (SUBSEQUENT OWNER AFTER REGISTRATION)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:8b30d2aca9f9ce0d4ee668a1
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=76072152&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
Yes
Owners as filed
City
San Diego
Name
Illumina, Inc.
Role
ORIGINAL REGISTRANT
Region
CALIFORNIA 92121, UNITED STATES
Entity Type
CORPORATION
As Published
Illumina, Inc. (CORPORATION; CALIFORNIA, USA)
Citizenship
CALIFORNIA, USA
City
San Diego
Name
Illumina, Inc.
Role
SUBSEQUENT OWNER AFTER REGISTRATION
Region
California 92122, UNITED STATES
Entity Type
CORPORATION
As Published
Illumina, Inc. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
REGISTERED AND RENEWED
Attorney
Susan M. Natland
Wordmark
ILLUMINA
Filed Date
2000-06-15
Mark Types
SERVICE MARK
Us Classes
100 103 106.
Registered
Yes
Status Code
800
Serial Number
76072152
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
First Use Any Date
1999-02-28
Goods And Services
IC 040: Developing, to the order and specification of others, biological and/or chemical sensing systems which use random array technology to identify [ inorganic and ] organic molecules, compounds and substances.
Queried Legal Name
ILLUMINA, INC.
Registration Date
2001-07-24
Registration Number
2471539
First Use Commerce Date
1999-02-28
International Classes
IC 040
Matching Owner Entries
Illumina, Inc. (CORPORATION; CALIFORNIA, USA), Illumina, Inc. (CORPORATION; DELAWARE, USA)
TURNING DATA INTO DISCOVERY REGISTERED AND RENEWED · Serial 76104822
Registration
2569431
Filed
Aug 7, 2000
Registered
May 14, 2002
Classes
IC 009
Attorney
Susan M. Natland
Goods & services
IC 009: COMPUTER SOFTWARE FOR DATABASE INTERACTION AND ANALYSIS FOR TRANSFORMING, EXTRAPOLATING AND PRESENTING DATA, AND USER MANUALS DISTRIBUTED AS A UNIT THEREWITH.
Owners as filed
- Partek Incorporated (ORIGINAL REGISTRANT)
- ILLUMINA, INC. (SUBSEQUENT OWNER AFTER REGISTRATION)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:4899774ea7afcbaf4a2e7b17
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=76104822&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
Yes
Owners as filed
City
Chesterfield
Name
Partek Incorporated
Role
ORIGINAL REGISTRANT
Region
MISSOURI 63005, UNITED STATES
Entity Type
CORPORATION
As Published
Partek Incorporated (CORPORATION; MISSOURI, USA)
Citizenship
MISSOURI, USA
City
SAN DIEGO
Name
ILLUMINA, INC.
Role
SUBSEQUENT OWNER AFTER REGISTRATION
Region
CALIFORNIA 92122, UNITED STATES
Entity Type
CORPORATION
As Published
ILLUMINA, INC. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
REGISTERED AND RENEWED
Attorney
Susan M. Natland
Wordmark
TURNING DATA INTO DISCOVERY
Filed Date
2000-08-07
Mark Types
TRADEMARK
Us Classes
021 023 026 036 038.
Registered
Yes
Status Code
800
Serial Number
76104822
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
First Use Any Date
2000-07-25
Goods And Services
IC 009: COMPUTER SOFTWARE FOR DATABASE INTERACTION AND ANALYSIS FOR TRANSFORMING, EXTRAPOLATING AND PRESENTING DATA, AND USER MANUALS DISTRIBUTED AS A UNIT THEREWITH.
Queried Legal Name
ILLUMINA, INC.
Registration Date
2002-05-14
Registration Number
2569431
First Use Commerce Date
2000-07-25
International Classes
IC 009
Matching Owner Entries
ILLUMINA, INC. (CORPORATION; DELAWARE, USA)
ILLUMINA REGISTERED AND RENEWED · Serial 76112547
Registration
2756703
Filed
Aug 18, 2000
Registered
Aug 26, 2003
Classes
IC 009
Attorney
Susan M. Natland
Goods & services
IC 009: Scientific equipment and instruments, namely scanners, hybridization stations and fluidics delivery and computer systems sold as a unit and cassettes containing molecular sensing optical fiber bundles for analyzing cells, proteins, nucleic acids and other molecules of 50 to 10,000 Dalton, sequencing DNA, genotype, gene expression profiling and high through-put screening.
Owners as filed
- Illumina, Inc. (ORIGINAL REGISTRANT)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:a4bcd2d3c47e12b1ff783d9b
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=76112547&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
Yes
Owners as filed
City
San Diego
Name
Illumina, Inc.
Role
ORIGINAL REGISTRANT
Region
California 92122, UNITED STATES
Entity Type
CORPORATION
As Published
Illumina, Inc. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
REGISTERED AND RENEWED
Attorney
Susan M. Natland
Wordmark
ILLUMINA
Filed Date
2000-08-18
Mark Types
TRADEMARK
Us Classes
021 023 026 036 038.
Registered
Yes
Status Code
800
Serial Number
76112547
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
First Use Any Date
2003-01-09
Goods And Services
IC 009: Scientific equipment and instruments, namely scanners, hybridization stations and fluidics delivery and computer systems sold as a unit and cassettes containing molecular sensing optical fiber bundles for analyzing cells, proteins, nucleic acids and other molecules of 50 to 10,000 Dalton, sequencing DNA, genotype, gene expression profiling and high through-put screening.
Queried Legal Name
ILLUMINA, INC.
Registration Date
2003-08-26
Registration Number
2756703
First Use Commerce Date
2003-01-09
International Classes
IC 009
Matching Owner Entries
Illumina, Inc. (CORPORATION; DELAWARE, USA)
ZIPEXPRESS no longer live · ABANDONED - AFTER INTER-PARTES DECISION · Serial 76131712
Filed
Sep 19, 2000
Classes
IC 001, IC 005, IC 009, IC 042
Attorney
F.T. Alexandra Mahaney
Goods & services
(ABANDONED) IC 001: [ Biotechnology preparations, namely reagents and reagents kits, nucleic acid arrays and nucleic acid array kits, comprised primarily of reagents and nucleic acid arrays, all for scientific and medical research in the field of genetic analysis ]. (ABANDONED) IC 005: [ Pharmaceutical preparations and clinical, medical and diagnostic reagents and reagents kits, nucleic acid arrays and nucleic acid array kits comprised primarily of clinical and diagnostic reagents and nucleic acid arrays, all for use in genetic analysis in clinical or medical laboratory use ]. (ABANDONED) IC 009: [ Computer software for accessing computerized information for genetic analysis, in the fields of pharmacology, diagnostics and biotechnology ]. (ABANDONED) IC 042: [ Scientific research in the field of genetic analysis of RNA or DNA sequences with nucleic acid arrays; medical diagnostic and clinical services through the genetic analysis of RNA or DNA sequences with nucleic acid arrays; generation of information from genetic analysis of RNA or DNA sequences for the benefit of others; and leasing access time to a computer database in the field of genetic analysis ].
Owners as filed
- ILLUMINA, INC. (OWNER AT PUBLICATION)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:d031651ed9194269a2f111c0
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=76131712&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
No
Owners as filed
City
San Diego
Name
ILLUMINA, INC.
Role
OWNER AT PUBLICATION
Region
CALIFORNIA 92121, UNITED STATES
Entity Type
CORPORATION
As Published
ILLUMINA, INC. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
ABANDONED - AFTER INTER-PARTES DECISION
Attorney
F.T. Alexandra Mahaney
Wordmark
ZIPEXPRESS
Filed Date
2000-09-19
Mark Types
TRADEMARK, SERVICE MARK
Us Classes
001 010 006 005 026 046., 006 018 052 046 044 051., 021 026 038 036 023., 100 101.
Registered
No
Status Code
604
Abandon Date
2003-03-14
Serial Number
76131712
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
Goods And Services
(ABANDONED) IC 001: [ Biotechnology preparations, namely reagents and reagents kits, nucleic acid arrays and nucleic acid array kits, comprised primarily of reagents and nucleic acid arrays, all for scientific and medical research in the field of genetic analysis ]., (ABANDONED) IC 005: [ Pharmaceutical preparations and clinical, medical and diagnostic reagents and reagents kits, nucleic acid arrays and nucleic acid array kits comprised primarily of clinical and diagnostic reagents and nucleic acid arrays, all for use in genetic analysis in clinical or medical laboratory use ]., (ABANDONED) IC 009: [ Computer software for accessing computerized information for genetic analysis, in the fields of pharmacology, diagnostics and biotechnology ]., (ABANDONED) IC 042: [ Scientific research in the field of genetic analysis of RNA or DNA sequences with nucleic acid arrays; medical diagnostic and clinical services through the genetic analysis of RNA or DNA sequences with nucleic acid arrays; generation of information from genetic analysis of RNA or DNA sequences for the benefit of others; and leasing access time to a computer database in the field of genetic analysis ].
Queried Legal Name
ILLUMINA, INC.
International Classes
IC 001, IC 005, IC 009, IC 042
Matching Owner Entries
ILLUMINA, INC. (CORPORATION; DELAWARE, USA)
ZIPSNP no longer live · ABANDONED - EXPRESS · Serial 76131723
Filed
Sep 19, 2000
Classes
IC 001, IC 005, IC 009, IC 042
Attorney
F.T. Alexandra Mahaney
Goods & services
(ABANDONED) IC 001: Biotechnology preparations, namely reagents and reagents kits, nucleic acid arrays and nucleic acid array kits, comprised primarily of reagents and nucleic acid arrays, all for scientific and medical research in the field of genetic analysis. (ABANDONED) IC 005: Pharmaceutical preparations and clinical medical and diagnostic reagents and reagents kits, nucleic acid arrays and nucleic acid arrays kits comprised primarily of clinical and diagnostic reagents and nucleic acid arrays, all for use in genetic analysis. (ABANDONED) IC 009: Computer software for accessing computerized information for genetic analysis, in the fields of pharmacology, diagnostics and biotechnology. (ABANDONED) IC 042: Scientific research in the field of genetic analysis of RNA or DNA sequences with nucleic acid arrays; medical diagnostic and clinical services through the genetic analysis of RNA or DNA sequences with nucleic acid arrays; generation of information from genetic analysis of RNA or DNA sequences for the benefit of others; and leasing access to a computerized database in the field of genetic analysis.
Owners as filed
- ILLUMINA, INC. (ORIGINAL APPLICANT)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:b0216f779b095fe04c96e1a6
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=76131723&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
No
Owners as filed
City
San Diego
Name
ILLUMINA, INC.
Role
ORIGINAL APPLICANT
Region
CALIFORNIA 92121, UNITED STATES
Entity Type
CORPORATION
As Published
ILLUMINA, INC. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
ABANDONED - EXPRESS
Attorney
F.T. Alexandra Mahaney
Wordmark
ZIPSNP
Filed Date
2000-09-19
Mark Types
TRADEMARK, SERVICE MARK
Us Classes
001 010 006 005 026 046., 006 018 052 046 044 051., 021 026 038 036 023., 100 101.
Registered
No
Status Code
601
Abandon Date
2003-06-24
Serial Number
76131723
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
Goods And Services
(ABANDONED) IC 001: Biotechnology preparations, namely reagents and reagents kits, nucleic acid arrays and nucleic acid array kits, comprised primarily of reagents and nucleic acid arrays, all for scientific and medical research in the field of genetic analysis., (ABANDONED) IC 005: Pharmaceutical preparations and clinical medical and diagnostic reagents and reagents kits, nucleic acid arrays and nucleic acid arrays kits comprised primarily of clinical and diagnostic reagents and nucleic acid arrays, all for use in genetic analysis., (ABANDONED) IC 009: Computer software for accessing computerized information for genetic analysis, in the fields of pharmacology, diagnostics and biotechnology., (ABANDONED) IC 042: Scientific research in the field of genetic analysis of RNA or DNA sequences with nucleic acid arrays; medical diagnostic and clinical services through the genetic analysis of RNA or DNA sequences with nucleic acid arrays; generation of information from genetic analysis of RNA or DNA sequences for the benefit of others; and leasing access to a computerized database in the field of genetic analysis.
Queried Legal Name
ILLUMINA, INC.
International Classes
IC 001, IC 005, IC 009, IC 042
Matching Owner Entries
ILLUMINA, INC. (CORPORATION; DELAWARE, USA)
MEGAPLEX no longer live · ABANDONED - NO STATEMENT OF USE FILED · Serial 76142342
Filed
Oct 7, 2000
Classes
IC 001, IC 005, IC 009, IC 042
Attorney
F.T. Alexandra Mahaney
Goods & services
(ABANDONED) IC 001: Biotechnology preparations, namely reagents and reagents kits, nucleic acid arrays and nucleic acid array kits, comprised primarily of reagents and nucleic acid arrays, all for scientific and medical research in the field of genetic analysis. (ABANDONED) IC 005: Pharmaceutical preparations and clinical medical and diagnostic reagents and reagents kits, nucleic acid arrays and nucleic acid array kits comprised primarily of clinical and diagnostic reagents and nucleic acid arrays, all for use in genetic analysis. (ABANDONED) IC 009: Computer software for accessing computerized information for genetic analysis, in the fields of pharmacology, diagnostics and biotechnology. (ABANDONED) IC 042: Scientific research in the field of genetic analysis of RNA or DNA sequences with nucleic acid arrays; medical diagnostic and clinical services through the genetic analysis of RNA or DNA sequences with nucleic acid arrays; generation of information from genetic analysis of RNA or DNA sequences for the benefit of others; and leasing access time to a computer database in the field of genetic analysis.
Owners as filed
- ILLUMINA, INC. (OWNER AT PUBLICATION)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:91375b9d8b7ed3e158a0b1f3
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=76142342&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
No
Owners as filed
City
San Diego
Name
ILLUMINA, INC.
Role
OWNER AT PUBLICATION
Region
CALIFORNIA 92121, UNITED STATES
Entity Type
CORPORATION
As Published
ILLUMINA, INC. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
ABANDONED - NO STATEMENT OF USE FILED
Attorney
F.T. Alexandra Mahaney
Wordmark
MEGAPLEX
Filed Date
2000-10-07
Mark Types
TRADEMARK, SERVICE MARK
Us Classes
001 010 005 006 026 046., 006 018 052 046 044 051., 021 026 038 036 023., 100 101.
Registered
No
Status Code
606
Abandon Date
2004-01-10
Serial Number
76142342
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
Goods And Services
(ABANDONED) IC 001: Biotechnology preparations, namely reagents and reagents kits, nucleic acid arrays and nucleic acid array kits, comprised primarily of reagents and nucleic acid arrays, all for scientific and medical research in the field of genetic analysis., (ABANDONED) IC 005: Pharmaceutical preparations and clinical medical and diagnostic reagents and reagents kits, nucleic acid arrays and nucleic acid array kits comprised primarily of clinical and diagnostic reagents and nucleic acid arrays, all for use in genetic analysis., (ABANDONED) IC 009: Computer software for accessing computerized information for genetic analysis, in the fields of pharmacology, diagnostics and biotechnology., (ABANDONED) IC 042: Scientific research in the field of genetic analysis of RNA or DNA sequences with nucleic acid arrays; medical diagnostic and clinical services through the genetic analysis of RNA or DNA sequences with nucleic acid arrays; generation of information from genetic analysis of RNA or DNA sequences for the benefit of others; and leasing access time to a computer database in the field of genetic analysis.
Queried Legal Name
ILLUMINA, INC.
International Classes
IC 001, IC 005, IC 009, IC 042
Matching Owner Entries
ILLUMINA, INC. (CORPORATION; DELAWARE, USA)
OLIGATOR no longer live · CANCELLED - SECTION 8 · Serial 76338671
Registration
2658952
Filed
Nov 15, 2001
Registered
Dec 10, 2002
Cancelled
Jul 18, 2009
Classes
IC 001
Attorney
Gabrielle A. Holley
Goods & services
(CANCELLED) IC 001: [ Chemicals, namely, oligonucleotides for research and scientific use ].
Owners as filed
- Illumina, Inc. (ORIGINAL REGISTRANT)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:7b861e70209b4af4690799cf
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=76338671&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
No
Owners as filed
City
San Diego
Name
Illumina, Inc.
Role
ORIGINAL REGISTRANT
Region
CALIFORNIA 92121, UNITED STATES
Entity Type
CORPORATION
As Published
Illumina, Inc. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
CANCELLED - SECTION 8
Attorney
Gabrielle A. Holley
Wordmark
OLIGATOR
Filed Date
2001-11-15
Mark Types
TRADEMARK
Us Classes
001 010 006 005 026 046.
Cancel Date
2009-07-18
Registered
No
Status Code
710
Serial Number
76338671
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
First Use Any Date
2001-02-23
Goods And Services
(CANCELLED) IC 001: [ Chemicals, namely, oligonucleotides for research and scientific use ].
Queried Legal Name
ILLUMINA, INC.
Registration Date
2002-12-10
Registration Number
2658952
First Use Commerce Date
2001-02-23
International Classes
IC 001
Matching Owner Entries
Illumina, Inc. (CORPORATION; DELAWARE, USA)
Trademark 76368161 no longer live · CANCELLED - SECTION 8
Registration
2671836
Filed
Feb 6, 2002
Registered
Jan 7, 2003
Cancelled
Aug 15, 2009
Classes
IC 001, IC 040
Attorney
Gabrielle A. Holley
Goods & services
(CANCELLED) IC 001: [ chemicals, namely oligonucleotides for scientific research, medical research, medical diagnostics and medical therapy ]. (CANCELLED) IC 040: [ custom synthesis of oligonucleotides to the order and specification of others ].
Owners as filed
- Illumina, Inc. (ORIGINAL REGISTRANT)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:39d9b8c2c1edc1df92dd54d0
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=76368161&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
No
Owners as filed
City
San Diego
Name
Illumina, Inc.
Role
ORIGINAL REGISTRANT
Region
CALIFORNIA 92121, UNITED STATES
Entity Type
CORPORATION
As Published
Illumina, Inc. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
CANCELLED - SECTION 8
Attorney
Gabrielle A. Holley
Filed Date
2002-02-06
Mark Types
TRADEMARK, SERVICE MARK
Us Classes
001 010 005 026 006 046., 106 100 103.
Cancel Date
2009-08-15
Registered
No
Status Code
710
Serial Number
76368161
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
First Use Any Date
2001-02-23
Goods And Services
(CANCELLED) IC 001: [ chemicals, namely oligonucleotides for scientific research, medical research, medical diagnostics and medical therapy ]., (CANCELLED) IC 040: [ custom synthesis of oligonucleotides to the order and specification of others ].
Queried Legal Name
ILLUMINA, INC.
Registration Date
2003-01-07
Registration Number
2671836
First Use Commerce Date
2001-02-23
International Classes
IC 001, IC 040
Matching Owner Entries
Illumina, Inc. (CORPORATION; DELAWARE, USA)
Trademark 76368162 no longer live · CANCELLED - SECTION 8
Registration
2828335
Filed
Feb 6, 2002
Registered
Mar 30, 2004
Cancelled
Nov 5, 2010
Classes
IC 009
Attorney
Gabrielle A. Holley
Goods & services
(CANCELLED) IC 009: [ scientific equipment and instruments for synthesizing oligonucleotides, namely oligonucleotide synthesizers and DNA synthesizers ].
Owners as filed
- Illumina, Inc. (ORIGINAL REGISTRANT)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:e82dfa509c62687bbcc303df
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=76368162&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
No
Owners as filed
City
San Diego
Name
Illumina, Inc.
Role
ORIGINAL REGISTRANT
Region
CALIFORNIA 92121, UNITED STATES
Entity Type
CORPORATION
As Published
Illumina, Inc. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
CANCELLED - SECTION 8
Attorney
Gabrielle A. Holley
Filed Date
2002-02-06
Mark Types
TRADEMARK
Us Classes
038 026 021 036 023.
Cancel Date
2010-11-05
Registered
No
Status Code
710
Serial Number
76368162
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
First Use Any Date
2001-02-23
Goods And Services
(CANCELLED) IC 009: [ scientific equipment and instruments for synthesizing oligonucleotides, namely oligonucleotide synthesizers and DNA synthesizers ].
Queried Legal Name
ILLUMINA, INC.
Registration Date
2004-03-30
Registration Number
2828335
First Use Commerce Date
2001-02-23
International Classes
IC 009
Matching Owner Entries
Illumina, Inc. (CORPORATION; DELAWARE, USA)
ISEQ REGISTERED AND RENEWED · Serial 77349991
Registration
4031877
Filed
Dec 12, 2007
Registered
Sep 27, 2011
Classes
IC 001, IC 009
Attorney
Susan M. Natland
Goods & services
IC 001: Chemical reagents and kits containing same, each for scientific purposes, namely, enzymes, buffers and nucleic-acid cleaving agents for use in nucleic acid analysis. IC 009: Computer software for obtaining and analyzing data relating to nucleic acid analysis.
Owners as filed
- SEQUENOM, INC. (ORIGINAL REGISTRANT)
- ILLUMINA, INC. (SUBSEQUENT OWNER AFTER REGISTRATION)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:1961f9b91396b8e4816f9369
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=77349991&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
Yes
Owners as filed
City
San Diego
Name
SEQUENOM, INC.
Role
ORIGINAL REGISTRANT
Region
CALIFORNIA 92121, UNITED STATES
Entity Type
CORPORATION
As Published
SEQUENOM, INC. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
City
San Diego
Name
ILLUMINA, INC.
Role
SUBSEQUENT OWNER AFTER REGISTRATION
Region
California 92122, UNITED STATES
Entity Type
CORPORATION
As Published
ILLUMINA, INC. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
REGISTERED AND RENEWED
Attorney
Susan M. Natland
Wordmark
ISEQ
Filed Date
2007-12-12
Mark Types
TRADEMARK
Us Classes
001 010 006 026 046 005., 026 038 036 021 023.
Registered
Yes
Status Code
800
Serial Number
77349991
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
First Use Any Date
2010-11-27
Goods And Services
IC 001: Chemical reagents and kits containing same, each for scientific purposes, namely, enzymes, buffers and nucleic-acid cleaving agents for use in nucleic acid analysis., IC 009: Computer software for obtaining and analyzing data relating to nucleic acid analysis.
Queried Legal Name
ILLUMINA, INC.
Registration Date
2011-09-27
Registration Number
4031877
First Use Commerce Date
2010-11-27
International Classes
IC 001, IC 009
Matching Owner Entries
ILLUMINA, INC. (CORPORATION; DELAWARE, USA)
ISCAN no longer live · ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE · Serial 77445376
Filed
Apr 10, 2008
Classes
IC 009
Attorney
Gabrielle Holley
Goods & services
(ABANDONED) IC 009: Laboratory equipment comprised of lasers, optics, namely a lens, filter and mirror, detectors, namely optical detectors, and sample containers, for detection, quantitation, and analysis of genotyping, diagnostic assays, and nucleic acid sequencing reactions.
Owners as filed
- Illumina, Inc. (ORIGINAL APPLICANT)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:7e3512a03d694efcfbfb1bf6
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=77445376&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
No
Owners as filed
City
San Diego
Name
Illumina, Inc.
Role
ORIGINAL APPLICANT
Region
CALIFORNIA 92121, UNITED STATES
Entity Type
CORPORATION
As Published
Illumina, Inc. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
Attorney
Gabrielle Holley
Wordmark
ISCAN
Filed Date
2008-04-10
Mark Types
TRADEMARK
Us Classes
021 026 038 036 023.
Registered
No
Status Code
602
Abandon Date
2009-03-27
Serial Number
77445376
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
Goods And Services
(ABANDONED) IC 009: Laboratory equipment comprised of lasers, optics, namely a lens, filter and mirror, detectors, namely optical detectors, and sample containers, for detection, quantitation, and analysis of genotyping, diagnostic assays, and nucleic acid sequencing reactions.
Queried Legal Name
ILLUMINA, INC.
International Classes
IC 009
Matching Owner Entries
Illumina, Inc. (CORPORATION; DELAWARE, USA)
GENOMESTUDIO REGISTERED AND RENEWED · Serial 77445416
Registration
3644641
Filed
Apr 10, 2008
Registered
Jun 23, 2009
Classes
IC 009
Attorney
Susan M. Natland
Goods & services
IC 009: Software for data collection, management, and analysis of genetic information.
Owners as filed
- Illumina, Inc. (ORIGINAL REGISTRANT)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:d232a66bf54dc1d89e08b6ac
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=77445416&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
Yes
Owners as filed
City
San Diego
Name
Illumina, Inc.
Role
ORIGINAL REGISTRANT
Region
California 92122, UNITED STATES
Entity Type
CORPORATION
As Published
Illumina, Inc. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
REGISTERED AND RENEWED
Attorney
Susan M. Natland
Wordmark
GENOMESTUDIO
Filed Date
2008-04-10
Mark Types
TRADEMARK
Us Classes
021 026 038 036 023.
Registered
Yes
Status Code
800
Serial Number
77445416
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
First Use Any Date
2009-02-06
Goods And Services
IC 009: Software for data collection, management, and analysis of genetic information.
Queried Legal Name
ILLUMINA, INC.
Registration Date
2009-06-23
Registration Number
3644641
First Use Commerce Date
2009-02-06
International Classes
IC 009
Matching Owner Entries
Illumina, Inc. (CORPORATION; DELAWARE, USA)
ILLUMINADX no longer live · ABANDONED - NO STATEMENT OF USE FILED · Serial 77747038
Filed
May 28, 2009
Classes
IC 042, IC 009
Attorney
Gabrielle A. Holley
Goods & services
(ABANDONED) IC 042: Clinical diagnostic services in preparing, amplifying, labeling, detecting, analyzing and sequencing nucleic acids and other biological molecules from human beings or animals. (ABANDONED) IC 009: Clinical diagnostic instruments, namely, nucleic acid sequencers, imaging devices and analyzers for use in scientific, diagnostic and clinical research and for clinical diagnostic purposes; laboratory equipment, namely, fluid containers, fluid mixers, fluid control valves and temperature-controlled incubators for sample preparation, amplification, mixing, hybridization, incubation, and washing; automated laboratory apparatus and systems, namely, sample loaders and bar code readers; computer systems, namely, computer hardware, computer software, and data files for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data, all the foregoing for use in the fields of scientific, diagnostic and clinical research and for clinical diagnostic purposes.
Owners as filed
- Illumina, Inc. (OWNER AT PUBLICATION)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:a3db2278797a3b0e19e061b4
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=77747038&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
No
Owners as filed
City
San Diego
Name
Illumina, Inc.
Role
OWNER AT PUBLICATION
Region
CALIFORNIA 92122, UNITED STATES
Entity Type
CORPORATION
As Published
Illumina, Inc. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
ABANDONED - NO STATEMENT OF USE FILED
Attorney
Gabrielle A. Holley
Wordmark
ILLUMINADX
Filed Date
2009-05-28
Mark Types
TRADEMARK, SERVICE MARK
Us Classes
100 101., 021 026 038 036 023.
Registered
No
Status Code
606
Abandon Date
2013-09-02
Serial Number
77747038
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
Goods And Services
(ABANDONED) IC 042: Clinical diagnostic services in preparing, amplifying, labeling, detecting, analyzing and sequencing nucleic acids and other biological molecules from human beings or animals., (ABANDONED) IC 009: Clinical diagnostic instruments, namely, nucleic acid sequencers, imaging devices and analyzers for use in scientific, diagnostic and clinical research and for clinical diagnostic purposes; laboratory equipment, namely, fluid containers, fluid mixers, fluid control valves and temperature-controlled incubators for sample preparation, amplification, mixing, hybridization, incubation, and washing; automated laboratory apparatus and systems, namely, sample loaders and bar code readers; computer systems, namely, computer hardware, computer software, and data files for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data, all the foregoing for use in the fields of scientific, diagnostic and clinical research and for clinical diagnostic purposes.
Queried Legal Name
ILLUMINA, INC.
International Classes
IC 042, IC 009
Matching Owner Entries
Illumina, Inc. (CORPORATION; DELAWARE, USA)
NEXIONSQ no longer live · ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE · Serial 77771062
Filed
Jun 30, 2009
Classes
IC 009
Attorney
Gabrielle A. Holley
Goods & services
(ABANDONED) IC 009: Scientific instruments, namely nucleic acid sequencers, imaging devices, and analyzers; equipment for sample preparation, amplification, mixing, hybridization, incubation, and washing, including arrays, beads, bead sets and flow cells; automated laboratory equipment and systems, including sample loaders and barcode readers; computer systems for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data, all the foregoing for use in the fields of scientific, diagnostic and clinical research.
Owners as filed
- Illumina, Inc. (ORIGINAL APPLICANT)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:7a5f0d76a28b1e1b73b64c2e
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=77771062&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
No
Owners as filed
City
San Diego
Name
Illumina, Inc.
Role
ORIGINAL APPLICANT
Region
CALIFORNIA 92121, UNITED STATES
Entity Type
CORPORATION
As Published
Illumina, Inc. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
Attorney
Gabrielle A. Holley
Wordmark
NEXIONSQ
Filed Date
2009-06-30
Mark Types
TRADEMARK
Us Classes
021 026 038 036 023.
Registered
No
Status Code
602
Abandon Date
2010-03-04
Serial Number
77771062
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
Goods And Services
(ABANDONED) IC 009: Scientific instruments, namely nucleic acid sequencers, imaging devices, and analyzers; equipment for sample preparation, amplification, mixing, hybridization, incubation, and washing, including arrays, beads, bead sets and flow cells; automated laboratory equipment and systems, including sample loaders and barcode readers; computer systems for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data, all the foregoing for use in the fields of scientific, diagnostic and clinical research.
Queried Legal Name
ILLUMINA, INC.
International Classes
IC 009
Matching Owner Entries
Illumina, Inc. (CORPORATION; DELAWARE, USA)
NEXION no longer live · ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE · Serial 77771094
Filed
Jun 30, 2009
Classes
IC 009
Attorney
Gabrielle A. Holley
Goods & services
(ABANDONED) IC 009: Scientific instruments, namely nucleic acid sequencers, imaging devices, and analyzers; equipment for sample preparation, amplification, mixing, hybridization, incubation, and washing, including arrays, beads, bead sets and flow cells; automated laboratory equipment and systems, including sample loaders and barcode readers; computer systems for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data, all the foregoing for use in the fields of scientific, diagnostic and clinical research.
Owners as filed
- Illumina, Inc. (ORIGINAL APPLICANT)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:9ceda16505692e6577aae9a7
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=77771094&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
No
Owners as filed
City
San Diego
Name
Illumina, Inc.
Role
ORIGINAL APPLICANT
Region
CALIFORNIA 92121, UNITED STATES
Entity Type
CORPORATION
As Published
Illumina, Inc. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
Attorney
Gabrielle A. Holley
Wordmark
NEXION
Filed Date
2009-06-30
Mark Types
TRADEMARK
Us Classes
021 026 038 036 023.
Registered
No
Status Code
602
Abandon Date
2010-03-04
Serial Number
77771094
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
Goods And Services
(ABANDONED) IC 009: Scientific instruments, namely nucleic acid sequencers, imaging devices, and analyzers; equipment for sample preparation, amplification, mixing, hybridization, incubation, and washing, including arrays, beads, bead sets and flow cells; automated laboratory equipment and systems, including sample loaders and barcode readers; computer systems for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data, all the foregoing for use in the fields of scientific, diagnostic and clinical research.
Queried Legal Name
ILLUMINA, INC.
International Classes
IC 009
Matching Owner Entries
Illumina, Inc. (CORPORATION; DELAWARE, USA)
MOBION no longer live · ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE · Serial 77771111
Filed
Jun 30, 2009
Classes
IC 009
Attorney
Gabrielle A. Holley
Goods & services
(ABANDONED) IC 009: Scientific instruments, namely nucleic acid sequencers, imaging devices, and analyzers; equipment for sample preparation, amplification, mixing, hybridization, incubation, and washing, including arrays, beads, bead sets and flow cells; automated laboratory equipment and systems, including sample loaders and barcode readers; computer systems for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data, all the foregoing for use in the fields of scientific, diagnostic and clinical research.
Owners as filed
- Illumina, Inc. (ORIGINAL APPLICANT)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:17e105c6d391e0b7bbbe0059
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=77771111&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
No
Owners as filed
City
San Diego
Name
Illumina, Inc.
Role
ORIGINAL APPLICANT
Region
CALIFORNIA 92121, UNITED STATES
Entity Type
CORPORATION
As Published
Illumina, Inc. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
Attorney
Gabrielle A. Holley
Wordmark
MOBION
Filed Date
2009-06-30
Mark Types
TRADEMARK
Us Classes
021 026 038 036 023.
Registered
No
Status Code
602
Abandon Date
2010-03-04
Serial Number
77771111
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
Goods And Services
(ABANDONED) IC 009: Scientific instruments, namely nucleic acid sequencers, imaging devices, and analyzers; equipment for sample preparation, amplification, mixing, hybridization, incubation, and washing, including arrays, beads, bead sets and flow cells; automated laboratory equipment and systems, including sample loaders and barcode readers; computer systems for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data, all the foregoing for use in the fields of scientific, diagnostic and clinical research.
Queried Legal Name
ILLUMINA, INC.
International Classes
IC 009
Matching Owner Entries
Illumina, Inc. (CORPORATION; DELAWARE, USA)
GENETIC ENERGY REGISTERED AND RENEWED · Serial 77816843
Registration
4514836
Filed
Aug 31, 2009
Registered
Apr 15, 2014
Classes
IC 005
Attorney
Susan M. Natland
Goods & services
IC 005: Medical diagnostic reagents, diagnostic reagent kits comprising nucleic acids, nucleotides, enzymes, labels, and buffers, and microscopic carrier beads with attached biomolecules for medical diagnostic purposes; enzymes, oligonucleotides, nucleic acids, natural and modified nucleotides, buffers, labels, and substrates for medical diagnostic purposes.
Owners as filed
- Illumina, Inc. (ORIGINAL REGISTRANT)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:cfe88dcce944600bb2d7b57b
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=77816843&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
Yes
Owners as filed
City
San Diego
Name
Illumina, Inc.
Role
ORIGINAL REGISTRANT
Region
California 92122, UNITED STATES
Entity Type
CORPORATION
As Published
Illumina, Inc. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
REGISTERED AND RENEWED
Attorney
Susan M. Natland
Wordmark
GENETIC ENERGY
Filed Date
2009-08-31
Mark Types
TRADEMARK
Us Classes
044 051 006 052 046 018.
Registered
Yes
Status Code
800
Serial Number
77816843
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
First Use Any Date
2013-10-28
Goods And Services
IC 005: Medical diagnostic reagents, diagnostic reagent kits comprising nucleic acids, nucleotides, enzymes, labels, and buffers, and microscopic carrier beads with attached biomolecules for medical diagnostic purposes; enzymes, oligonucleotides, nucleic acids, natural and modified nucleotides, buffers, labels, and substrates for medical diagnostic purposes.
Queried Legal Name
ILLUMINA, INC.
Registration Date
2014-04-15
Registration Number
4514836
First Use Commerce Date
2013-10-28
International Classes
IC 005
Matching Owner Entries
Illumina, Inc. (CORPORATION; DELAWARE, USA)
HARNESS YOUR GENETIC ENERGY no longer live · ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE · Serial 77816858
Filed
Aug 31, 2009
Classes
IC 001, IC 005, IC 009, IC 010, IC 040, IC 042
Attorney
Gabrielle A. Holley
Goods & services
(ABANDONED) IC 001: Reagents, reagent kits, beads with attached biomolecules, buffers, and enzymes for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, genes, genomes, sequence variants and modifications, regulation, transcription, and expression, and for studying related associations in the fields of scientific, diagnostic and clinical research. (ABANDONED) IC 005: Pharmaceutical and veterinary preparations; clinical diagnostic reagents, reagent kits, and beads with attached biomolecules; enzymes, oligonucleotides, nucleic acids, natural and modified nucleotides, buffers, labels, and substrates, all the foregoing for use in clinical diagnostic analysis, genotyping, and sequencing. (ABANDONED) IC 009: Scientific instruments, namely nucleic acid sequencers, imaging devices, and analyzers; equipment for sample preparation, amplification, mixing, hybridization, incubation, and washing, including arrays, flow cells, beads, bead sets; automated laboratory equipment and systems, including sample loaders and barcode readers; computer systems and software for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data, all the foregoing for use in the fields of scientific, diagnostic and clinical research. (ABANDONED) IC 010: Clinical or medical diagnostic apparatus and instruments; arrays, beads, bead sets and flow cells; automated laboratory apparatus and systems; sample loaders and bar code readers for automated laboratory apparatus; computer systems for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data, all the foregoing for use in clinical diagnostic analysis, genotyping, and sequencing. (ABANDONED) IC 040: Custom synthesis of nucleotides, oligonucleotides, and other nucleic acids, and labeled derivatives thereof; and attachment to substrates; developing equipment for use in preparing, detecting, analyzing and sequencing nucleic acids and other biological molecules, and automated laboratory equipment and systems, and computer systems for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data to the order and specification of others, all the foregoing in the fields of scientific, diagnostic and clinical research. (ABANDONED) IC 042: Scientific and technological services and research services relating thereto; laboratory services for preparation, detection, quantitation, and analysis of biological material, for genotyping, for diagnostic assays, and for carrying out nucleic acid sequencing reactions; consultancy, information and advisory services relating to the aforesaid services; clinical diagnostic services in preparing, amplifying, labeling, detecting, analyzing and sequencing nucleic acids and other biological molecules.
Owners as filed
- Illumina, Inc. (ORIGINAL APPLICANT)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:abbe73d13bea35868c9527d6
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=77816858&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
No
Owners as filed
City
San Diego
Name
Illumina, Inc.
Role
ORIGINAL APPLICANT
Region
CALIFORNIA 92121, UNITED STATES
Entity Type
CORPORATION
As Published
Illumina, Inc. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
Attorney
Gabrielle A. Holley
Wordmark
HARNESS YOUR GENETIC ENERGY
Filed Date
2009-08-31
Mark Types
TRADEMARK, SERVICE MARK
Us Classes
001 010 026 006 046 005., 044 051 006 052 046 018., 026 038 036 021 023., 026 039 044., 106 100 103., 100 101.
Registered
No
Status Code
602
Abandon Date
2010-06-08
Serial Number
77816858
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
Goods And Services
(ABANDONED) IC 001: Reagents, reagent kits, beads with attached biomolecules, buffers, and enzymes for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, genes, genomes, sequence variants and modifications, regulation, transcription, and expression, and for studying related associations in the fields of scientific, diagnostic and clinical research., (ABANDONED) IC 005: Pharmaceutical and veterinary preparations; clinical diagnostic reagents, reagent kits, and beads with attached biomolecules; enzymes, oligonucleotides, nucleic acids, natural and modified nucleotides, buffers, labels, and substrates, all the foregoing for use in clinical diagnostic analysis, genotyping, and sequencing., (ABANDONED) IC 009: Scientific instruments, namely nucleic acid sequencers, imaging devices, and analyzers; equipment for sample preparation, amplification, mixing, hybridization, incubation, and washing, including arrays, flow cells, beads, bead sets; automated laboratory equipment and systems, including sample loaders and barcode readers; computer systems and software for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data, all the foregoing for use in the fields of scientific, diagnostic and clinical research., (ABANDONED) IC 010: Clinical or medical diagnostic apparatus and instruments; arrays, beads, bead sets and flow cells; automated laboratory apparatus and systems; sample loaders and bar code readers for automated laboratory apparatus; computer systems for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data, all the foregoing for use in clinical diagnostic analysis, genotyping, and sequencing., (ABANDONED) IC 040: Custom synthesis of nucleotides, oligonucleotides, and other nucleic acids, and labeled derivatives thereof; and attachment to substrates; developing equipment for use in preparing, detecting, analyzing and sequencing nucleic acids and other biological molecules, and automated laboratory equipment and systems, and computer systems for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data to the order and specification of others, all the foregoing in the fields of scientific, diagnostic and clinical research., (ABANDONED) IC 042: Scientific and technological services and research services relating thereto; laboratory services for preparation, detection, quantitation, and analysis of biological material, for genotyping, for diagnostic assays, and for carrying out nucleic acid sequencing reactions; consultancy, information and advisory services relating to the aforesaid services; clinical diagnostic services in preparing, amplifying, labeling, detecting, analyzing and sequencing nucleic acids and other biological molecules.
Queried Legal Name
ILLUMINA, INC.
International Classes
IC 001, IC 005, IC 009, IC 010, IC 040, IC 042
Matching Owner Entries
Illumina, Inc. (CORPORATION; DELAWARE, USA)
HISCAN no longer live · CANCELLED - SECTION 8 · Serial 77840642
Registration
4006743
Filed
Oct 2, 2009
Registered
Aug 2, 2011
Cancelled
Mar 9, 2018
Classes
IC 009
Attorney
Julia Anne Matheson
Goods & services
(CANCELLED) IC 009: [ Scientific instruments, namely, nucleic acid sequencers, imaging devices, namely, electronic imaging apparatus for detecting images and optical signals, and for processing images and optical signals into data, for use in genotyping and sequencing; equipment for sample preparation, amplification, mixing, hybridization, incubation, and washing, namely, sample containers, reagent holders, and pipettes, carrying multiple reagents, chemically modified microscopic beads, sets of chemically modified microscopic beads and sample containers and hollow chambers having chemically modified surfaces; automated laboratory equipment and systems, namely, robotic equipment in the nature of a mechanical arm for positioning and moving containers for samples or adding reagents thereto, and barcode readers; computer systems comprised of computer hardware, computer operating systems, computer software, data files, modems and computer peripheral devices for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data, all the foregoing for use in the fields of scientific, diagnostic and clinical research ].
Owners as filed
- Illumina, Inc. (ORIGINAL REGISTRANT)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:773672934a264f411ba8956b
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=77840642&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
No
Owners as filed
City
San Diego
Name
Illumina, Inc.
Role
ORIGINAL REGISTRANT
Region
CALIFORNIA 92122, UNITED STATES
Entity Type
CORPORATION
As Published
Illumina, Inc. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
CANCELLED - SECTION 8
Attorney
Julia Anne Matheson
Wordmark
HISCAN
Filed Date
2009-10-02
Mark Types
TRADEMARK
Us Classes
021 026 038 036 023.
Cancel Date
2018-03-09
Registered
No
Status Code
710
Serial Number
77840642
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
First Use Any Date
2010-06-30
Goods And Services
(CANCELLED) IC 009: [ Scientific instruments, namely, nucleic acid sequencers, imaging devices, namely, electronic imaging apparatus for detecting images and optical signals, and for processing images and optical signals into data, for use in genotyping and sequencing; equipment for sample preparation, amplification, mixing, hybridization, incubation, and washing, namely, sample containers, reagent holders, and pipettes, carrying multiple reagents, chemically modified microscopic beads, sets of chemically modified microscopic beads and sample containers and hollow chambers having chemically modified surfaces; automated laboratory equipment and systems, namely, robotic equipment in the nature of a mechanical arm for positioning and moving containers for samples or adding reagents thereto, and barcode readers; computer systems comprised of computer hardware, computer operating systems, computer software, data files, modems and computer peripheral devices for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data, all the foregoing for use in the fields of scientific, diagnostic and clinical research ].
Queried Legal Name
ILLUMINA, INC.
Registration Date
2011-08-02
Registration Number
4006743
First Use Commerce Date
2010-06-30
International Classes
IC 009
Matching Owner Entries
Illumina, Inc. (CORPORATION; DELAWARE, USA)
MISEQ REGISTERED AND RENEWED · Serial 77840648
Registration
4042598
Filed
Oct 2, 2009
Registered
Oct 18, 2011
Classes
IC 009
Attorney
Susan M. Natland
Goods & services
IC 009: Scientific instruments, namely, nucleic acid sequencers, imaging devices, namely, electronic imaging apparatus for detecting images and optical signals, and for processing images and optical signals into data, for use in genotyping and sequencing; equipment for sample preparation, amplification, mixing, hybridization, incubation, and washing, namely, sample containers, and reagent holders, carrying multiple reagents, and sample containers and hollow chambers having chemically modified surfaces; automated laboratory equipment and systems, namely, robotic equipment in the nature of a mechanical arm for positioning and moving containers for samples or adding reagents thereto, and barcode readers; computer systems comprised of computer hardware, computer operating systems, computer software, data files, modems and computer peripheral devices for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data, all the foregoing for use in the fields of scientific and clinical research.
Owners as filed
- Illumina, Inc. (ORIGINAL REGISTRANT)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:2f3f7afa06c794ba7a5822b6
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=77840648&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
Yes
Owners as filed
City
San Diego
Name
Illumina, Inc.
Role
ORIGINAL REGISTRANT
Region
California 92122, UNITED STATES
Entity Type
CORPORATION
As Published
Illumina, Inc. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
REGISTERED AND RENEWED
Attorney
Susan M. Natland
Wordmark
MISEQ
Filed Date
2009-10-02
Mark Types
TRADEMARK
Us Classes
021 026 038 036 023.
Registered
Yes
Status Code
800
Serial Number
77840648
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
First Use Any Date
2011-07-26
Goods And Services
IC 009: Scientific instruments, namely, nucleic acid sequencers, imaging devices, namely, electronic imaging apparatus for detecting images and optical signals, and for processing images and optical signals into data, for use in genotyping and sequencing; equipment for sample preparation, amplification, mixing, hybridization, incubation, and washing, namely, sample containers, and reagent holders, carrying multiple reagents, and sample containers and hollow chambers having chemically modified surfaces; automated laboratory equipment and systems, namely, robotic equipment in the nature of a mechanical arm for positioning and moving containers for samples or adding reagents thereto, and barcode readers; computer systems comprised of computer hardware, computer operating systems, computer software, data files, modems and computer peripheral devices for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data, all the foregoing for use in the fields of scientific and clinical research.
Queried Legal Name
ILLUMINA, INC.
Registration Date
2011-10-18
Registration Number
4042598
First Use Commerce Date
2011-07-26
International Classes
IC 009
Matching Owner Entries
Illumina, Inc. (CORPORATION; DELAWARE, USA)
HISEQ REGISTERED AND RENEWED · Serial 77840659
Registration
4009953
Filed
Oct 2, 2009
Registered
Aug 9, 2011
Classes
IC 009
Attorney
Susan M. Natland
Goods & services
IC 009: [ Scientific instruments, namely, nucleic acid sequencers, imaging devices, namely, electronic imaging apparatus for detecting images and optical signals, and for processing images and optical signals into data, for use in genotyping and sequencing; ] equipment for sample preparation, amplification, mixing, hybridization, incubation, and washing, namely, sample containers, reagent holders, and pipettes, carrying multiple reagents, and sample containers and hollow chambers having chemically modified surfaces; automated laboratory equipment and systems, namely, robotic equipment in the nature of a mechanical arm for positioning and moving containers for samples or adding reagents thereto, [ and barcode readers; ] computer systems comprised of [ computer hardware, computer operating systems, ] computer software, data files, [ modems and computer peripheral devices ] for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data, all the foregoing for use in the fields of scientific, diagnostic and clinical research.
Owners as filed
- Illumina, Inc. (ORIGINAL REGISTRANT)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:59991ac79841d84417c82100
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=77840659&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
Yes
Owners as filed
City
San Diego
Name
Illumina, Inc.
Role
ORIGINAL REGISTRANT
Region
California 92122, UNITED STATES
Entity Type
CORPORATION
As Published
Illumina, Inc. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
REGISTERED AND RENEWED
Attorney
Susan M. Natland
Wordmark
HISEQ
Filed Date
2009-10-02
Mark Types
TRADEMARK
Us Classes
021 026 038 036 023.
Registered
Yes
Status Code
800
Serial Number
77840659
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
First Use Any Date
2010-03-03
Goods And Services
IC 009: [ Scientific instruments, namely, nucleic acid sequencers, imaging devices, namely, electronic imaging apparatus for detecting images and optical signals, and for processing images and optical signals into data, for use in genotyping and sequencing; ] equipment for sample preparation, amplification, mixing, hybridization, incubation, and washing, namely, sample containers, reagent holders, and pipettes, carrying multiple reagents, and sample containers and hollow chambers having chemically modified surfaces; automated laboratory equipment and systems, namely, robotic equipment in the nature of a mechanical arm for positioning and moving containers for samples or adding reagents thereto, [ and barcode readers; ] computer systems comprised of [ computer hardware, computer operating systems, ] computer software, data files, [ modems and computer peripheral devices ] for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data, all the foregoing for use in the fields of scientific, diagnostic and clinical research.
Queried Legal Name
ILLUMINA, INC.
Registration Date
2011-08-09
Registration Number
4009953
First Use Commerce Date
2010-03-03
International Classes
IC 009
Matching Owner Entries
Illumina, Inc. (CORPORATION; DELAWARE, USA)
CISCAN no longer live · ABANDONED - EXPRESS AFTER PUB · Serial 77840668
Filed
Oct 2, 2009
Classes
IC 009
Attorney
Gabrielle A. Holley
Goods & services
(ABANDONED) IC 009: [ Scientific instruments, namely, nucleic acid sequencers, imaging devices, namely, electronic imaging apparatus for detecting images and optical signals, and for processing images and optical signals into data, for use in genotyping and sequencing; equipment for sample preparation, amplification, mixing, hybridization, incubation, and washing, namely, sample containers, reagent holders, and pipettes, carrying multiple reagents, chemically modified microscopic beads, sets of chemically modified microscopic beads and sample containers and hollow chambers having chemically modified surfaces; automated laboratory equipment and systems, namely, robotic equipment in the nature of a mechanical arm for positioning and moving containers for samples or adding reagents thereto, and barcode readers; computer systems comprised of computer hardware, computer operating systems, computer software, data files, modems and computer peripheral devices for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data, all the foregoing for use in the fields of scientific, diagnostic and clinical research ].
Owners as filed
- Illumina, Inc. (OWNER AT PUBLICATION)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:ecf7b3f1fe5178123ba70f76
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=77840668&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
No
Owners as filed
City
San Diego
Name
Illumina, Inc.
Role
OWNER AT PUBLICATION
Region
CALIFORNIA 92121, UNITED STATES
Entity Type
CORPORATION
As Published
Illumina, Inc. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
ABANDONED - EXPRESS AFTER PUB
Attorney
Gabrielle A. Holley
Wordmark
CISCAN
Filed Date
2009-10-02
Mark Types
TRADEMARK
Us Classes
021 026 038 036 023.
Registered
No
Status Code
605
Abandon Date
2011-03-25
Serial Number
77840668
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
Goods And Services
(ABANDONED) IC 009: [ Scientific instruments, namely, nucleic acid sequencers, imaging devices, namely, electronic imaging apparatus for detecting images and optical signals, and for processing images and optical signals into data, for use in genotyping and sequencing; equipment for sample preparation, amplification, mixing, hybridization, incubation, and washing, namely, sample containers, reagent holders, and pipettes, carrying multiple reagents, chemically modified microscopic beads, sets of chemically modified microscopic beads and sample containers and hollow chambers having chemically modified surfaces; automated laboratory equipment and systems, namely, robotic equipment in the nature of a mechanical arm for positioning and moving containers for samples or adding reagents thereto, and barcode readers; computer systems comprised of computer hardware, computer operating systems, computer software, data files, modems and computer peripheral devices for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data, all the foregoing for use in the fields of scientific, diagnostic and clinical research ].
Queried Legal Name
ILLUMINA, INC.
International Classes
IC 009
Matching Owner Entries
Illumina, Inc. (CORPORATION; DELAWARE, USA)
ILLUMINADX no longer live · CANCELLED - SECTION 8 · Serial 77982582
Registration
4053668
Filed
May 28, 2009
Registered
Nov 8, 2011
Cancelled
Jun 15, 2018
Classes
IC 005
Attorney
Julia Anne Matheson
Goods & services
(CANCELLED) IC 005: [ Clinical diagnostic reagents, reagent kits, and beads with attached biomolecules, comprised primarily of oligonucleotides and other nucleic acids, natural and modified nucleotides, buffers, labels, and substrates, for clinical diagnostic purposes ].
Owners as filed
- Illumina, Inc. (ORIGINAL REGISTRANT)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:d42114eb86ca2e548e6e9812
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=77982582&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
No
Owners as filed
City
San Diego
Name
Illumina, Inc.
Role
ORIGINAL REGISTRANT
Region
CALIFORNIA 92122, UNITED STATES
Entity Type
CORPORATION
As Published
Illumina, Inc. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
CANCELLED - SECTION 8
Attorney
Julia Anne Matheson
Wordmark
ILLUMINADX
Filed Date
2009-05-28
Mark Types
TRADEMARK
Us Classes
006 018 046 052 044 051.
Cancel Date
2018-06-15
Registered
No
Status Code
710
Serial Number
77982582
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
First Use Any Date
2010-03-19
Goods And Services
(CANCELLED) IC 005: [ Clinical diagnostic reagents, reagent kits, and beads with attached biomolecules, comprised primarily of oligonucleotides and other nucleic acids, natural and modified nucleotides, buffers, labels, and substrates, for clinical diagnostic purposes ].
Queried Legal Name
ILLUMINA, INC.
Registration Date
2011-11-08
Registration Number
4053668
First Use Commerce Date
2010-03-19
International Classes
IC 005
Matching Owner Entries
Illumina, Inc. (CORPORATION; DELAWARE, USA)
GENETIC ENERGY REGISTERED AND RENEWED · Serial 77983028
Registration
4139586
Filed
Aug 31, 2009
Registered
May 8, 2012
Classes
IC 001, IC 040, IC 042
Attorney
Susan M. Natland
Goods & services
IC 001: Reagents for research purposes, reagent kits comprising nucleic acids, nucleotides, enzymes, labels, and buffers, microscopic carrier beads with attached biomolecules, buffers, and enzymes, for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, genes, genomes, sequence variants and modifications, regulation, transcription, and expression, and for studying related associations in the fields of scientific, diagnostic and clinical research. IC 040: Custom synthesis services, namely, custom synthesis of nucleotides, oligonucleotides, and other nucleic acids, and labeled derivatives thereof; and custom nucleotide attachment to substrates. IC 042: Product development, namely, developing equipment for use in preparing, detecting, analyzing and sequencing nucleic acids and other biological molecules, and automated laboratory equipment and systems, and computer systems for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data to the order and specification of others, all the foregoing in the fields of scientific, diagnostic and clinical research; Scientific and technological services and research services in the fields of genetics, epigenetics and expression analysis; laboratory services for preparation, detection, quantitation, and analysis of biological material, for genotyping, for diagnostic assays, and for carrying out nucleic acid sequencing reactions; consultancy, information and advisory services relating to the aforesaid services; clinical diagnostic services in preparing, amplifying, labeling, detecting, analyzing and sequencing nucleic acids and other biological molecules.
Owners as filed
- Illumina, Inc. (ORIGINAL REGISTRANT)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:4ee749ad21cc3348ce4f7d50
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=77983028&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
Yes
Owners as filed
City
San Diego
Name
Illumina, Inc.
Role
ORIGINAL REGISTRANT
Region
California 92122, UNITED STATES
Entity Type
CORPORATION
As Published
Illumina, Inc. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
REGISTERED AND RENEWED
Attorney
Susan M. Natland
Wordmark
GENETIC ENERGY
Filed Date
2009-08-31
Mark Types
TRADEMARK, SERVICE MARK
Us Classes
001 010 006 005 026 046., 100 103 106., 100 101.
Registered
Yes
Status Code
800
Serial Number
77983028
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
First Use Any Date
2009-10-24
Goods And Services
IC 001: Reagents for research purposes, reagent kits comprising nucleic acids, nucleotides, enzymes, labels, and buffers, microscopic carrier beads with attached biomolecules, buffers, and enzymes, for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, genes, genomes, sequence variants and modifications, regulation, transcription, and expression, and for studying related associations in the fields of scientific, diagnostic and clinical research., IC 040: Custom synthesis services, namely, custom synthesis of nucleotides, oligonucleotides, and other nucleic acids, and labeled derivatives thereof; and custom nucleotide attachment to substrates., IC 042: Product development, namely, developing equipment for use in preparing, detecting, analyzing and sequencing nucleic acids and other biological molecules, and automated laboratory equipment and systems, and computer systems for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data to the order and specification of others, all the foregoing in the fields of scientific, diagnostic and clinical research; Scientific and technological services and research services in the fields of genetics, epigenetics and expression analysis; laboratory services for preparation, detection, quantitation, and analysis of biological material, for genotyping, for diagnostic assays, and for carrying out nucleic acid sequencing reactions; consultancy, information and advisory services relating to the aforesaid services; clinical diagnostic services in preparing, amplifying, labeling, detecting, analyzing and sequencing nucleic acids and other biological molecules.
Queried Legal Name
ILLUMINA, INC.
Registration Date
2012-05-08
Registration Number
4139586
First Use Commerce Date
2009-10-24
International Classes
IC 001, IC 040, IC 042
Matching Owner Entries
Illumina, Inc. (CORPORATION; DELAWARE, USA)
GENETIC ENERGY REGISTERED AND RENEWED · Serial 77983265
Registration
4183697
Filed
Aug 31, 2009
Registered
Jul 31, 2012
Classes
IC 009
Attorney
Susan M. Natland
Goods & services
IC 009: Scientific instruments, namely, nucleic acid sequencers, imaging devices, namely, electronic imaging apparatus for detecting images and optical signals, and for processing images and optical signals into data, for use in genotyping and sequencing for research purposes; equipment for sample preparation, amplification, mixing, hybridization, incubation, and washing, namely, microscopic carrier beads with chemically attached DNA fragments, sets of microscopic carrier beads with chemically attached DNA fragments, and biological sample containers in the form of microscope slides with internal channels and chips having multi-well arrays with chemically attached DNA fragments; automated laboratory equipment and systems, namely, devices for positioning and moving containers for samples or adding reagents thereto in the nature of robotic arms and movable sample containers for laboratory use and barcode readers; computer systems comprised of computer hardware, computer operating systems, computer software, data files, modems and peripheral devices for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data, all the foregoing for use in the fields of scientific, diagnostic and clinical research, clinical diagnostic analysis, genotyping and sequencing.
Owners as filed
- Illumina, Inc. (ORIGINAL REGISTRANT)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:224a3a055ccdb942e4cfa85d
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=77983265&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
Yes
Owners as filed
City
San Diego
Name
Illumina, Inc.
Role
ORIGINAL REGISTRANT
Region
California 92122, UNITED STATES
Entity Type
CORPORATION
As Published
Illumina, Inc. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
REGISTERED AND RENEWED
Attorney
Susan M. Natland
Wordmark
GENETIC ENERGY
Filed Date
2009-08-31
Mark Types
TRADEMARK
Us Classes
021 026 038 036 023.
Registered
Yes
Status Code
800
Serial Number
77983265
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
First Use Any Date
2010-11-22
Goods And Services
IC 009: Scientific instruments, namely, nucleic acid sequencers, imaging devices, namely, electronic imaging apparatus for detecting images and optical signals, and for processing images and optical signals into data, for use in genotyping and sequencing for research purposes; equipment for sample preparation, amplification, mixing, hybridization, incubation, and washing, namely, microscopic carrier beads with chemically attached DNA fragments, sets of microscopic carrier beads with chemically attached DNA fragments, and biological sample containers in the form of microscope slides with internal channels and chips having multi-well arrays with chemically attached DNA fragments; automated laboratory equipment and systems, namely, devices for positioning and moving containers for samples or adding reagents thereto in the nature of robotic arms and movable sample containers for laboratory use and barcode readers; computer systems comprised of computer hardware, computer operating systems, computer software, data files, modems and peripheral devices for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data, all the foregoing for use in the fields of scientific, diagnostic and clinical research, clinical diagnostic analysis, genotyping and sequencing.
Queried Legal Name
ILLUMINA, INC.
Registration Date
2012-07-31
Registration Number
4183697
First Use Commerce Date
2010-11-22
International Classes
IC 009
Matching Owner Entries
Illumina, Inc. (CORPORATION; DELAWARE, USA)
MAKING SENSE OUT OF LIFE no longer live · CANCELLED - SECTION 8 · Serial 78063483
Registration
2525301
Filed
May 14, 2001
Registered
Jan 1, 2002
Cancelled
Aug 3, 2012
Classes
IC 042
Attorney
Gabrielle A. Holley
Goods & services
(CANCELLED) IC 042: [ Genomic and proteomic analytical services. ].
Owners as filed
- Illumina, Inc. (ORIGINAL REGISTRANT)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:15a0dea55bdf28b08951ebd6
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=78063483&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
No
Owners as filed
City
San Diego
Name
Illumina, Inc.
Role
ORIGINAL REGISTRANT
Region
CALIFORNIA 92121, UNITED STATES
Entity Type
CORPORATION
As Published
Illumina, Inc. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
CANCELLED - SECTION 8
Attorney
Gabrielle A. Holley
Wordmark
MAKING SENSE OUT OF LIFE
Filed Date
2001-05-14
Mark Types
SERVICE MARK
Us Classes
100 101.
Cancel Date
2012-08-03
Registered
No
Status Code
710
Serial Number
78063483
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
First Use Any Date
2001-05-03
Goods And Services
(CANCELLED) IC 042: [ Genomic and proteomic analytical services. ].
Queried Legal Name
ILLUMINA, INC.
Registration Date
2002-01-01
Registration Number
2525301
First Use Commerce Date
2001-05-03
International Classes
IC 042
Matching Owner Entries
Illumina, Inc. (CORPORATION; DELAWARE, USA)
MOSAIC no longer live · ABANDONED - EXPRESS · Serial 78069682
Filed
Jun 18, 2001
Classes
IC 001, IC 009
Attorney
F.T. Alexandra Mahaney
Goods & services
(ABANDONED) IC 001: Nucleic acid and chemical reagents used with randomly assembled arrays of microspheres on solid substrates for detecting nucleic acids, proteins or molecules for chemical, scientific and medical research purposes. (ABANDONED) IC 009: Randomly assembled arrays of microspheres on solid substrates used as sensors for detecting nucleic acids, proteins or molecules for chemical, scientific and medical research purposes.
Owners as filed
- Illumina, Inc. (ORIGINAL APPLICANT)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:bc64bf1c7e964e95ffe47537
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=78069682&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
No
Owners as filed
City
San Diego
Name
Illumina, Inc.
Role
ORIGINAL APPLICANT
Region
CALIFORNIA 92121, UNITED STATES
Entity Type
CORPORATION
As Published
Illumina, Inc. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
ABANDONED - EXPRESS
Attorney
F.T. Alexandra Mahaney
Wordmark
MOSAIC
Filed Date
2001-06-18
Mark Types
TRADEMARK
Us Classes
001 010 005 006 026 046., 021 026 038 036 023.
Registered
No
Status Code
601
Abandon Date
2001-11-16
Serial Number
78069682
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
Goods And Services
(ABANDONED) IC 001: Nucleic acid and chemical reagents used with randomly assembled arrays of microspheres on solid substrates for detecting nucleic acids, proteins or molecules for chemical, scientific and medical research purposes., (ABANDONED) IC 009: Randomly assembled arrays of microspheres on solid substrates used as sensors for detecting nucleic acids, proteins or molecules for chemical, scientific and medical research purposes.
Queried Legal Name
ILLUMINA, INC.
International Classes
IC 001, IC 009
Matching Owner Entries
Illumina, Inc. (CORPORATION; DELAWARE, USA)
GENCALL no longer live · ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE · Serial 78084780
Filed
Sep 20, 2001
Classes
IC 009, IC 042
Attorney
F.T. Alexandra Mahaney
Goods & services
(ABANDONED) IC 009: Software used in the analysis of genetic information.. (ABANDONED) IC 042: Genetic analysis services..
Owners as filed
- Illumina, Inc. (ORIGINAL APPLICANT)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:678f90d5792d8a62e9fab9ce
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=78084780&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
No
Owners as filed
City
San Diego
Name
Illumina, Inc.
Role
ORIGINAL APPLICANT
Region
CALIFORNIA 92121, UNITED STATES
Entity Type
CORPORATION
As Published
Illumina, Inc. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
Attorney
F.T. Alexandra Mahaney
Wordmark
GENCALL
Filed Date
2001-09-20
Mark Types
TRADEMARK, SERVICE MARK
Us Classes
038 026 021 036 023., 100 101.
Registered
No
Status Code
602
Abandon Date
2002-06-04
Serial Number
78084780
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
Goods And Services
(ABANDONED) IC 009: Software used in the analysis of genetic information.., (ABANDONED) IC 042: Genetic analysis services..
Queried Legal Name
ILLUMINA, INC.
International Classes
IC 009, IC 042
Matching Owner Entries
Illumina, Inc. (CORPORATION; DELAWARE, USA)
GENTRAIN no longer live · ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE · Serial 78084781
Filed
Sep 20, 2001
Classes
IC 009, IC 042
Attorney
F.T. Alexandra Mahaney
Goods & services
(ABANDONED) IC 009: Software used in the analysis of genetic information. (ABANDONED) IC 042: Genetic analysis services.
Owners as filed
- Illumina, Inc. (OWNER AT PUBLICATION)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:b72bc5e5845a3fcd8d9f9636
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=78084781&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
No
Owners as filed
City
San Diego
Name
Illumina, Inc.
Role
OWNER AT PUBLICATION
Region
CALIFORNIA 92121, UNITED STATES
Entity Type
CORPORATION
As Published
Illumina, Inc. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
Attorney
F.T. Alexandra Mahaney
Wordmark
GENTRAIN
Filed Date
2001-09-20
Mark Types
TRADEMARK, SERVICE MARK
Us Classes
038 026 021 036 023., 100 101.
Registered
No
Status Code
602
Abandon Date
2003-11-16
Serial Number
78084781
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
First Use Any Date
2003-01-09
Goods And Services
(ABANDONED) IC 009: Software used in the analysis of genetic information., (ABANDONED) IC 042: Genetic analysis services.
Queried Legal Name
ILLUMINA, INC.
First Use Commerce Date
2003-01-09
International Classes
IC 009, IC 042
Matching Owner Entries
Illumina, Inc. (CORPORATION; DELAWARE, USA)
POSITRAK no longer live · ABANDONED - NO STATEMENT OF USE FILED · Serial 78084810
Filed
Sep 20, 2001
Classes
IC 009, IC 042
Attorney
F.T. Alexandra Mahaney
Goods & services
(ABANDONED) IC 009: Software and hardware used for automated laboratory handling of genetic material used in genetic assays. (ABANDONED) IC 042: Automated laboratory handling of genetic material used in genetic assays.
Owners as filed
- Illumina, Inc. (OWNER AT PUBLICATION)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:12d0a032959de19dd623bafa
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=78084810&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
No
Owners as filed
City
San Diego
Name
Illumina, Inc.
Role
OWNER AT PUBLICATION
Region
CALIFORNIA 92121, UNITED STATES
Entity Type
CORPORATION
As Published
Illumina, Inc. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
ABANDONED - NO STATEMENT OF USE FILED
Attorney
F.T. Alexandra Mahaney
Wordmark
POSITRAK
Filed Date
2001-09-20
Mark Types
TRADEMARK, SERVICE MARK
Us Classes
038 026 021 036 023., 100 101.
Registered
No
Status Code
606
Abandon Date
2003-07-17
Serial Number
78084810
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
Goods And Services
(ABANDONED) IC 009: Software and hardware used for automated laboratory handling of genetic material used in genetic assays., (ABANDONED) IC 042: Automated laboratory handling of genetic material used in genetic assays.
Queried Legal Name
ILLUMINA, INC.
International Classes
IC 009, IC 042
Matching Owner Entries
Illumina, Inc. (CORPORATION; DELAWARE, USA)
SENTRIX no longer live · CANCELLED - SECTION 8 · Serial 78091095
Registration
2776837
Filed
Oct 31, 2001
Registered
Oct 21, 2003
Cancelled
May 29, 2010
Classes
IC 009
Attorney
Gabrielle A. Holley
Goods & services
(CANCELLED) IC 009: [ Array cassettes, associated decoding files and associated reagents used as sensors for detecting nucleic acids, proteins or molecules for chemical, scientific and medical research purposes; software and array scanning instrumentation and related hardware for the analysis of such arrays ].
Owners as filed
- ILLUMINA, INC. (ORIGINAL REGISTRANT)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:74a23c2411baa1c9c8330209
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=78091095&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
No
Owners as filed
City
San Diego
Name
ILLUMINA, INC.
Role
ORIGINAL REGISTRANT
Region
CALIFORNIA 92121, UNITED STATES
Entity Type
CORPORATION
As Published
ILLUMINA, INC. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
CANCELLED - SECTION 8
Attorney
Gabrielle A. Holley
Wordmark
SENTRIX
Filed Date
2001-10-31
Mark Types
TRADEMARK
Us Classes
026 038 036 021 023.
Cancel Date
2010-05-29
Registered
No
Status Code
710
Serial Number
78091095
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
First Use Any Date
2002-09-30
Goods And Services
(CANCELLED) IC 009: [ Array cassettes, associated decoding files and associated reagents used as sensors for detecting nucleic acids, proteins or molecules for chemical, scientific and medical research purposes; software and array scanning instrumentation and related hardware for the analysis of such arrays ].
Queried Legal Name
ILLUMINA, INC.
Registration Date
2003-10-21
Registration Number
2776837
First Use Commerce Date
2002-10-31
International Classes
IC 009
Matching Owner Entries
ILLUMINA, INC. (CORPORATION; DELAWARE, USA)
SHERLOCK no longer live · ABANDONED - NO STATEMENT OF USE FILED · Serial 78109809
Filed
Feb 19, 2002
Classes
IC 009
Attorney
F.T. Alexandra Mahaney, Esq.
Goods & services
(ABANDONED) IC 009: Visual analysis instrument system, comprised of optical scanner, computer hardware and software, for use in the scanning and analysis of microarrays of nucleic acids and proteins, in the life sciences industry, and instruction and user manuals sold therewith.
Owners as filed
- Illumina, Inc. (OWNER AT PUBLICATION)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:ebec652ee8d3e104e46352e4
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=78109809&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
No
Owners as filed
City
San Diego
Name
Illumina, Inc.
Role
OWNER AT PUBLICATION
Region
CALIFORNIA 92121, UNITED STATES
Entity Type
CORPORATION
As Published
Illumina, Inc. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
ABANDONED - NO STATEMENT OF USE FILED
Attorney
F.T. Alexandra Mahaney, Esq.
Wordmark
SHERLOCK
Filed Date
2002-02-19
Mark Types
TRADEMARK
Us Classes
021 026 038 036 023.
Registered
No
Status Code
606
Abandon Date
2004-01-23
Serial Number
78109809
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
Goods And Services
(ABANDONED) IC 009: Visual analysis instrument system, comprised of optical scanner, computer hardware and software, for use in the scanning and analysis of microarrays of nucleic acids and proteins, in the life sciences industry, and instruction and user manuals sold therewith.
Queried Legal Name
ILLUMINA, INC.
International Classes
IC 009
Matching Owner Entries
Illumina, Inc. (CORPORATION; DELAWARE, USA)
ILLUMICODE no longer live · ABANDONED - NO STATEMENT OF USE FILED · Serial 78148066
Filed
Jul 26, 2002
Classes
IC 001
Attorney
F.T. Alexandra Mahaney
Goods & services
(ABANDONED) IC 001: DNA microarrays and reagent kits comprising chemicals and oligonucleotides used for nucleic acid and protein analysis.
Owners as filed
- Illumina, Inc. (OWNER AT PUBLICATION)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:5662ec78398b0ff039558def
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=78148066&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
No
Owners as filed
City
San Diego
Name
Illumina, Inc.
Role
OWNER AT PUBLICATION
Region
CALIFORNIA 921211975, UNITED STATES
Entity Type
CORPORATION
As Published
Illumina, Inc. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
ABANDONED - NO STATEMENT OF USE FILED
Attorney
F.T. Alexandra Mahaney
Wordmark
ILLUMICODE
Filed Date
2002-07-26
Mark Types
TRADEMARK
Us Classes
001 010 006 005 026 046.
Registered
No
Status Code
606
Abandon Date
2003-11-14
Serial Number
78148066
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
Goods And Services
(ABANDONED) IC 001: DNA microarrays and reagent kits comprising chemicals and oligonucleotides used for nucleic acid and protein analysis.
Queried Legal Name
ILLUMINA, INC.
International Classes
IC 001
Matching Owner Entries
Illumina, Inc. (CORPORATION; DELAWARE, USA)
GOLDEN GATE REGISTERED AND RENEWED · Serial 78149769
Registration
2898069
Filed
Aug 1, 2002
Registered
Oct 26, 2004
Classes
IC 001, IC 042
Attorney
Julia Anne Matheson
Goods & services
IC 001: Reagent kits composed primarily of oligonucleotides, enzymes and buffers for nucleic acid detection in the fields of scientific, pharmaceutical and medical research. IC 042: Nucleic acid analysis services in the field of scientific, pharmaceutical and medical research.
Owners as filed
- Illumina, Inc. (ORIGINAL REGISTRANT)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:012a814218c8eeb7f6c5ad4c
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=78149769&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
Yes
Owners as filed
City
San Diego
Name
Illumina, Inc.
Role
ORIGINAL REGISTRANT
Region
California 92122, UNITED STATES
Entity Type
CORPORATION
As Published
Illumina, Inc. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
REGISTERED AND RENEWED
Attorney
Julia Anne Matheson
Wordmark
GOLDEN GATE
Filed Date
2002-08-01
Mark Types
TRADEMARK, SERVICE MARK
Us Classes
001 010 005 006 026 046., 100 101.
Registered
Yes
Status Code
800
Serial Number
78149769
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
First Use Any Date
2002-08-31
Goods And Services
IC 001: Reagent kits composed primarily of oligonucleotides, enzymes and buffers for nucleic acid detection in the fields of scientific, pharmaceutical and medical research., IC 042: Nucleic acid analysis services in the field of scientific, pharmaceutical and medical research.
Queried Legal Name
ILLUMINA, INC.
Registration Date
2004-10-26
Registration Number
2898069
First Use Commerce Date
2002-08-31
International Classes
IC 001, IC 042
Matching Owner Entries
Illumina, Inc. (CORPORATION; DELAWARE, USA)
RASL no longer live · ABANDONED - NO STATEMENT OF USE FILED · Serial 78163060
Filed
Sep 11, 2002
Classes
IC 001, IC 042
Attorney
GABRIELLE A. HOLLEY
Goods & services
(ABANDONED) IC 001: Reagent kits composed primarily of enzymes, oligonucleotides, and buffers used for nucleic acid detection in the field of scientific, pharmaceutical and medical research. (ABANDONED) IC 042: Nucleic acid analysis services in the field of scientific, pharmaceutical and medical research..
Owners as filed
- Illumina, Inc. (OWNER AT PUBLICATION)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:28f65853d9533203e13ce962
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=78163060&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
No
Owners as filed
City
San Diego
Name
Illumina, Inc.
Role
OWNER AT PUBLICATION
Region
CALIFORNIA 921211975, UNITED STATES
Entity Type
CORPORATION
As Published
Illumina, Inc. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
ABANDONED - NO STATEMENT OF USE FILED
Attorney
GABRIELLE A. HOLLEY
Wordmark
RASL
Filed Date
2002-09-11
Mark Types
TRADEMARK, SERVICE MARK
Us Classes
001 010 005 006 026 046., 100 101.
Registered
No
Status Code
606
Abandon Date
2005-12-24
Serial Number
78163060
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
Goods And Services
(ABANDONED) IC 001: Reagent kits composed primarily of enzymes, oligonucleotides, and buffers used for nucleic acid detection in the field of scientific, pharmaceutical and medical research., (ABANDONED) IC 042: Nucleic acid analysis services in the field of scientific, pharmaceutical and medical research..
Queried Legal Name
ILLUMINA, INC.
International Classes
IC 001, IC 042
Matching Owner Entries
Illumina, Inc. (CORPORATION; DELAWARE, USA)
DASL no longer live · CANCELLED - SECTION 8 · Serial 78163065
Registration
3030006
Filed
Sep 11, 2002
Registered
Dec 13, 2005
Cancelled
Jul 20, 2012
Classes
IC 042
Attorney
GABRIELLE A. HOLLEY
Goods & services
(CANCELLED) IC 042: [ Nucleic acid analysis services in the field of scientific, pharmaceutical and medical research ].
Owners as filed
- Illumina, Inc. (ORIGINAL REGISTRANT)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:26cfa2784dc1dc59ec453e65
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=78163065&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
No
Owners as filed
City
San Diego
Name
Illumina, Inc.
Role
ORIGINAL REGISTRANT
Region
CALIFORNIA 921211975, UNITED STATES
Entity Type
CORPORATION
As Published
Illumina, Inc. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
CANCELLED - SECTION 8
Attorney
GABRIELLE A. HOLLEY
Wordmark
DASL
Filed Date
2002-09-11
Mark Types
SERVICE MARK
Us Classes
100 101.
Cancel Date
2012-07-20
Registered
No
Status Code
710
Serial Number
78163065
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
First Use Any Date
2005-02-02
Goods And Services
(CANCELLED) IC 042: [ Nucleic acid analysis services in the field of scientific, pharmaceutical and medical research ].
Queried Legal Name
ILLUMINA, INC.
Registration Date
2005-12-13
Registration Number
3030006
First Use Commerce Date
2005-02-02
International Classes
IC 042
Matching Owner Entries
Illumina, Inc. (CORPORATION; DELAWARE, USA)
AUTOGENOPIPE no longer live · ABANDONED - NO STATEMENT OF USE FILED · Serial 78182219
Filed
Nov 6, 2002
Classes
IC 042
Attorney
F. T. Alexandra Mahaney
Goods & services
(ABANDONED) IC 042: Genetic analysis services utilizing computer software..
Owners as filed
- ILLUMINA, INC. (OWNER AT PUBLICATION)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:ce9789ffa3eb2cbf4e16a0fa
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=78182219&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
No
Owners as filed
City
San Diego
Name
ILLUMINA, INC.
Role
OWNER AT PUBLICATION
Region
CALIFORNIA 921211975, UNITED STATES
Entity Type
CORPORATION
As Published
ILLUMINA, INC. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
ABANDONED - NO STATEMENT OF USE FILED
Attorney
F. T. Alexandra Mahaney
Wordmark
AUTOGENOPIPE
Filed Date
2002-11-06
Mark Types
SERVICE MARK
Us Classes
100 101.
Registered
No
Status Code
606
Abandon Date
2004-03-03
Serial Number
78182219
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
Goods And Services
(ABANDONED) IC 042: Genetic analysis services utilizing computer software..
Queried Legal Name
ILLUMINA, INC.
International Classes
IC 042
Matching Owner Entries
ILLUMINA, INC. (CORPORATION; DELAWARE, USA)
AUTOGENOPIPE no longer live · ABANDONED - NO STATEMENT OF USE FILED · Serial 78182225
Filed
Nov 6, 2002
Classes
IC 009
Attorney
F. T. Alexandra Mahaney
Goods & services
(ABANDONED) IC 009: Computer software for use in the analysis of genetic information..
Owners as filed
- ILLUMINA, INC. (OWNER AT PUBLICATION)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:f6afae558c67c99c7b5635f7
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=78182225&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
No
Owners as filed
City
San Diego
Name
ILLUMINA, INC.
Role
OWNER AT PUBLICATION
Region
CALIFORNIA 921211975, UNITED STATES
Entity Type
CORPORATION
As Published
ILLUMINA, INC. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
ABANDONED - NO STATEMENT OF USE FILED
Attorney
F. T. Alexandra Mahaney
Wordmark
AUTOGENOPIPE
Filed Date
2002-11-06
Mark Types
TRADEMARK
Us Classes
026 036 038 021 023.
Registered
No
Status Code
606
Abandon Date
2004-03-03
Serial Number
78182225
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
Goods And Services
(ABANDONED) IC 009: Computer software for use in the analysis of genetic information..
Queried Legal Name
ILLUMINA, INC.
International Classes
IC 009
Matching Owner Entries
ILLUMINA, INC. (CORPORATION; DELAWARE, USA)
REFSET no longer live · ABANDONED - NO STATEMENT OF USE FILED · Serial 78202920
Filed
Jan 14, 2003
Classes
IC 001
Attorney
F. T. Alexandra Mahaney
Goods & services
(ABANDONED) IC 001: Chemicals, namely oligonucleotides for research and scientific use.
Owners as filed
- ILLUMINA, INC. (OWNER AT PUBLICATION)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:3db488455acebeb103c817ce
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=78202920&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
No
Owners as filed
City
San Diego
Name
ILLUMINA, INC.
Role
OWNER AT PUBLICATION
Region
CALIFORNIA 921211975, UNITED STATES
Entity Type
CORPORATION
As Published
ILLUMINA, INC. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
ABANDONED - NO STATEMENT OF USE FILED
Attorney
F. T. Alexandra Mahaney
Wordmark
REFSET
Filed Date
2003-01-14
Mark Types
TRADEMARK
Us Classes
001 010 026 006 046 005.
Registered
No
Status Code
606
Abandon Date
2004-06-24
Serial Number
78202920
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
Goods And Services
(ABANDONED) IC 001: Chemicals, namely oligonucleotides for research and scientific use.
Queried Legal Name
ILLUMINA, INC.
International Classes
IC 001
Matching Owner Entries
ILLUMINA, INC. (CORPORATION; DELAWARE, USA)
DURASCRIPT no longer live · CANCELLED - SECTION 8 · Serial 78232259
Registration
2931776
Filed
Apr 1, 2003
Registered
Mar 8, 2005
Cancelled
Sep 19, 2025
Classes
IC 001
Attorney
Susan M. Natland
Goods & services
(CANCELLED) IC 001: [ nucleic acid comprising the pyrimidine 2'-fluoro-2'-deoxyribonucleotides 2'-F-dUMP and 2'-F-dCMP and the canonical purine ribonucleotides AMP and GMP for scientific or research use ].
Owners as filed
- Epicentre Technologies Corporation (ORIGINAL REGISTRANT)
- ILLUMINA, INC. (SUBSEQUENT OWNER AFTER REGISTRATION)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:78a7e30bd2eb53e3a4e6b132
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=78232259&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
No
Owners as filed
City
San Diego
Name
Epicentre Technologies Corporation
Role
ORIGINAL REGISTRANT
Region
WISCONSIN 92122, UNITED STATES
Entity Type
CORPORATION
As Published
Epicentre Technologies Corporation (CORPORATION; WISCONSIN, USA)
Citizenship
WISCONSIN, USA
City
SAN DIEGO
Name
ILLUMINA, INC.
Role
SUBSEQUENT OWNER AFTER REGISTRATION
Region
CALIFORNIA 92122, UNITED STATES
Entity Type
CORPORATION
As Published
ILLUMINA, INC. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
CANCELLED - SECTION 8
Attorney
Susan M. Natland
Wordmark
DURASCRIPT
Filed Date
2003-04-01
Mark Types
TRADEMARK
Us Classes
001 010 006 005 026 046.
Cancel Date
2025-09-19
Registered
No
Status Code
710
Serial Number
78232259
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
First Use Any Date
2001-10-17
Goods And Services
(CANCELLED) IC 001: [ nucleic acid comprising the pyrimidine 2'-fluoro-2'-deoxyribonucleotides 2'-F-dUMP and 2'-F-dCMP and the canonical purine ribonucleotides AMP and GMP for scientific or research use ].
Queried Legal Name
ILLUMINA, INC.
Registration Date
2005-03-08
Registration Number
2931776
First Use Commerce Date
2001-10-22
International Classes
IC 001
Matching Owner Entries
ILLUMINA, INC. (CORPORATION; DELAWARE, USA)
CYVERA no longer live · ABANDONED - NO STATEMENT OF USE FILED · Serial 78326350
Filed
Nov 11, 2003
Classes
IC 009, IC 042
Attorney
Gerald L. DePardo
Goods & services
(ABANDONED) IC 009: Scientific and industrial equipment and instruments, namely scanners; devices for monitoring optical signals and wavelengths; devices for reading and detecting optical codes; devices for performing hybridization experiments and reactions; molecular detection and analysis equipment; devices for moving fluids; equipment for detecting the presence of analytes in samples and identifying sample type; devices for reading, identifying, analyzing, monitoring, sorting, dispensing, tracking, screening, verifying, and authenticating encoded substrates, beads, particles, and microbeads in the fields of chemical, biochemical, biomedical, combinatorial chemistry, pharmaceutical, drug discovery, genomics, proteomics, identification, verification, authentication, sensing, anti-counterfeit, anti-terrorism, and security applications; equipment for reading, identifying, analyzing, monitoring, sorting, tracking, screening, verifying, and authenticating labeled items, namely, chemicals, molecules, nucleic acids, proteins, cells, liquids, solids, gases, powders, fluids, steam, slurries, organic and inorganic materials, animals, plants, people, and objects in the fields of chemical, biochemical, biomedical, combinatorial chemistry, pharmaceutical, drug discovery, genomics, proteomics, identification, verification, authentication, sensing, anti-counterfeit, anti-terrorism, and security applications; and devices for detecting optical, electromagnetic, and radioactive, emissions and absorption; encoded substrates, particles, beads, and microbeads for performing identification, authentication, screening, experiments, evaluations, and assays; and substrates, particles, beads, and microbeads having labels, tags, codes, digital codes, and bar codes associated therewith; diffraction gratings; holograms; light filters; encoded substrates, beads, particles, and microbeads for labeling, identifying, monitoring, sensing, sorting, tracking, tagging, screening, verifying, and authenticating items, namely, chemicals, molecules, nucleic acids, proteins, cells, liquids, solids, gases, powders, fluids, steam, slurries, organic and inorganic materials, animals, plants, people, currency, and objects; kits comprising substrates, particles, beads, microbeads, and encoded substrates, particles, beads, and microbeads for performing identification, authentication, screening, experiments, evaluations, and assays; holders, plates, slides, vials, cuvettes, cassettes, and containers for holding, aligning, and reading substrates, particles, beads, and microbeads, and for performing identification, screening, experiments, evaluations, and assays; reaction vessels; vessels for performing screening, experiments, evaluations, and assays; computer programs for use in reading, identifying, analyzing, monitoring, sorting, tracking, verifying, and authenticating encoded substrates, beads, particles, and microbeads; and computer programs for use in monitoring and analyzing data in the fields of chemical, biochemical, biomedical, combinatorial chemistry, pharmaceutical, drug discovery, genomics, proteomics, identification, verification, authentication, sensing, anti-counterfeit, anti-terrorism, and security applications. (ABANDONED) IC 042: design and development for others of scientific and industrial equipment and instruments, namely scanners; devices for monitoring optical signals and wavelengths; devices for reading and detecting optical codes; hybridization equipment; molecular detection and analysis equipment; fluidics equipment; equipment for detecting the presence of analytes in samples and identifying sample type; devices for reading, identifying, analyzing, monitoring, sorting, dispensing, tracking, screening, verifying, and authenticating encoded substrates, beads, particles, and microbeads; devices for reading, identifying, analyzing, monitoring, sorting, tracking, screening, verifying, and authenticating labeled items, namely, chemicals, molecules, nucleic acids, proteins, cells, liquids, solids, gases, powders, fluids, steam, slurries, organic and inorganic materials, animals, plants, people, and objects; and devices for detecting optical, electromagnetic, and radioactive, emissions and absorption; design and development for others of substrates, particles, beads, microbeads, and encoded, coated, and polarized substrates, particles, beads, and microbeads; substrates, particles, beads, and microbeads having labels, tags, codes, digital codes, and bar codes; optically readable encoded substrates, particles, beads, and microbeads; diffraction gratings; holograms; light filters; design and development of kits for others comprising substrates, particles, beads, microbeads, and encoded substrates, particles, beads, and microbeads; and computer programming for others and updating of computer software for others in the fields of chemical, biochemical, biomedical, combinatorial chemistry, pharmaceutical, drug discovery, genomics, proteomics, identification, verification, authentication, sensing, anti-counterfeit, anti-terrorism, and security applications.
Owners as filed
- ILLUMINA, INC. (SUBSEQUENT OWNER AFTER PUBLICATION)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:4113f13e02941c650dcea4e3
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=78326350&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
No
Owners as filed
City
SAN DIEGO
Name
ILLUMINA, INC.
Role
SUBSEQUENT OWNER AFTER PUBLICATION
Region
CALIFORNIA 921211975, UNITED STATES
Entity Type
CORPORATION
As Published
ILLUMINA, INC. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
ABANDONED - NO STATEMENT OF USE FILED
Attorney
Gerald L. DePardo
Wordmark
CYVERA
Filed Date
2003-11-11
Mark Types
TRADEMARK, SERVICE MARK
Us Classes
026 021 036 038 023., 100 101.
Registered
No
Status Code
606
Abandon Date
2006-07-06
Serial Number
78326350
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
Goods And Services
(ABANDONED) IC 009: Scientific and industrial equipment and instruments, namely scanners; devices for monitoring optical signals and wavelengths; devices for reading and detecting optical codes; devices for performing hybridization experiments and reactions; molecular detection and analysis equipment; devices for moving fluids; equipment for detecting the presence of analytes in samples and identifying sample type; devices for reading, identifying, analyzing, monitoring, sorting, dispensing, tracking, screening, verifying, and authenticating encoded substrates, beads, particles, and microbeads in the fields of chemical, biochemical, biomedical, combinatorial chemistry, pharmaceutical, drug discovery, genomics, proteomics, identification, verification, authentication, sensing, anti-counterfeit, anti-terrorism, and security applications; equipment for reading, identifying, analyzing, monitoring, sorting, tracking, screening, verifying, and authenticating labeled items, namely, chemicals, molecules, nucleic acids, proteins, cells, liquids, solids, gases, powders, fluids, steam, slurries, organic and inorganic materials, animals, plants, people, and objects in the fields of chemical, biochemical, biomedical, combinatorial chemistry, pharmaceutical, drug discovery, genomics, proteomics, identification, verification, authentication, sensing, anti-counterfeit, anti-terrorism, and security applications; and devices for detecting optical, electromagnetic, and radioactive, emissions and absorption; encoded substrates, particles, beads, and microbeads for performing identification, authentication, screening, experiments, evaluations, and assays; and substrates, particles, beads, and microbeads having labels, tags, codes, digital codes, and bar codes associated therewith; diffraction gratings; holograms; light filters; encoded substrates, beads, particles, and microbeads for labeling, identifying, monitoring, sensing, sorting, tracking, tagging, screening, verifying, and authenticating items, namely, chemicals, molecules, nucleic acids, proteins, cells, liquids, solids, gases, powders, fluids, steam, slurries, organic and inorganic materials, animals, plants, people, currency, and objects; kits comprising substrates, particles, beads, microbeads, and encoded substrates, particles, beads, and microbeads for performing identification, authentication, screening, experiments, evaluations, and assays; holders, plates, slides, vials, cuvettes, cassettes, and containers for holding, aligning, and reading substrates, particles, beads, and microbeads, and for performing identification, screening, experiments, evaluations, and assays; reaction vessels; vessels for performing screening, experiments, evaluations, and assays; computer programs for use in reading, identifying, analyzing, monitoring, sorting, tracking, verifying, and authenticating encoded substrates, beads, particles, and microbeads; and computer programs for use in monitoring and analyzing data in the fields of chemical, biochemical, biomedical, combinatorial chemistry, pharmaceutical, drug discovery, genomics, proteomics, identification, verification, authentication, sensing, anti-counterfeit, anti-terrorism, and security applications., (ABANDONED) IC 042: design and development for others of scientific and industrial equipment and instruments, namely scanners; devices for monitoring optical signals and wavelengths; devices for reading and detecting optical codes; hybridization equipment; molecular detection and analysis equipment; fluidics equipment; equipment for detecting the presence of analytes in samples and identifying sample type; devices for reading, identifying, analyzing, monitoring, sorting, dispensing, tracking, screening, verifying, and authenticating encoded substrates, beads, particles, and microbeads; devices for reading, identifying, analyzing, monitoring, sorting, tracking, screening, verifying, and authenticating labeled items, namely, chemicals, molecules, nucleic acids, proteins, cells, liquids, solids, gases, powders, fluids, steam, slurries, organic and inorganic materials, animals, plants, people, and objects; and devices for detecting optical, electromagnetic, and radioactive, emissions and absorption; design and development for others of substrates, particles, beads, microbeads, and encoded, coated, and polarized substrates, particles, beads, and microbeads; substrates, particles, beads, and microbeads having labels, tags, codes, digital codes, and bar codes; optically readable encoded substrates, particles, beads, and microbeads; diffraction gratings; holograms; light filters; design and development of kits for others comprising substrates, particles, beads, microbeads, and encoded substrates, particles, beads, and microbeads; and computer programming for others and updating of computer software for others in the fields of chemical, biochemical, biomedical, combinatorial chemistry, pharmaceutical, drug discovery, genomics, proteomics, identification, verification, authentication, sensing, anti-counterfeit, anti-terrorism, and security applications.
Queried Legal Name
ILLUMINA, INC.
International Classes
IC 009, IC 042
Matching Owner Entries
ILLUMINA, INC. (CORPORATION; DELAWARE, USA)
HAPMAPCHIP no longer live · ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE · Serial 78374824
Filed
Feb 26, 2004
Classes
IC 009
Attorney
Gabrielle A. Holley
Goods & services
(ABANDONED) IC 009: Array cassettes, associated decoding files and associated reagents used as sensors for detecting nucleic acids, proteins or molecules for chemical, scientific and medical research purposes; software and array scanning instrumentation and related hardware for the analysis of such arrays.
Owners as filed
- Illumina, Inc. (ORIGINAL APPLICANT)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:d2b8bbc8b64f55e24518361e
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=78374824&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
No
Owners as filed
City
San Diego
Name
Illumina, Inc.
Role
ORIGINAL APPLICANT
Region
CALIFORNIA 92121, UNITED STATES
Entity Type
CORPORATION
As Published
Illumina, Inc. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
Attorney
Gabrielle A. Holley
Wordmark
HAPMAPCHIP
Filed Date
2004-02-26
Mark Types
TRADEMARK
Us Classes
021 026 038 036 023.
Registered
No
Status Code
602
Abandon Date
2005-03-21
Serial Number
78374824
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
Goods And Services
(ABANDONED) IC 009: Array cassettes, associated decoding files and associated reagents used as sensors for detecting nucleic acids, proteins or molecules for chemical, scientific and medical research purposes; software and array scanning instrumentation and related hardware for the analysis of such arrays.
Queried Legal Name
ILLUMINA, INC.
International Classes
IC 009
Matching Owner Entries
Illumina, Inc. (CORPORATION; DELAWARE, USA)
HAPCHIP no longer live · ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE · Serial 78374833
Filed
Feb 26, 2004
Classes
IC 009
Attorney
Gabrielle A. Holley
Goods & services
(ABANDONED) IC 009: Array cassettes, associated decoding files and associated reagents used as sensors for detecting nucleic acids, proteins or molecules for chemical, scientific and medical research purposes; software and array scanning instrumentation and related hardware for the analysis of such arrays.
Owners as filed
- Illumina, Inc. (ORIGINAL APPLICANT)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:138a939cffaec816c1ec5f64
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=78374833&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
No
Owners as filed
City
San Diego
Name
Illumina, Inc.
Role
ORIGINAL APPLICANT
Region
CALIFORNIA 92121, UNITED STATES
Entity Type
CORPORATION
As Published
Illumina, Inc. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
Attorney
Gabrielle A. Holley
Wordmark
HAPCHIP
Filed Date
2004-02-26
Mark Types
TRADEMARK
Us Classes
021 026 038 036 023.
Registered
No
Status Code
602
Abandon Date
2005-03-18
Serial Number
78374833
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
Goods And Services
(ABANDONED) IC 009: Array cassettes, associated decoding files and associated reagents used as sensors for detecting nucleic acids, proteins or molecules for chemical, scientific and medical research purposes; software and array scanning instrumentation and related hardware for the analysis of such arrays.
Queried Legal Name
ILLUMINA, INC.
International Classes
IC 009
Matching Owner Entries
Illumina, Inc. (CORPORATION; DELAWARE, USA)
VIRTUAL CYTOMETER no longer live · ABANDONED - NO STATEMENT OF USE FILED · Serial 78415960
Filed
May 10, 2004
Classes
IC 009
Attorney
Gerald L. DePardo
Goods & services
(ABANDONED) IC 009: scientific and industrial equipment and instruments, namely scanners; devices for monitoring optical signals and wavelengths; devices for reading and detecting optical codes; devices for performing hybridization experiments and reactions; molecular detection and analysis equipment; devices for moving fluids for use in laboratories and medical offices for chemical, biochemical, biomedical and pharmaceutical applications; equipment for detecting the presence of analytes in samples and identifying sample type; devices for reading, identifying, analyzing, monitoring, sorting, dispensing, tracking, screening, verifying, and authenticating encoded substrates, beads, particles, and microbeads in the fields of chemical, biochemical, biomedical, combinatorial chemistry, pharmaceutical, drug discovery, genomics, proteomics, identification, verification, authentication, sensing, anti-counterfeit, anti-terrorism, and security applications; equipment for reading, identifying, analyzing, monitoring, sorting, tracking, screening, verifying, and authenticating labeled items, namely, chemicals, molecules, nucleic acids, proteins, cells, liquids, solids, gases, powders, fluids, steam, slurries, organic and inorganic materials, animals, plants, people, and objects in the fields of chemical, biochemical, biomedical, combinatorial chemistry, pharmaceutical, drug discovery, genomics, proteomics, identification, verification, authentication, sensing, anti-counterfeit, anti-terrorism, and security applications; and devices for detecting optical, electromagnetic, and radioactive, emissions and absorption; encoded substrates, particles, beads, and microbeads for performing identification, authentication, screening, experiments, evaluations, and assays; and substrates, particles, beads, and microbeads having labels, tags, codes, digital codes, and bar codes associated therewith; diffraction gratings; hologram apparatus; light filters; encoded substrates, beads, particles, and microbeads for labeling, identifying, monitoring, sensing, sorting, tracking, tagging, screening, verifying, and authenticating items, namely, chemicals, molecules, nucleic acids, proteins, cells, liquids, solids, gases, powders, fluids, steam, slurries, organic and inorganic materials, animals, plants, people, currency, and objects; kits comprising substrates, particles, beads, microbeads, and encoded substrates, particles, beads, and microbeads for performing identification, authentication, screening, experiments, evaluations, and assays; holders, plates, slides, vials, cuvettes, cassettes, and containers for holding, aligning, and reading substrates, particles, beads, and microbeads, and for performing identification, screening, experiments, evaluations, and assays; reaction vessels; vessels for performing screening, experiments, evaluations, and assays; computer programs for use in reading, identifying, analyzing, monitoring, sorting, tracking, verifying, and authenticating encoded substrates, beads, particles, and microbeads; and computer programs for use in monitoring and analyzing data in the fields of chemical, biochemical, biomedical, combinatorial chemistry, pharmaceutical, drug discovery, genomics, proteomics, identification, verification, authentication, sensing, anti-counterfeit, anti-terrorism, and security applications.
Owners as filed
- ILLUMINA, INC. (SUBSEQUENT OWNER AFTER PUBLICATION)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:e2a4db76909377f9b5c88c8c
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=78415960&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
No
Owners as filed
City
SAN DIEGO
Name
ILLUMINA, INC.
Role
SUBSEQUENT OWNER AFTER PUBLICATION
Region
CALIFORNIA 92121, UNITED STATES
Entity Type
CORPORATION
As Published
ILLUMINA, INC. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
ABANDONED - NO STATEMENT OF USE FILED
Attorney
Gerald L. DePardo
Wordmark
VIRTUAL CYTOMETER
Filed Date
2004-05-10
Mark Types
TRADEMARK
Us Classes
021 026 038 036 023.
Registered
No
Status Code
606
Abandon Date
2007-02-15
Serial Number
78415960
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
Goods And Services
(ABANDONED) IC 009: scientific and industrial equipment and instruments, namely scanners; devices for monitoring optical signals and wavelengths; devices for reading and detecting optical codes; devices for performing hybridization experiments and reactions; molecular detection and analysis equipment; devices for moving fluids for use in laboratories and medical offices for chemical, biochemical, biomedical and pharmaceutical applications; equipment for detecting the presence of analytes in samples and identifying sample type; devices for reading, identifying, analyzing, monitoring, sorting, dispensing, tracking, screening, verifying, and authenticating encoded substrates, beads, particles, and microbeads in the fields of chemical, biochemical, biomedical, combinatorial chemistry, pharmaceutical, drug discovery, genomics, proteomics, identification, verification, authentication, sensing, anti-counterfeit, anti-terrorism, and security applications; equipment for reading, identifying, analyzing, monitoring, sorting, tracking, screening, verifying, and authenticating labeled items, namely, chemicals, molecules, nucleic acids, proteins, cells, liquids, solids, gases, powders, fluids, steam, slurries, organic and inorganic materials, animals, plants, people, and objects in the fields of chemical, biochemical, biomedical, combinatorial chemistry, pharmaceutical, drug discovery, genomics, proteomics, identification, verification, authentication, sensing, anti-counterfeit, anti-terrorism, and security applications; and devices for detecting optical, electromagnetic, and radioactive, emissions and absorption; encoded substrates, particles, beads, and microbeads for performing identification, authentication, screening, experiments, evaluations, and assays; and substrates, particles, beads, and microbeads having labels, tags, codes, digital codes, and bar codes associated therewith; diffraction gratings; hologram apparatus; light filters; encoded substrates, beads, particles, and microbeads for labeling, identifying, monitoring, sensing, sorting, tracking, tagging, screening, verifying, and authenticating items, namely, chemicals, molecules, nucleic acids, proteins, cells, liquids, solids, gases, powders, fluids, steam, slurries, organic and inorganic materials, animals, plants, people, currency, and objects; kits comprising substrates, particles, beads, microbeads, and encoded substrates, particles, beads, and microbeads for performing identification, authentication, screening, experiments, evaluations, and assays; holders, plates, slides, vials, cuvettes, cassettes, and containers for holding, aligning, and reading substrates, particles, beads, and microbeads, and for performing identification, screening, experiments, evaluations, and assays; reaction vessels; vessels for performing screening, experiments, evaluations, and assays; computer programs for use in reading, identifying, analyzing, monitoring, sorting, tracking, verifying, and authenticating encoded substrates, beads, particles, and microbeads; and computer programs for use in monitoring and analyzing data in the fields of chemical, biochemical, biomedical, combinatorial chemistry, pharmaceutical, drug discovery, genomics, proteomics, identification, verification, authentication, sensing, anti-counterfeit, anti-terrorism, and security applications.
Queried Legal Name
ILLUMINA, INC.
International Classes
IC 009
Matching Owner Entries
ILLUMINA, INC. (CORPORATION; DELAWARE, USA)
INFINIUM REGISTERED AND RENEWED · Serial 78553541
Registration
3137084
Filed
Jan 25, 2005
Registered
Aug 29, 2006
Classes
IC 001, (CANCELLED) IC 042
Attorney
Susan M. Natland
Goods & services
IC 001: Reagent kits composed primarily of oligonucleotides, enzymes and buffers for nucleic acid detection in the fields of scientific, pharmaceutical and medical research. IC 042: [ [ Nucleic acid analysis services in the fields of scientific, pharmaceutical and medical research ] ].
Owners as filed
- Illumina, Inc. (ORIGINAL REGISTRANT)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:f207204c53780b69445f7719
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=78553541&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
Yes
Owners as filed
City
San Diego
Name
Illumina, Inc.
Role
ORIGINAL REGISTRANT
Region
California 92122, UNITED STATES
Entity Type
CORPORATION
As Published
Illumina, Inc. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
REGISTERED AND RENEWED
Attorney
Susan M. Natland
Wordmark
INFINIUM
Filed Date
2005-01-25
Mark Types
TRADEMARK
Us Classes
001 010 026 005 046 006., 101 100.
Registered
Yes
Status Code
800
Serial Number
78553541
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
First Use Any Date
2005-08-11
Goods And Services
IC 001: Reagent kits composed primarily of oligonucleotides, enzymes and buffers for nucleic acid detection in the fields of scientific, pharmaceutical and medical research., IC 042: [ [ Nucleic acid analysis services in the fields of scientific, pharmaceutical and medical research ] ].
Queried Legal Name
ILLUMINA, INC.
Registration Date
2006-08-29
Registration Number
3137084
First Use Commerce Date
2005-08-11
International Classes
IC 001, (CANCELLED) IC 042
Matching Owner Entries
Illumina, Inc. (CORPORATION; DELAWARE, USA)
CSPRO no longer live · CANCELLED - SECTION 8 · Serial 78641226
Registration
3220705
Filed
Jun 1, 2005
Registered
Mar 20, 2007
Cancelled
Oct 27, 2017
Classes
IC 042
Attorney
Julia Anne Matheson
Goods & services
(CANCELLED) IC 042: [ Nucleic acid analysis services in the fields of scientific, pharmaceutical and medical research ].
Owners as filed
- Illumina, Inc. (ORIGINAL REGISTRANT)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:59d9d18a424e689aeb894908
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=78641226&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
No
Owners as filed
City
San Diego
Name
Illumina, Inc.
Role
ORIGINAL REGISTRANT
Region
CALIFORNIA 92122, UNITED STATES
Entity Type
CORPORATION
As Published
Illumina, Inc. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
CANCELLED - SECTION 8
Attorney
Julia Anne Matheson
Wordmark
CSPRO
Filed Date
2005-06-01
Mark Types
SERVICE MARK
Us Classes
100 101.
Cancel Date
2017-10-27
Registered
No
Status Code
710
Serial Number
78641226
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
First Use Any Date
2006-07-20
Goods And Services
(CANCELLED) IC 042: [ Nucleic acid analysis services in the fields of scientific, pharmaceutical and medical research ].
Queried Legal Name
ILLUMINA, INC.
Registration Date
2007-03-20
Registration Number
3220705
First Use Commerce Date
2006-07-20
International Classes
IC 042
Matching Owner Entries
Illumina, Inc. (CORPORATION; DELAWARE, USA)
BEADXPRESS no longer live · CANCELLED - SECTION 8 · Serial 78867316
Registration
3413263
Filed
Apr 21, 2006
Registered
Apr 15, 2008
Cancelled
Nov 16, 2018
Classes
IC 009
Attorney
Julia Anne Matheson
Goods & services
(CANCELLED) IC 009: [ Laboratory equipment for bio analysis, namely, a scanner, sample incubation unit, reagent carrier, fluidic system comprised of automatic fluid composition controls and machines, electronic valves for fluid control, hybridization unit, and sample mixing unit; computer hardware and computer software for the analysis of bioassays ].
Owners as filed
- Illumina, Inc. (ORIGINAL REGISTRANT)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:10db9269faa52bb6367812f8
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=78867316&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
No
Owners as filed
City
San Diego
Name
Illumina, Inc.
Role
ORIGINAL REGISTRANT
Region
CALIFORNIA 92122, UNITED STATES
Entity Type
CORPORATION
As Published
Illumina, Inc. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
CANCELLED - SECTION 8
Attorney
Julia Anne Matheson
Wordmark
BEADXPRESS
Filed Date
2006-04-21
Mark Types
TRADEMARK
Us Classes
026 038 036 021 023.
Cancel Date
2018-11-16
Registered
No
Status Code
710
Serial Number
78867316
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
First Use Any Date
2007-03-15
Goods And Services
(CANCELLED) IC 009: [ Laboratory equipment for bio analysis, namely, a scanner, sample incubation unit, reagent carrier, fluidic system comprised of automatic fluid composition controls and machines, electronic valves for fluid control, hybridization unit, and sample mixing unit; computer hardware and computer software for the analysis of bioassays ].
Queried Legal Name
ILLUMINA, INC.
Registration Date
2008-04-15
Registration Number
3413263
First Use Commerce Date
2007-03-15
International Classes
IC 009
Matching Owner Entries
Illumina, Inc. (CORPORATION; DELAWARE, USA)
VERACODE no longer live · CANCELLED - SECTION 8 · Serial 78868020
Registration
3730113
Filed
Apr 24, 2006
Registered
Dec 22, 2009
Cancelled
Jul 29, 2016
Classes
IC 005
Attorney
Julia Anne Matheson
Goods & services
(CANCELLED) IC 005: [ Clinical diagnostic reagents, beads, and reagent kits comprised primarily of oligonucleotides, chemical preparations, enzymes and buffers for clinical diagnostic purposes ].
Owners as filed
- Illumina, Inc. (ORIGINAL REGISTRANT)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:f16cc0b732e4474df1b324e6
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=78868020&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
No
Owners as filed
City
San Diego
Name
Illumina, Inc.
Role
ORIGINAL REGISTRANT
Region
CALIFORNIA 92122, UNITED STATES
Entity Type
CORPORATION
As Published
Illumina, Inc. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
CANCELLED - SECTION 8
Attorney
Julia Anne Matheson
Wordmark
VERACODE
Filed Date
2006-04-24
Mark Types
TRADEMARK
Us Classes
044 051 052 006 046 018.
Cancel Date
2016-07-29
Registered
No
Status Code
710
Serial Number
78868020
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
First Use Any Date
2009-04-30
Goods And Services
(CANCELLED) IC 005: [ Clinical diagnostic reagents, beads, and reagent kits comprised primarily of oligonucleotides, chemical preparations, enzymes and buffers for clinical diagnostic purposes ].
Queried Legal Name
ILLUMINA, INC.
Registration Date
2009-12-22
Registration Number
3730113
First Use Commerce Date
2009-04-30
International Classes
IC 005
Matching Owner Entries
Illumina, Inc. (CORPORATION; DELAWARE, USA)
ISELECT REGISTERED AND RENEWED · Serial 78928316
Registration
3383295
Filed
Jul 12, 2006
Registered
Feb 12, 2008
Classes
IC 042, IC 001
Attorney
Susan M. Natland
Goods & services
IC 042: Nucleic acid analysis services in the fields of scientific, pharmaceutical and medical research. IC 001: Kits composed primarily of oligonucleotides, microarrays, enzymes and buffers for nucleic acid detection in the fields of scientific, pharmaceutical and medical research.
Owners as filed
- Illumina, Inc. (ORIGINAL REGISTRANT)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:852eaa36ecc059025cb5ecf2
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=78928316&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
Yes
Owners as filed
City
San Diego
Name
Illumina, Inc.
Role
ORIGINAL REGISTRANT
Region
California 92122, UNITED STATES
Entity Type
CORPORATION
As Published
Illumina, Inc. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
REGISTERED AND RENEWED
Attorney
Susan M. Natland
Wordmark
ISELECT
Filed Date
2006-07-12
Mark Types
TRADEMARK, SERVICE MARK
Us Classes
100 101., 001 010 006 005 026 046.
Registered
Yes
Status Code
800
Serial Number
78928316
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
First Use Any Date
2006-07-13
Goods And Services
IC 042: Nucleic acid analysis services in the fields of scientific, pharmaceutical and medical research., IC 001: Kits composed primarily of oligonucleotides, microarrays, enzymes and buffers for nucleic acid detection in the fields of scientific, pharmaceutical and medical research.
Queried Legal Name
ILLUMINA, INC.
Registration Date
2008-02-12
Registration Number
3383295
First Use Commerce Date
2006-07-13
International Classes
IC 042, IC 001
Matching Owner Entries
Illumina, Inc. (CORPORATION; DELAWARE, USA)
INTELLIHYB no longer live · CANCELLED - SECTION 8 · Serial 78929189
Registration
3292334
Filed
Jul 13, 2006
Registered
Sep 11, 2007
Cancelled
Apr 18, 2014
Classes
IC 009
Attorney
Gabrielle A. Holley
Goods & services
(CANCELLED) IC 009: [ Seal system comprised of a frame, spacer and cover sheet for use with microarray chips for the separation and hybridization of biological samples for analysis ].
Owners as filed
- Illumina, Inc. (ORIGINAL REGISTRANT)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:2acfa1c874053f5611afd990
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=78929189&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
No
Owners as filed
City
San Diego
Name
Illumina, Inc.
Role
ORIGINAL REGISTRANT
Region
CALIFORNIA 92122, UNITED STATES
Entity Type
CORPORATION
As Published
Illumina, Inc. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
CANCELLED - SECTION 8
Attorney
Gabrielle A. Holley
Wordmark
INTELLIHYB
Filed Date
2006-07-13
Mark Types
TRADEMARK
Us Classes
021 026 038 036 023.
Cancel Date
2014-04-18
Registered
No
Status Code
710
Serial Number
78929189
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
First Use Any Date
2006-11-14
Goods And Services
(CANCELLED) IC 009: [ Seal system comprised of a frame, spacer and cover sheet for use with microarray chips for the separation and hybridization of biological samples for analysis ].
Queried Legal Name
ILLUMINA, INC.
Registration Date
2007-09-11
Registration Number
3292334
First Use Commerce Date
2006-11-14
International Classes
IC 009
Matching Owner Entries
Illumina, Inc. (CORPORATION; DELAWARE, USA)
DASL no longer live · CANCELLED - SECTION 8 · Serial 78976214
Registration
3006667
Filed
Sep 11, 2002
Registered
Oct 11, 2005
Cancelled
May 13, 2016
Classes
IC 001
Attorney
Julia Anne Matheson
Goods & services
(CANCELLED) IC 001: [ Reagent kits composed primarily of enzymes, oligonucleotides, and buffers used for nucleic acid detection in the field of scientific, pharmaceutical and medical research ].
Owners as filed
- Illumina, Inc. (ORIGINAL REGISTRANT)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:0adfe23f48f2bc17e2835231
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=78976214&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
No
Owners as filed
City
San Diego
Name
Illumina, Inc.
Role
ORIGINAL REGISTRANT
Region
CALIFORNIA 92122, UNITED STATES
Entity Type
CORPORATION
As Published
Illumina, Inc. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
CANCELLED - SECTION 8
Attorney
Julia Anne Matheson
Wordmark
DASL
Filed Date
2002-09-11
Mark Types
TRADEMARK
Us Classes
001 010 005 006 026 046.
Cancel Date
2016-05-13
Registered
No
Status Code
710
Serial Number
78976214
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
First Use Any Date
2005-04-11
Goods And Services
(CANCELLED) IC 001: [ Reagent kits composed primarily of enzymes, oligonucleotides, and buffers used for nucleic acid detection in the field of scientific, pharmaceutical and medical research ].
Queried Legal Name
ILLUMINA, INC.
Registration Date
2005-10-11
Registration Number
3006667
First Use Commerce Date
2005-04-11
International Classes
IC 001
Matching Owner Entries
Illumina, Inc. (CORPORATION; DELAWARE, USA)
VERACODE no longer live · CANCELLED - SECTION 8 · Serial 78979475
Registration
3374466
Filed
Apr 24, 2006
Registered
Jan 22, 2008
Cancelled
Aug 24, 2018
Classes
IC 001
Attorney
Julia Anne Matheson
Goods & services
(CANCELLED) IC 001: [ Reagents, beads, and reagent kits comprised primarily of oligonucleotides, chemical preparations, enzymes and buffers, all for use in the detection of nucleic acids, proteins, and molecules in the fields of scientific, pharmaceutical, medical and clinical research ].
Owners as filed
- Illumina, Inc. (ORIGINAL REGISTRANT)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:f56c0236921b37169cb88791
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=78979475&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
No
Owners as filed
City
San Diego
Name
Illumina, Inc.
Role
ORIGINAL REGISTRANT
Region
CALIFORNIA 92122, UNITED STATES
Entity Type
CORPORATION
As Published
Illumina, Inc. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
CANCELLED - SECTION 8
Attorney
Julia Anne Matheson
Wordmark
VERACODE
Filed Date
2006-04-24
Mark Types
TRADEMARK
Us Classes
001 010 005 006 026 046.
Cancel Date
2018-08-24
Registered
No
Status Code
710
Serial Number
78979475
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
First Use Any Date
2007-05-22
Goods And Services
(CANCELLED) IC 001: [ Reagents, beads, and reagent kits comprised primarily of oligonucleotides, chemical preparations, enzymes and buffers, all for use in the detection of nucleic acids, proteins, and molecules in the fields of scientific, pharmaceutical, medical and clinical research ].
Queried Legal Name
ILLUMINA, INC.
Registration Date
2008-01-22
Registration Number
3374466
First Use Commerce Date
2007-05-22
International Classes
IC 001
Matching Owner Entries
Illumina, Inc. (CORPORATION; DELAWARE, USA)
ASSIGN SECTION 71 ACCEPTED · Serial 79101429
Registration
4177587
Filed
May 6, 2011
Registered
Jul 24, 2012
Classes
IC 009
Attorney
Susan M. Natland
Goods & services
IC 009: Computer software for use in the analysis of nucleic acid and sequencing.
Owners as filed
- Conexio 4 Pty Ltd (ORIGINAL REGISTRANT)
- Illumina, Inc. (SUBSEQUENT OWNER AFTER REGISTRATION)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:a6e172d520d074d65227c1da
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=79101429&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
Yes
Owners as filed
City

Name
Conexio 4 Pty Ltd
Role
ORIGINAL REGISTRANT
Region
AUSTRALIA
Entity Type
OTHER
As Published
Conexio 4 Pty Ltd (PROPRIETARY LIMITED COMPANY; AUSTRALIA)
Citizenship
AUSTRALIA
City
San Diego
Name
Illumina, Inc.
Role
SUBSEQUENT OWNER AFTER REGISTRATION
Region
California 92122, UNITED STATES
Entity Type
CORPORATION
As Published
Illumina, Inc. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
SECTION 71 ACCEPTED
Attorney
Susan M. Natland
Wordmark
ASSIGN
Filed Date
2011-05-06
Mark Types
TRADEMARK
Us Classes
038 026 036 023 021.
Registered
Yes
Status Code
706
Serial Number
79101429
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
Goods And Services
IC 009: Computer software for use in the analysis of nucleic acid and sequencing.
Queried Legal Name
ILLUMINA, INC.
Registration Date
2012-07-24
Registration Number
4177587
International Classes
IC 009
Matching Owner Entries
Illumina, Inc. (CORPORATION; DELAWARE, USA)
TRUSEQ no longer live · ABANDONED - NO STATEMENT OF USE FILED · Serial 85091478
Filed
Jul 23, 2010
Classes
IC 009, IC 042
Attorney
Gabrielle A. Holley
Goods & services
(ABANDONED) IC 009: Scientific instruments, namely, nucleic acid sequencers, imaging devices, namely, electronic imaging apparatus for detecting images and optical signals, and for processing images and optical signals into data, for use in genotyping and sequencing; laboratory equipment for sample preparation, amplification, mixing, hybridization, incubation, and washing, namely, biological sample trays carrying multiple reagents, microscopic carrier beads with chemically attached DNA fragments, sets of microscopic carrier beads with chemically attached DNA fragments, and biological sample containers in the form of microscope slides with internal channels and chips having multi-well arrays and with chemically attached DNA fragments; Automated laboratory equipment and systems, namely, devices for positioning, controlling temperature, and moving containers for samples or adding reagents thereto in the nature of robotic arms and movable sample containers for laboratory use and barcode readers; Computer systems comprised of computer hardware, computer operating systems, computer software, electronic data files, modems and computer peripheral devices for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data; all the foregoing for use in the fields of scientific, diagnostic and clinical research, clinical diagnostic analysis, genotyping and nucleotide sequencing. (ABANDONED) IC 042: Product development, namely, developing equipment for use in preparing, detecting, analyzing and sequencing nucleic acids and other biological molecules, and automated laboratory equipment and systems, and computer systems for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data to the order and specification of others, all the foregoing in the fields of scientific, diagnostic and clinical research; Scientific and technological services and research services in the fields of genetics, epigenetics and gene expression analysis; Laboratory services, namely, preparation, detection, quantification, and analysis of biological material, for genotyping, for diagnostic assays, and for carrying out nucleic acid sequencing reactions; Consultancy, information and advisory services relating to the aforesaid services; Clinical diagnostic services in preparing, amplifying, labeling, detecting, analyzing and sequencing nucleic acids and other biological molecules.
Owners as filed
- Illumina, Inc. (OWNER AT PUBLICATION)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:c866c9b57f81a8814e9d042f
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=85091478&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
No
Owners as filed
City
San Diego
Name
Illumina, Inc.
Role
OWNER AT PUBLICATION
Region
CALIFORNIA 92122, UNITED STATES
Entity Type
CORPORATION
As Published
Illumina, Inc. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
ABANDONED - NO STATEMENT OF USE FILED
Attorney
Gabrielle A. Holley
Wordmark
TRUSEQ
Filed Date
2010-07-23
Mark Types
TRADEMARK, SERVICE MARK
Us Classes
021 026 038 036 023., 100 101.
Registered
No
Status Code
606
Abandon Date
2013-01-21
Serial Number
85091478
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
Goods And Services
(ABANDONED) IC 009: Scientific instruments, namely, nucleic acid sequencers, imaging devices, namely, electronic imaging apparatus for detecting images and optical signals, and for processing images and optical signals into data, for use in genotyping and sequencing; laboratory equipment for sample preparation, amplification, mixing, hybridization, incubation, and washing, namely, biological sample trays carrying multiple reagents, microscopic carrier beads with chemically attached DNA fragments, sets of microscopic carrier beads with chemically attached DNA fragments, and biological sample containers in the form of microscope slides with internal channels and chips having multi-well arrays and with chemically attached DNA fragments; Automated laboratory equipment and systems, namely, devices for positioning, controlling temperature, and moving containers for samples or adding reagents thereto in the nature of robotic arms and movable sample containers for laboratory use and barcode readers; Computer systems comprised of computer hardware, computer operating systems, computer software, electronic data files, modems and computer peripheral devices for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data; all the foregoing for use in the fields of scientific, diagnostic and clinical research, clinical diagnostic analysis, genotyping and nucleotide sequencing., (ABANDONED) IC 042: Product development, namely, developing equipment for use in preparing, detecting, analyzing and sequencing nucleic acids and other biological molecules, and automated laboratory equipment and systems, and computer systems for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data to the order and specification of others, all the foregoing in the fields of scientific, diagnostic and clinical research; Scientific and technological services and research services in the fields of genetics, epigenetics and gene expression analysis; Laboratory services, namely, preparation, detection, quantification, and analysis of biological material, for genotyping, for diagnostic assays, and for carrying out nucleic acid sequencing reactions; Consultancy, information and advisory services relating to the aforesaid services; Clinical diagnostic services in preparing, amplifying, labeling, detecting, analyzing and sequencing nucleic acids and other biological molecules.
Queried Legal Name
ILLUMINA, INC.
International Classes
IC 009, IC 042
Matching Owner Entries
Illumina, Inc. (CORPORATION; DELAWARE, USA)
MIO no longer live · ABANDONED - NO STATEMENT OF USE FILED · Serial 85093691
Filed
Jul 27, 2010
Classes
IC 009, IC 010
Attorney
Gabrielle A. Holley
Goods & services
(ABANDONED) IC 009: Scientific instruments and medical laboratory apparatus and instruments, namely, nucleic acid sequencers, and imaging devices, namely, electronic imaging apparatus for detecting images and optical signals, and for processing images and optical signals into data, for use in nucleic acid detection, quantification, genotyping and sequencing; laboratory equipment and medical laboratory equipment for sample preparation, amplification, mixing, hybridization, incubation, thermocycling, and washing, namely, biological sample trays carrying multiple reagents, microscopic carrier beads with chemically attached DNA fragments, sets of microscopic carrier beads with chemically attached DNA fragments, and biological sample containers in the form of microscope slides with internal channels and chips having multi-well arrays and with chemically attached DNA fragments; automated laboratory equipment and systems, namely, devices for positioning, controlling temperature and moving containers for samples or adding reagents thereto in the nature of robotic arms and movable sample containers and barcode readers; computer systems comprised of computer hardware, computer operating systems, computer software, electronic data files, modems and computer peripheral devices for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data: all the foregoing for use in the fields of scientific, diagnostic and clinical research, clinical diagnostic analysis, genotyping and gene sequencing. (ABANDONED) IC 010: Apparatus for clinical diagnosis; medical diagnostic apparatus and instruments, namely, electronic imaging apparatus for detecting images and optical signals, and for processing images and optical signals into data for use in detecting or treating genetic, epigenetic, acquired, dysplastic, and neoplastic conditions.
Owners as filed
- Illumina, Inc. (OWNER AT PUBLICATION)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:ca1b9b83a883c1a35b848dbb
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=85093691&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
No
Owners as filed
City
San Diego
Name
Illumina, Inc.
Role
OWNER AT PUBLICATION
Region
CALIFORNIA 92122, UNITED STATES
Entity Type
CORPORATION
As Published
Illumina, Inc. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
ABANDONED - NO STATEMENT OF USE FILED
Attorney
Gabrielle A. Holley
Wordmark
MIO
Filed Date
2010-07-27
Mark Types
TRADEMARK
Us Classes
021 026 038 036 023., 039 026 044.
Registered
No
Status Code
606
Abandon Date
2012-05-07
Serial Number
85093691
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
Goods And Services
(ABANDONED) IC 009: Scientific instruments and medical laboratory apparatus and instruments, namely, nucleic acid sequencers, and imaging devices, namely, electronic imaging apparatus for detecting images and optical signals, and for processing images and optical signals into data, for use in nucleic acid detection, quantification, genotyping and sequencing; laboratory equipment and medical laboratory equipment for sample preparation, amplification, mixing, hybridization, incubation, thermocycling, and washing, namely, biological sample trays carrying multiple reagents, microscopic carrier beads with chemically attached DNA fragments, sets of microscopic carrier beads with chemically attached DNA fragments, and biological sample containers in the form of microscope slides with internal channels and chips having multi-well arrays and with chemically attached DNA fragments; automated laboratory equipment and systems, namely, devices for positioning, controlling temperature and moving containers for samples or adding reagents thereto in the nature of robotic arms and movable sample containers and barcode readers; computer systems comprised of computer hardware, computer operating systems, computer software, electronic data files, modems and computer peripheral devices for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data: all the foregoing for use in the fields of scientific, diagnostic and clinical research, clinical diagnostic analysis, genotyping and gene sequencing., (ABANDONED) IC 010: Apparatus for clinical diagnosis; medical diagnostic apparatus and instruments, namely, electronic imaging apparatus for detecting images and optical signals, and for processing images and optical signals into data for use in detecting or treating genetic, epigenetic, acquired, dysplastic, and neoplastic conditions.
Queried Legal Name
ILLUMINA, INC.
International Classes
IC 009, IC 010
Matching Owner Entries
Illumina, Inc. (CORPORATION; DELAWARE, USA)
SBOT no longer live · CANCELLED - SECTION 8 · Serial 85222107
Registration
4158633
Filed
Jan 20, 2011
Registered
Jun 12, 2012
Cancelled
Jan 18, 2019
Classes
IC 009
Attorney
Julia Anne Matheson
Goods & services
(CANCELLED) IC 009: [ Automated laboratory apparatus and computer systems for use in analysis of biomolecules ].
Owners as filed
- Illumina, Inc. (ORIGINAL REGISTRANT)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:1dc01dc168a5d975b068ecc4
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=85222107&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
No
Owners as filed
City
San Diego
Name
Illumina, Inc.
Role
ORIGINAL REGISTRANT
Region
CALIFORNIA 92122, UNITED STATES
Entity Type
CORPORATION
As Published
Illumina, Inc. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
CANCELLED - SECTION 8
Attorney
Julia Anne Matheson
Wordmark
SBOT
Filed Date
2011-01-20
Mark Types
TRADEMARK
Us Classes
021 026 038 036 023.
Cancel Date
2019-01-18
Registered
No
Status Code
710
Serial Number
85222107
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
First Use Any Date
2010-12-20
Goods And Services
(CANCELLED) IC 009: [ Automated laboratory apparatus and computer systems for use in analysis of biomolecules ].
Queried Legal Name
ILLUMINA, INC.
Registration Date
2012-06-12
Registration Number
4158633
First Use Commerce Date
2010-12-20
International Classes
IC 009
Matching Owner Entries
Illumina, Inc. (CORPORATION; DELAWARE, USA)
FLOW REGISTERED AND RENEWED · Serial 85266542
Registration
4172549
Filed
Mar 14, 2011
Registered
Jul 10, 2012
Classes
IC 009
Attorney
Susan M. Natland
Goods & services
IC 009: Computer software for analyzing and transforming genome sequencing data.
Owners as filed
- Partek Incorporated (ORIGINAL REGISTRANT)
- ILLUMINA, INC. (SUBSEQUENT OWNER AFTER REGISTRATION)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:fcf2533bbb0d3f1b0a67f379
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=85266542&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
Yes
Owners as filed
City
Chesterfield
Name
Partek Incorporated
Role
ORIGINAL REGISTRANT
Region
Missouri 63005, UNITED STATES
Entity Type
CORPORATION
As Published
Partek Incorporated (CORPORATION; MISSOURI, USA)
Citizenship
MISSOURI, USA
City
SAN DIEGO
Name
ILLUMINA, INC.
Role
SUBSEQUENT OWNER AFTER REGISTRATION
Region
CALIFORNIA 92122, UNITED STATES
Entity Type
CORPORATION
As Published
ILLUMINA, INC. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
REGISTERED AND RENEWED
Attorney
Susan M. Natland
Wordmark
FLOW
Filed Date
2011-03-14
Mark Types
TRADEMARK
Us Classes
021 023 026 036 038.
Registered
Yes
Status Code
800
Serial Number
85266542
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
First Use Any Date
2011-12-13
Goods And Services
IC 009: Computer software for analyzing and transforming genome sequencing data.
Queried Legal Name
ILLUMINA, INC.
Registration Date
2012-07-10
Registration Number
4172549
First Use Commerce Date
2011-12-13
International Classes
IC 009
Matching Owner Entries
ILLUMINA, INC. (CORPORATION; DELAWARE, USA)
NEXTERA REGISTERED AND RENEWED · Serial 85287105
Registration
4066474
Filed
Apr 5, 2011
Registered
Dec 6, 2011
Classes
IC 001
Attorney
Susan M. Natland
Goods & services
IC 001: Enzymes, nucleic acids, and chemical preparations for scientific and research purposes, all in the field of biotechnology; kits comprised of enzymes, nucleic acids, and chemical preparations for scientific and research purposes, all in the field of biotechnology.
Owners as filed
- Illumina, Inc. (ORIGINAL REGISTRANT)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:00778bbf6785c859ce3b1bdd
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=85287105&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
Yes
Owners as filed
City
San Diego
Name
Illumina, Inc.
Role
ORIGINAL REGISTRANT
Region
California 92122, UNITED STATES
Entity Type
CORPORATION
As Published
Illumina, Inc. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
REGISTERED AND RENEWED
Attorney
Susan M. Natland
Wordmark
NEXTERA
Filed Date
2011-04-05
Mark Types
TRADEMARK
Us Classes
001 010 005 006 026 046.
Registered
Yes
Status Code
800
Serial Number
85287105
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
First Use Any Date
2009-10-08
Goods And Services
IC 001: Enzymes, nucleic acids, and chemical preparations for scientific and research purposes, all in the field of biotechnology; kits comprised of enzymes, nucleic acids, and chemical preparations for scientific and research purposes, all in the field of biotechnology.
Queried Legal Name
ILLUMINA, INC.
Registration Date
2011-12-06
Registration Number
4066474
First Use Commerce Date
2009-12-17
International Classes
IC 001
Matching Owner Entries
Illumina, Inc. (CORPORATION; DELAWARE, USA)
DESIGNSTUDIO no longer live · ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE · Serial 85390042
Filed
Aug 4, 2011
Classes
IC 042
Attorney
Julia Anne Matheson
Goods & services
(ABANDONED) IC 042: Providing online non-downloadable software for the custom design and ordering of assays and reagents.
Owners as filed
- Illumina, Inc. (ORIGINAL APPLICANT)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:9c407bfa21e1a4b8b2543211
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=85390042&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
No
Owners as filed
City
San Diego
Name
Illumina, Inc.
Role
ORIGINAL APPLICANT
Region
CALIFORNIA 92122, UNITED STATES
Entity Type
CORPORATION
As Published
Illumina, Inc. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
Attorney
Julia Anne Matheson
Wordmark
DESIGNSTUDIO
Filed Date
2011-08-04
Mark Types
SERVICE MARK
Us Classes
100 101.
Registered
No
Status Code
602
Abandon Date
2014-05-28
Serial Number
85390042
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
First Use Any Date
2011-07-13
Goods And Services
(ABANDONED) IC 042: Providing online non-downloadable software for the custom design and ordering of assays and reagents.
Queried Legal Name
ILLUMINA, INC.
First Use Commerce Date
2011-07-13
International Classes
IC 042
Matching Owner Entries
Illumina, Inc. (CORPORATION; DELAWARE, USA)
BASESPACE REGISTERED AND RENEWED · Serial 85427492
Registration
4162484
Filed
Sep 20, 2011
Registered
Jun 19, 2012
Classes
IC 042
Attorney
Susan M. Natland
Goods & services
IC 042: Computer services, namely, cloud hosting provider services for storing, analyzing and sharing biological information; providing an online network service that enables users to store, analyze and share data in the fields of life science; technical support services, namely, infrastructure management services for monitoring, administration and management of cloud computing IT and application systems in the fields of life science; consulting services in the field of cloud computing in the fields of life science.
Owners as filed
- Illumina, Inc. (ORIGINAL REGISTRANT)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:d5786649face4ebd1a631bf3
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=85427492&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
Yes
Owners as filed
City
San Diego
Name
Illumina, Inc.
Role
ORIGINAL REGISTRANT
Region
California 92122, UNITED STATES
Entity Type
CORPORATION
As Published
Illumina, Inc. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
REGISTERED AND RENEWED
Attorney
Susan M. Natland
Wordmark
BASESPACE
Filed Date
2011-09-20
Mark Types
SERVICE MARK
Us Classes
100 101.
Registered
Yes
Status Code
800
Serial Number
85427492
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
First Use Any Date
2011-10-11
Goods And Services
IC 042: Computer services, namely, cloud hosting provider services for storing, analyzing and sharing biological information; providing an online network service that enables users to store, analyze and share data in the fields of life science; technical support services, namely, infrastructure management services for monitoring, administration and management of cloud computing IT and application systems in the fields of life science; consulting services in the field of cloud computing in the fields of life science.
Queried Legal Name
ILLUMINA, INC.
Registration Date
2012-06-19
Registration Number
4162484
First Use Commerce Date
2011-10-11
International Classes
IC 042
Matching Owner Entries
Illumina, Inc. (CORPORATION; DELAWARE, USA)
SEQMONITOR no longer live · CANCELLED - SECTION 8 · Serial 85427565
Registration
4127168
Filed
Sep 20, 2011
Registered
Apr 10, 2012
Cancelled
Nov 16, 2018
Classes
IC 009
Attorney
Julia Anne Matheson
Goods & services
(CANCELLED) IC 009: [ Computer application software for use on mobile or networked computing devices for receiving and displaying information from scientific instruments ].
Owners as filed
- Illumina, Inc. (ORIGINAL REGISTRANT)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:9de9104393f85287a781f558
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=85427565&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
No
Owners as filed
City
San Diego
Name
Illumina, Inc.
Role
ORIGINAL REGISTRANT
Region
CALIFORNIA 92122, UNITED STATES
Entity Type
CORPORATION
As Published
Illumina, Inc. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
CANCELLED - SECTION 8
Attorney
Julia Anne Matheson
Wordmark
SEQMONITOR
Filed Date
2011-09-20
Mark Types
TRADEMARK
Us Classes
038 026 021 036 023.
Cancel Date
2018-11-16
Registered
No
Status Code
710
Serial Number
85427565
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
First Use Any Date
2011-01-20
Goods And Services
(CANCELLED) IC 009: [ Computer application software for use on mobile or networked computing devices for receiving and displaying information from scientific instruments ].
Queried Legal Name
ILLUMINA, INC.
Registration Date
2012-04-10
Registration Number
4127168
First Use Commerce Date
2011-01-20
International Classes
IC 009
Matching Owner Entries
Illumina, Inc. (CORPORATION; DELAWARE, USA)
A G C T REGISTERED AND RENEWED · Serial 85441949
Registration
4160543
Filed
Oct 7, 2011
Registered
Jun 19, 2012
Classes
IC 001
Attorney
Susan M. Natland
Goods & services
IC 001: Reagents and reagent kits comprising nucleic acids, naturally occurring or modified nucleotides, enzymes, labels, and buffers, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulation, transcription, and expression in the fields of scientific, diagnostic and clinical research.
Owners as filed
- Illumina, Inc. (ORIGINAL REGISTRANT)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:4d1781db3e853bbec59de28e
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=85441949&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
Yes
Owners as filed
City
San Diego
Name
Illumina, Inc.
Role
ORIGINAL REGISTRANT
Region
California 92122, UNITED STATES
Entity Type
CORPORATION
As Published
Illumina, Inc. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
REGISTERED AND RENEWED
Attorney
Susan M. Natland
Wordmark
A G C T
Filed Date
2011-10-07
Mark Types
TRADEMARK
Us Classes
001 010 006 005 026 046.
Registered
Yes
Status Code
800
Serial Number
85441949
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
First Use Any Date
2010-11-22
Goods And Services
IC 001: Reagents and reagent kits comprising nucleic acids, naturally occurring or modified nucleotides, enzymes, labels, and buffers, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulation, transcription, and expression in the fields of scientific, diagnostic and clinical research.
Queried Legal Name
ILLUMINA, INC.
Registration Date
2012-06-19
Registration Number
4160543
First Use Commerce Date
2010-11-22
International Classes
IC 001
Matching Owner Entries
Illumina, Inc. (CORPORATION; DELAWARE, USA)
AGCT REGISTERED AND RENEWED · Serial 85442004
Registration
4251245
Filed
Oct 7, 2011
Registered
Nov 27, 2012
Classes
IC 009, IC 042
Attorney
Susan M. Natland
Goods & services
IC 009: Scientific instruments, namely, nucleic acid sequencers, imaging devices, namely, electronic imaging apparatus for detecting images and optical signals, and for processing images and optical signals into data, for use in genotyping and sequencing; laboratory equipment for sample preparation, amplification, mixing, hybridization, incubation, and washing, namely, biological sample trays carrying multiple reagents, microscopic carrier beads with chemically attached DNA fragments, sets of microscopic carrier beads with chemically attached DNA fragments, and biological sample containers in the form of microscope slides with internal channels and chips having multi-well arrays and with chemically attached DNA fragments; Automated laboratory equipment and systems, namely, devices for positioning, controlling temperature, and moving containers for samples or adding reagents thereto in the nature of robotic arms and movable sample containers for laboratory use and barcode readers; Computer systems comprised of computer hardware, computer operating systems, computer software, electronic data files, modems and computer peripheral devices for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data; all the foregoing for use in the fields of scientific, diagnostic and clinical research, clinical diagnostic analysis, genotyping and nucleotide sequencing. IC 042: Product development, namely, developing equipment for use in preparing, detecting, analyzing and sequencing nucleic acids and other biological molecules, and automated laboratory equipment and systems, and developing computer systems to the order and specification of others for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data to the order and specification of others, all the foregoing in the fields of scientific, diagnostic and clinical research; Scientific and technological services, namely, research services in the fields of genetics, epigenetics and gene expression analysis; Laboratory services, namely, preparation, detection, quantification, and analysis of biological material, for genotyping, for diagnostic assays, and for carrying out nucleic acid sequencing reactions; Consultancy, information and advisory services relating to the aforesaid services; Clinical diagnostic services in preparing, amplifying, labeling, detecting, analyzing and sequencing nucleic acids and other biological molecules.
Owners as filed
- Illumina, Inc. (ORIGINAL REGISTRANT)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:51f2513f113ed141bb608b9f
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=85442004&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
Yes
Owners as filed
City
San Diego
Name
Illumina, Inc.
Role
ORIGINAL REGISTRANT
Region
California 92122, UNITED STATES
Entity Type
CORPORATION
As Published
Illumina, Inc. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
REGISTERED AND RENEWED
Attorney
Susan M. Natland
Wordmark
AGCT
Filed Date
2011-10-07
Mark Types
TRADEMARK, SERVICE MARK
Us Classes
021 026 038 036 023., 100 101.
Registered
Yes
Status Code
800
Serial Number
85442004
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
First Use Any Date
2012-09-27
Goods And Services
IC 009: Scientific instruments, namely, nucleic acid sequencers, imaging devices, namely, electronic imaging apparatus for detecting images and optical signals, and for processing images and optical signals into data, for use in genotyping and sequencing; laboratory equipment for sample preparation, amplification, mixing, hybridization, incubation, and washing, namely, biological sample trays carrying multiple reagents, microscopic carrier beads with chemically attached DNA fragments, sets of microscopic carrier beads with chemically attached DNA fragments, and biological sample containers in the form of microscope slides with internal channels and chips having multi-well arrays and with chemically attached DNA fragments; Automated laboratory equipment and systems, namely, devices for positioning, controlling temperature, and moving containers for samples or adding reagents thereto in the nature of robotic arms and movable sample containers for laboratory use and barcode readers; Computer systems comprised of computer hardware, computer operating systems, computer software, electronic data files, modems and computer peripheral devices for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data; all the foregoing for use in the fields of scientific, diagnostic and clinical research, clinical diagnostic analysis, genotyping and nucleotide sequencing., IC 042: Product development, namely, developing equipment for use in preparing, detecting, analyzing and sequencing nucleic acids and other biological molecules, and automated laboratory equipment and systems, and developing computer systems to the order and specification of others for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data to the order and specification of others, all the foregoing in the fields of scientific, diagnostic and clinical research; Scientific and technological services, namely, research services in the fields of genetics, epigenetics and gene expression analysis; Laboratory services, namely, preparation, detection, quantification, and analysis of biological material, for genotyping, for diagnostic assays, and for carrying out nucleic acid sequencing reactions; Consultancy, information and advisory services relating to the aforesaid services; Clinical diagnostic services in preparing, amplifying, labeling, detecting, analyzing and sequencing nucleic acids and other biological molecules.
Queried Legal Name
ILLUMINA, INC.
Registration Date
2012-11-27
Registration Number
4251245
First Use Commerce Date
2012-09-27
International Classes
IC 009, IC 042
Matching Owner Entries
Illumina, Inc. (CORPORATION; DELAWARE, USA)
DREAMSEQ no longer live · ABANDONED - NO STATEMENT OF USE FILED · Serial 85510811
Filed
Jan 6, 2012
Classes
IC 009, IC 042
Attorney
Julia Anne Matheson
Goods & services
(ABANDONED) IC 009: Scientific and clinical diagnostic instruments, namely, nucleic acid sequencers, imaging devices, namely, electronic imaging apparatus for detecting images and optical signals, and for processing images and optical signals into data, for use in genotyping and sequencing; equipment for sample preparation, amplification, mixing, hybridization, incubation, and washing, namely, sample containers, reagent holders, and pipettes, carrying multiple reagents, and sample containers and hollow chambers having chemically modified surfaces; automated laboratory equipment and systems, namely, robotic equipment in the nature of a mechanical arm for positioning and moving containers for samples or adding reagents thereto, and barcode readers; computer systems comprised of networked, desktop, mobile, and hand-held computer hardware, computer operating systems, wireless data networks, computer software, computer application programs for use on mobile and networked computing devices for receiving and displaying information from scientific instruments, data files, modems and computer peripheral devices for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data, all the foregoing for use in the fields of scientific, diagnostic, clinical research, and for clinical diagnostic purposes. (ABANDONED) IC 042: Scientific and clinical diagnostic services in preparing, amplifying, labeling, detecting, analyzing and sequencing nucleic acids and other biological molecules from human beings or animals; computer services, namely, cloud hosting provider services for storing, analyzing and sharing biological information; providing an online network service that enables users to store, analyze and share data in the fields of life science; technical support services, namely, infrastructure management services for monitoring, administration and management of cloud computing IT and application systems in the fields of life science; consulting services in the field of cloud computing in the fields of life science.
Owners as filed
- Illumina, Inc. (OWNER AT PUBLICATION)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:aa3ce4467715ca9d05cff0a6
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=85510811&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
No
Owners as filed
City
San Diego
Name
Illumina, Inc.
Role
OWNER AT PUBLICATION
Region
CALIFORNIA 92122, UNITED STATES
Entity Type
CORPORATION
As Published
Illumina, Inc. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
ABANDONED - NO STATEMENT OF USE FILED
Attorney
Julia Anne Matheson
Wordmark
DREAMSEQ
Filed Date
2012-01-06
Mark Types
TRADEMARK, SERVICE MARK
Us Classes
021 026 038 036 023., 100 101.
Registered
No
Status Code
606
Abandon Date
2015-09-14
Serial Number
85510811
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
Goods And Services
(ABANDONED) IC 009: Scientific and clinical diagnostic instruments, namely, nucleic acid sequencers, imaging devices, namely, electronic imaging apparatus for detecting images and optical signals, and for processing images and optical signals into data, for use in genotyping and sequencing; equipment for sample preparation, amplification, mixing, hybridization, incubation, and washing, namely, sample containers, reagent holders, and pipettes, carrying multiple reagents, and sample containers and hollow chambers having chemically modified surfaces; automated laboratory equipment and systems, namely, robotic equipment in the nature of a mechanical arm for positioning and moving containers for samples or adding reagents thereto, and barcode readers; computer systems comprised of networked, desktop, mobile, and hand-held computer hardware, computer operating systems, wireless data networks, computer software, computer application programs for use on mobile and networked computing devices for receiving and displaying information from scientific instruments, data files, modems and computer peripheral devices for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data, all the foregoing for use in the fields of scientific, diagnostic, clinical research, and for clinical diagnostic purposes., (ABANDONED) IC 042: Scientific and clinical diagnostic services in preparing, amplifying, labeling, detecting, analyzing and sequencing nucleic acids and other biological molecules from human beings or animals; computer services, namely, cloud hosting provider services for storing, analyzing and sharing biological information; providing an online network service that enables users to store, analyze and share data in the fields of life science; technical support services, namely, infrastructure management services for monitoring, administration and management of cloud computing IT and application systems in the fields of life science; consulting services in the field of cloud computing in the fields of life science.
Queried Legal Name
ILLUMINA, INC.
International Classes
IC 009, IC 042
Matching Owner Entries
Illumina, Inc. (CORPORATION; DELAWARE, USA)
NEXTSEQ REGISTERED AND RENEWED · Serial 85568711
Registration
4534052
Filed
Mar 13, 2012
Registered
May 20, 2014
Classes
IC 009
Attorney
Susan M. Natland
Goods & services
IC 009: Scientific and clinical diagnostic instruments, namely, nucleic acid sequencers, imaging devices, namely, electronic imaging apparatus for detecting images and optical signals, and for processing images and optical signals into data, for use in sequencing.
Owners as filed
- Illumina, Inc. (ORIGINAL REGISTRANT)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:329d8afc030cd568700d8041
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=85568711&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
Yes
Owners as filed
City
San Diego
Name
Illumina, Inc.
Role
ORIGINAL REGISTRANT
Region
California 92122, UNITED STATES
Entity Type
CORPORATION
As Published
Illumina, Inc. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
REGISTERED AND RENEWED
Attorney
Susan M. Natland
Wordmark
NEXTSEQ
Filed Date
2012-03-13
Mark Types
TRADEMARK
Us Classes
038 026 036 023 021.
Registered
Yes
Status Code
800
Serial Number
85568711
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
First Use Any Date
2014-01-15
Goods And Services
IC 009: Scientific and clinical diagnostic instruments, namely, nucleic acid sequencers, imaging devices, namely, electronic imaging apparatus for detecting images and optical signals, and for processing images and optical signals into data, for use in sequencing.
Queried Legal Name
ILLUMINA, INC.
Registration Date
2014-05-20
Registration Number
4534052
First Use Commerce Date
2014-01-15
International Classes
IC 009
Matching Owner Entries
Illumina, Inc. (CORPORATION; DELAWARE, USA)
MISEQDX REGISTERED AND RENEWED · Serial 85647229
Registration
4538433
Filed
Jun 8, 2012
Registered
May 27, 2014
Classes
IC 005
Attorney
Susan M. Natland
Goods & services
IC 005: Medical diagnostic reagents; clinical diagnostic reagents.
Owners as filed
- Illumina, Inc. (ORIGINAL REGISTRANT)
USPTO record names this owner; current ownership is not inferred from historical owner entries.
View trademark record
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://tmsearch.uspto.gov/prod-v1-0-0/tmsearch → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://tmsearch.uspto.gov
Interpreted by rule
trademarks-v2
Evidence ID
uspto:62146d0fd1df0980af42d8df
All published fields
Source URL
https://tsdr.uspto.gov/#caseNumber=85647229&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Live mark
Yes
Owners as filed
City
San Diego
Name
Illumina, Inc.
Role
ORIGINAL REGISTRANT
Region
California 92122, UNITED STATES
Entity Type
CORPORATION
As Published
Illumina, Inc. (CORPORATION; DELAWARE, USA)
Citizenship
DELAWARE, USA
Status
REGISTERED AND RENEWED
Attorney
Susan M. Natland
Wordmark
MISEQDX
Filed Date
2012-06-08
Mark Types
TRADEMARK
Us Classes
006 018 052 046 044 051.
Registered
Yes
Status Code
800
Serial Number
85647229
Ownership scope
USPTO record names this owner; current ownership is not inferred from historical owner entries.
First Use Any Date
2013-10-28
Goods And Services
IC 005: Medical diagnostic reagents; clinical diagnostic reagents.
Queried Legal Name
ILLUMINA, INC.
Registration Date
2014-05-27
Registration Number
4538433
First Use Commerce Date
2013-10-28
International Classes
IC 005
Matching Owner Entries
Illumina, Inc. (CORPORATION; DELAWARE, USA)

SEC EDGAR

RegistrantILLUMINA, INC.
About ILLUMINA, INC., the SEC registrant the site links
Published by a third-party source
Observed via
https://data.sec.gov/submissions/CIK0001110803.json → https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://data.sec.gov
CIK1110803
About ILLUMINA, INC., the SEC registrant the site links
Published by a third-party source
Observed via
https://data.sec.gov/submissions/CIK0001110803.json → https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://data.sec.gov
EIN33-0804655
About ILLUMINA, INC., the SEC registrant the site links
Published by a third-party source
Observed via
https://data.sec.gov/submissions/CIK0001110803.json → https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://data.sec.gov
SIC3826 Laboratory Analytical Instruments
About ILLUMINA, INC., the SEC registrant the site links
Published by a third-party source
Observed via
https://data.sec.gov/submissions/CIK0001110803.json → https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://data.sec.gov
Entity typeoperating
About ILLUMINA, INC., the SEC registrant the site links
Published by a third-party source
Observed via
https://data.sec.gov/submissions/CIK0001110803.json → https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://data.sec.gov
Filer categoryLarge accelerated filer
About ILLUMINA, INC., the SEC registrant the site links
Published by a third-party source
Observed via
https://data.sec.gov/submissions/CIK0001110803.json → https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://data.sec.gov
State of incorporationDE
About ILLUMINA, INC., the SEC registrant the site links
Published by a third-party source
Observed via
https://data.sec.gov/submissions/CIK0001110803.json → https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://data.sec.gov
Fiscal year end01-03
About ILLUMINA, INC., the SEC registrant the site links
Published by a third-party source
Observed via
https://data.sec.gov/submissions/CIK0001110803.json → https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://data.sec.gov
Listed asNasdaq:ILMN
About ILLUMINA, INC., the SEC registrant the site links
Published by a third-party source
Observed via
https://data.sec.gov/submissions/CIK0001110803.json → https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://data.sec.gov
Business address5200 ILLUMINA WAY, SAN DIEGO, CA, 92122
About ILLUMINA, INC., the SEC registrant the site links
Published by a third-party source
Observed via
https://data.sec.gov/submissions/CIK0001110803.json → https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://data.sec.gov
Former nameILLUMINA INC
About ILLUMINA, INC., the SEC registrant the site links
Published by a third-party source
Observed via
https://data.sec.gov/submissions/CIK0001110803.json → https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://data.sec.gov

Consolidated balance sheets

	2025-12-28Dec. 28, 2025	2024-12-29Dec. 29, 2024
Current assets:
Cash and cash equivalents	1,418,000,000	1,127,000,000
Short-term investments	215,000,000	93,000,000
Accounts receivable, net	854,000,000	735,000,000
Inventory, net	564,000,000	547,000,000
Prepaid expenses and other current assets	238,000,000	244,000,000
Total current assets	3,289,000,000	2,746,000,000
Property and equipment, net	759,000,000	815,000,000
Operating lease right-of-use assets	370,000,000	419,000,000
Goodwill	1,113,000,000	1,113,000,000
Intangible assets, net	210,000,000	295,000,000
Deferred tax assets, net	454,000,000	567,000,000

Show the remaining 20 line items

	2025-12-28Dec. 28, 2025	2024-12-29Dec. 29, 2024
Other assets	449,000,000	348,000,000
Total assets	6,644,000,000	6,303,000,000
Current liabilities:
Accounts payable	240,000,000	221,000,000
Accrued liabilities	846,000,000	827,000,000
Term debt, current portion	499,000,000	499,000,000
Total current liabilities	1,585,000,000	1,547,000,000
Operating lease liabilities	486,000,000	554,000,000
Term debt	1,490,000,000	1,490,000,000
Other long-term liabilities	360,000,000	339,000,000
Commitments and contingencies
Stockholders’ equity:
Preferred stock, $0.01 par value, 10 million shares authorized; no shares issued and outstanding at December 28, 2025 and December 29, 2024	0	0
Common stock, $0.01 par value, 320 million shares authorized; 201 million shares issued and 153 million outstanding at December 28, 2025; 200 million shares issued and 159 million outstanding at December 29, 2024	2,000,000	2,000,000
Additional paid-in capital	7,822,000,000	7,525,000,000
Accumulated other comprehensive (loss) income	(10,000,000)	22,000,000
Accumulated deficit	(392,000,000)	(1,242,000,000)
Treasury stock, at cost; 48 million shares and 41 million shares at December 28, 2025 and December 29, 2024, respectively	(4,699,000,000)	(3,934,000,000)
Total stockholders’ equity	2,723,000,000	2,373,000,000
Total liabilities and stockholders’ equity	6,644,000,000	6,303,000,000

About ILLUMINA, INC., the SEC registrant the site links

Published by a third-party source

Observed via: https://www.sec.gov/Archives/edgar/data/1110803/000111080326000024/R3.htm → https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About: ILLUMINA, INC., the SEC registrant the site links
Read from: https://www.sec.gov

CONSOLIDATED BALANCE SHEETS (Parenthetical)

	2025-12-28Dec. 28, 2025	2024-12-29Dec. 29, 2024
Statement of Financial Position [Abstract]
Preferred stock, par value (in dollars per share)	0.01	0.01
Preferred stock, shares authorized (in shares)	10,000,000	10,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	0.01	0.01
Common stock, shares authorized (in shares)	320,000,000	320,000,000
Common stock, shares issued (in shares)	201,000,000	200,000,000
Common stock, shares outstanding (in shares)	153,000,000	159,000,000
Treasury stock, common shares (in shares)	48,000,000	41,000,000

About ILLUMINA, INC., the SEC registrant the site links

Published by a third-party source

Observed via: https://www.sec.gov/Archives/edgar/data/1110803/000111080326000024/R4.htm → https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About: ILLUMINA, INC., the SEC registrant the site links
Read from: https://www.sec.gov

Consolidated statements of operations

12 Months Ended	2025-12-28	2024-12-29	2023-12-31
Revenue:
Total revenue	4,343,000,000	4,372,000,000	4,504,000,000
Cost of revenue:
Amortization of acquired intangible assets	66,000,000	127,000,000	191,000,000
Total cost of revenue	1,473,000,000	1,511,000,000	1,760,000,000
Gross profit	2,870,000,000	2,861,000,000	2,744,000,000
Operating expense:
Research and development	967,000,000	1,169,000,000	1,354,000,000
Selling, general and administrative	1,086,000,000	1,092,000,000	1,612,000,000
Goodwill and intangible impairment	0	1,889,000,000	827,000,000
Legal contingency and settlement	10,000,000	(456,000,000)	20,000,000
Total operating expense	2,063,000,000	3,694,000,000	3,813,000,000

Show the remaining 25 line items

12 Months Ended	2025-12-28	2024-12-29	2023-12-31
Income (loss) from operations	807,000,000	(833,000,000)	(1,069,000,000)
Other income (expense):
Interest income	40,000,000	46,000,000	58,000,000
Interest expense	(101,000,000)	(100,000,000)	(77,000,000)
Other income (expense), net	340,000,000	(292,000,000)	(29,000,000)
Total other income (expense), net	279,000,000	(346,000,000)	(48,000,000)
Income (loss) before income taxes	1,086,000,000	(1,179,000,000)	(1,117,000,000)
Provision for income taxes	236,000,000	44,000,000	44,000,000
Net income (loss)	850,000,000	(1,223,000,000)	(1,161,000,000)
Earnings (loss) per share:
Basic (in dollars per share)	5.47	(7.69)	(7.34)
Diluted (in dollars per share)	5.45	(7.69)	(7.34)
Shares used in computing earnings (loss) per share:
Basic (in shares)	155,000,000	159,000,000	158,000,000
Diluted (in shares)	156,000,000	159,000,000	158,000,000
ProductProduct
ProductRevenue:
ProductTotal revenue	3,709,000,000	3,656,000,000	3,787,000,000
ProductCost of revenue:
ProductCost of revenue	1,107,000,000	1,017,000,000	1,177,000,000
ServiceService
ServiceRevenue:
ServiceTotal revenue	634,000,000	716,000,000	717,000,000
ServiceCost of revenue:
ServiceCost of revenue	300,000,000	367,000,000	392,000,000

About ILLUMINA, INC., the SEC registrant the site links

Published by a third-party source

Observed via: https://www.sec.gov/Archives/edgar/data/1110803/000111080326000024/R5.htm → https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About: ILLUMINA, INC., the SEC registrant the site links
Read from: https://www.sec.gov

Consolidated statements of comprehensive income (loss)

12 Months Ended	2025-12-28	2024-12-29	2023-12-31
Statement of Comprehensive Income [Abstract]
Net income (loss)	850,000,000	(1,223,000,000)	(1,161,000,000)
Unrealized (loss) gain on cash flow hedges, net of deferred tax	(32,000,000)	23,000,000	(4,000,000)
Total comprehensive income (loss)	818,000,000	(1,200,000,000)	(1,165,000,000)

About ILLUMINA, INC., the SEC registrant the site links

Published by a third-party source

Observed via: https://www.sec.gov/Archives/edgar/data/1110803/000111080326000024/R6.htm → https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About: ILLUMINA, INC., the SEC registrant the site links
Read from: https://www.sec.gov

Consolidated statements of cash flows

12 Months Ended	2025-12-28	2024-12-29	2023-12-31
Cash flows from operating activities:
Net income (loss)	850,000,000	(1,223,000,000)	(1,161,000,000)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation expense	203,000,000	224,000,000	235,000,000
Amortization of intangible assets	67,000,000	130,000,000	197,000,000
Share-based compensation expense	275,000,000	370,000,000	380,000,000
Deferred income taxes	119,000,000	(112,000,000)	(33,000,000)
Net (gains) losses on strategic investments(this filer’s own measure)	(328,000,000)	312,000,000	40,000,000
Change in fair value of contingent consideration liabilities	(18,000,000)	(315,000,000)	(24,000,000)
Goodwill and intangible impairment(this filer’s own measure)	23,000,000	1,889,000,000	827,000,000
Property and equipment and right-of-use asset impairment(this filer’s own measure)	4,000,000	46,000,000	100,000,000
Non-cash charitable contribution	19,000,000	0	0

Show the remaining 38 line items

12 Months Ended	2025-12-28	2024-12-29	2023-12-31
Gain on Helix contingent value right(this filer’s own measure)	0	(15,000,000)	(10,000,000)
Other	18,000,000	14,000,000	17,000,000
Changes in operating assets and liabilities:
Accounts receivable	(108,000,000)	(25,000,000)	(40,000,000)
Inventory	(17,000,000)	19,000,000	(20,000,000)
Prepaid expenses and other current assets	(8,000,000)	(14,000,000)	11,000,000
Operating lease right-of-use assets and liabilities, net(this filer’s own measure)	(34,000,000)	(32,000,000)	(16,000,000)
Other assets	(21,000,000)	(15,000,000)	5,000,000
Accounts payable	2,000,000	(4,000,000)	(44,000,000)
Accrued liabilities	0	(440,000,000)	15,000,000
Other long-term liabilities	33,000,000	28,000,000	(1,000,000)
Net cash provided by operating activities	1,079,000,000	837,000,000	478,000,000
Cash flows from investing activities:
Net purchases of property and equipment	(148,000,000)	(128,000,000)	(195,000,000)
Net sales (purchases) of strategic investments(this filer’s own measure)	103,000,000	(52,000,000)	(6,000,000)
Cash paid for acquisitions and intangible assets, net of cash acquired	(10,000,000)	(81,000,000)	(30,000,000)
Cash received for Helix contingent value right	0	83,000,000	0
Net cash used in investing activities	(55,000,000)	(178,000,000)	(231,000,000)
Cash flows from financing activities:
Common stock repurchases	(742,000,000)	(116,000,000)	0
Taxes paid related to net share settlement of equity awards	(40,000,000)	(32,000,000)	(40,000,000)
Proceeds from issuance of common stock	44,000,000	56,000,000	67,000,000
Payments on contingent consideration liabilities	(1,000,000)	(1,000,000)	(1,000,000)
Proceeds from debt, net of issuance costs(this filer’s own measure)			(1,000,000)
Proceeds from debt, net of issuance costs	495,000,000	1,241,000,000
Payments on debt obligations	(500,000,000)	(750,000,000)	(1,235,000,000)
GRAIL cash deconsolidated as a result of spin-off(this filer’s own measure)	0	(968,000,000)	0
Net cash used in financing activities	(744,000,000)	(570,000,000)	(1,210,000,000)
Effect of exchange rate changes on cash and cash equivalents	11,000,000	(10,000,000)	0
Net increase (decrease) in cash and cash equivalents	291,000,000	79,000,000	(963,000,000)
Cash and cash equivalents at beginning of year	1,127,000,000	1,048,000,000	2,011,000,000
Cash and cash equivalents at end of year	1,418,000,000	1,127,000,000	1,048,000,000
Supplemental cash flow information:
Cash paid for interest	95,000,000	83,000,000	73,000,000
Cash paid for income taxes (see Note 10)	73,000,000	105,000,000	65,000,000
Cash paid for operating lease liabilities	114,000,000	132,000,000	123,000,000
Purchases of property and equipment included in accounts payable and accrued liabilities	22,000,000	4,000,000	12,000,000
GRAIL net assets, excluding cash and cash equivalents, deconsolidated as a result of spin-off(this filer’s own measure)	0	1,770,000,000	0

About ILLUMINA, INC., the SEC registrant the site links

Published by a third-party source

Observed via: https://www.sec.gov/Archives/edgar/data/1110803/000111080326000024/R8.htm → https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About: ILLUMINA, INC., the SEC registrant the site links
Read from: https://www.sec.gov

Revenue by type
12 Months Ended 2025-12-28 2024-12-29 2023-12-31
Product 3,709,000,000 3,656,000,000 3,787,000,000
Service 634,000,000 716,000,000 717,000,000
About ILLUMINA, INC., the SEC registrant the site links
Published by a third-party source
Observed via
https://www.sec.gov/Archives/edgar/data/1110803/000111080326000024/R5.htm → https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://www.sec.gov
Cash and Cash Equivalents, at Carrying ValueUSD 1,144,000,000 · as at 2018-12-30 · 10-K filed 2019-02-12 · NOT CURRENT: this filer last reported this concept here, and reports more recent periods under another
About ILLUMINA, INC., the SEC registrant the site links
Published by a third-party source
Observed via
https://data.sec.gov/api/xbrl/companyconcept/CIK0001110803/us-gaap/CashAndCashEquivalentsAtCarryingValue.json → https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://data.sec.gov
Entity Public FloatUSD 9,200,000,000 · as at 2025-06-29 · 10-K filed 2026-02-12
About ILLUMINA, INC., the SEC registrant the site links
Published by a third-party source
Observed via
https://data.sec.gov/api/xbrl/companyconcept/CIK0001110803/dei/EntityPublicFloat.json → https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://data.sec.gov
Entity Common Stock, Shares Outstandingshares 152,900,000 · as at 2026-02-06 · 10-K filed 2026-02-12
About ILLUMINA, INC., the SEC registrant the site links
Published by a third-party source
Observed via
https://data.sec.gov/api/xbrl/companyconcept/CIK0001110803/dei/EntityCommonStockSharesOutstanding.json → https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://data.sec.gov
Operating Lease, CostUSD 78,000,000 · year to 2025-12-28 · 10-K filed 2026-02-12
About ILLUMINA, INC., the SEC registrant the site links
Published by a third-party source
Observed via
https://data.sec.gov/api/xbrl/companyconcept/CIK0001110803/us-gaap/OperatingLeaseCost.json → https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://data.sec.gov
Subsidiaries named in the annual report
- Advanced Liquid Logic Inc. · Delaware
- BlueBee Holding BV · Netherlands
- Emedgene Technologies Ltd · Israel
- Fluent Biosciences Inc. · Delaware
- Illumina AB · Sweden
- Illumina Australia Pty. Ltd. · Australia
- Illumina Austria GmbH · Austria
- Illumina Belgium BV · Belgium
- Illumina Brasil Produtos de Biotecnologia Ltda. · Brazil
- Illumina Cambridge, Ltd. · United Kingdom
- Illumina Cambridge Limited Singapore Branch · Singapore
- Illumina Canada ULC · Canada
Show the remaining 33
Illumina (China) Scientific Co Ltd · China
Illumina (China) Scientific Co., Ltd. – Beijing Branch · China
Illumina (China) Scientific Co., Ltd. – Guangzhou Branch · China
Illumina Colombia S.A.S. · Colombia
Illumina Commercial South Africa (Pty) · South Africa
Illumina Denmark ApS · Denmark
Illumina Diagnostics (Shanghai) Co., Ltd. · China
Illumina Finland Oy · Finland
Illumina France Holding Sarl · France
Illumina France Sarl · France
Illumina GmbH · Germany
Illumina Hong Kong Limited · Hong Kong
Illumina India Biotechnology Private Limited · India
Illumina International Genomics Pte. Ltd. · Singapore
Illumina Ireland Commercial Limited · Ireland
Illumina Italy S.r.l. · Italy
Illumina Korea Ltd. · Republic of Korea
Illumina K.K. · Japan
Illumina MENA Regional Headquarters · Saudi Arabia
Illumina México Productos de Biotecnología, S. de R.L. de C.V. · Mexico
Illumina Middle East FZE · United Arab Emirates
Illumina Netherlands B.V. · Netherlands
Illumina New Zealand Limited · New Zealand
Illumina Norway AS · Norway
Illumina Productos de Espana, S.L.U. · Spain
Illumina Singapore Genomics Pte. Ltd. · Singapore
Illumina Singapore Pte. Ltd. · Singapore
Illumina Software, Inc. · Delaware
Illumina Switzerland GmbH · Switzerland
Illumina US Manufacturing Operations, Inc. · Delaware
Illumina Taiwan Biotechnology Co., Ltd. · Taiwan
Illumina Turkey Biyoteknoloji Limited Sirketii · Turkey
Verinata Health, Inc. · Delaware
About ILLUMINA, INC., the SEC registrant the site links
Published by a third-party source
Observed via
https://www.sec.gov/Archives/edgar/data/1110803/000111080326000024/ex211subsidiariesfy2510-k.htm → https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://www.sec.gov
ILLUMINA, INC.
ten percent owner
- SEC insider of GRAIL, Inc.
Holds
3,502,126 Common stock, par value $0.001 per share
SEC CIK
1110803
Show 1 reported transaction
2025-11-17 open-market or private sale 1,000,000 @ 79.85 disposed
About ILLUMINA, INC., the SEC registrant the site links
Published by a third-party source
Observed via
https://www.sec.gov/Archives/edgar/data/1110803/000095015725000953/form4.xml → https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://www.sec.gov

DORSA CAROLINE

director

SEC insider of ILLUMINA, INC.

Holds: 15,754 Common Stock
SEC CIK: 1181174

Show 2 reported transactions

2026-05-21	grant or awardGrant of restricted stock units. 100% of the shares subject to the restricted stock unit award shall vest on the earlier of (i) the one year anniversary of the date of grant of the award and (ii) the date immediately preceding the date of the annual meeting of the company's stockholders for the year following the year of grant of the award, provided, in each case, that the awardee continues to serve as a director on such date.	2,072 @ 144.83	acquired
2026-05-20	shares withheld for exercise price or tax	1,512 @ 141.92	disposed

About ILLUMINA, INC., the SEC registrant the site links

Published by a third-party source

Observed via: https://www.sec.gov/Archives/edgar/data/1110803/000111080326000114/form4.xml → https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About: ILLUMINA, INC., the SEC registrant the site links
Read from: https://www.sec.gov

RICHO ANNA

director

SEC insider of ILLUMINA, INC.

Holds: 8,527 Common Stock
SEC CIK: 1199306

Show 1 reported transaction

2026-05-21

grant or awardGrant of restricted stock units. 100% of the shares subject to the restricted stock unit award shall vest on the earlier of (i) the one year anniversary of the date of grant of the award and (ii) the date immediately preceding the date of the annual meeting of the company's stockholders for the year following the year of grant of the award, provided, in each case, that the awardee continues to serve as a director on such date.

2,072 @ 144.83

acquired

About ILLUMINA, INC., the SEC registrant the site links

Published by a third-party source

Observed via: https://www.sec.gov/Archives/edgar/data/1110803/000111080326000117/form4.xml → https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About: ILLUMINA, INC., the SEC registrant the site links
Read from: https://www.sec.gov

SCHILLER PHILIP W

director

SEC insider of ILLUMINA, INC.

Holds: 22,220 Common Stock
SEC CIK: 1214110

Show 1 reported transaction

2026-05-21

grant or awardGrant of restricted stock units. 100% of the shares subject to the restricted stock unit award shall vest on the earlier of (i) the one year anniversary of the date of grant of the award and (ii) the date immediately preceding the date of the annual meeting of the company's stockholders for the year following the year of grant of the award, provided, in each case, that the awardee continues to serve as a director on such date.

2,072 @ 144.83

acquired

About ILLUMINA, INC., the SEC registrant the site links

Published by a third-party source

Observed via: https://www.sec.gov/Archives/edgar/data/1110803/000111080326000118/form4.xml → https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About: ILLUMINA, INC., the SEC registrant the site links
Read from: https://www.sec.gov

SIEGEL SUSAN E

director

SEC insider of ILLUMINA, INC.

Holds: 16,535 Common Stock
Reed-Siegel Revocable Trust: 4,006 Common Stock
SEC CIK: 1240363

Show 1 reported transaction

2026-05-21

grant or awardGrant of restricted stock units. 100% of the shares subject to the restricted stock unit award shall vest on the earlier of (i) the one year anniversary of the date of grant of the award and (ii) the date immediately preceding the date of the annual meeting of the company's stockholders for the year following the year of grant of the award, provided, in each case, that the awardee continues to serve as a director on such date.

2,072 @ 144.83

acquired

About ILLUMINA, INC., the SEC registrant the site links

Published by a third-party source

Observed via: https://www.sec.gov/Archives/edgar/data/1110803/000111080326000120/form4.xml → https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About: ILLUMINA, INC., the SEC registrant the site links
Read from: https://www.sec.gov

KING DAVID P

director

SEC insider of ILLUMINA, INC.

Holds: 2,072 Common Stock
SEC CIK: 1275654

Show 1 reported transaction

2026-05-21

grant or awardGrant of restricted stock units. 100% of the shares subject to the restricted stock unit award shall vest on the earlier of (i) the one year anniversary of the date of grant of the award and (ii) the date immediately preceding the date of the annual meeting of the company's stockholders for the year following the year of grant of the award, provided, in each case, that the awardee continues to serve as a director on such date.

2,072 @ 144.83

acquired

About ILLUMINA, INC., the SEC registrant the site links

Published by a third-party source

Observed via: https://www.sec.gov/Archives/edgar/data/1110803/000111080326000121/form4.xml → https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About: ILLUMINA, INC., the SEC registrant the site links
Read from: https://www.sec.gov

Meister Keith A.

director

SEC insider of ILLUMINA, INC.

Holds: 6,887 Common Stock
See footnote: 770,350 Common Stock
SEC CIK: 1307631

Show 109 reported transactions

2026-09-30	grant or awardMr. Meister elected to receive 100% of his 2026 board and committee cash retainer fees in Illumina stock. The number of shares issued in lieu of cash is based on the quotient of (i) the cash compensation otherwise payable for the immediately completed quarter divided by (ii) the volume weighted average closing price per share during the immediately completed quarter, calculated by reference to each trading day during such quarter. The amount reported on this Form represents Mr. Meister's 3rd quarter 2026 retainer fees.	107 @ 219.8037	acquired
2026-09-04	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $218.00 to $218.99.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	100,650 @ 218.39	disposed
2026-09-04	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $219.00 to $219.56.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	11,351 @ 219.18	disposed
2026-09-04	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $217.00 to $217.84.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	7,500 @ 217.28	disposed
2026-09-03	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $215.81 to $216.80.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	13,261 @ 216.38	disposed
2026-09-03	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $218.88 to $219.87.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	13,717 @ 219.41	disposed
2026-09-03	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $216.81 to $217.78.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	14,196 @ 217.29	disposed
2026-09-03	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $219.88 to $220.85.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	6,656 @ 220.17	disposed
2026-09-03	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $214.80 to $215.77.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	8,439 @ 215.2	disposed
2026-09-03	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $217.86 to $218.85.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	9,721 @ 218.33	disposed
2026-09-03	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $220.88 to $221.66.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	9,961 @ 221.55	disposed
2026-09-02	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $213.42 to $214.02.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	10,620 @ 213.73	disposed
2026-09-02	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $212.42 to $213.41. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3)-(14) to this Form 4.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	57,488 @ 213.2	disposed
2026-08-27	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $229.04 to $230.03.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	16,990 @ 229.72	disposed
2026-08-27	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $228.04 to $229.03.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	24,363 @ 228.64	disposed
2026-08-27	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $230.04 to $231.03.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	28,439 @ 230.54	disposed
2026-08-27	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $226.04 to $227.03.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	4,873 @ 226.74	disposed
2026-08-27	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $227.04 to $228.03.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	54,309 @ 227.67	disposed
2026-08-27	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $231.04 to $231.71.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	9,405 @ 231.23	disposed
2026-08-26	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $226.09 to $226.95.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	14,782 @ 226.5	disposed
2026-08-26	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $224.09 to $225.08.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	38,213 @ 224.72	disposed
2026-08-26	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $227.09 to $227.50.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	425 @ 227.22	disposed
2026-08-26	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $225.09 to $226.08.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	53,123 @ 225.69	disposed
2026-08-25	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $225.77 to $226.75.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	38,201 @ 226.13	disposed
2026-08-25	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $226.78 to $226.80.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	42 @ 226.79	disposed
2026-08-25	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $224.77 to $225.76. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3)-(15) to this Form 4.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	92,776 @ 225.26	disposed
2026-08-21	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $216.07 to $217.06.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	12,602 @ 216.44	disposed
2026-08-21	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $212.06 to $213.05.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	13,050 @ 212.65	disposed
2026-08-21	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $219.07 to $220.06.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	133,256 @ 219.47	disposed
2026-08-21	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $214.07 to $215.06.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	13,668 @ 214.64	disposed
2026-08-21	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $220.07 to $220.43.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	3,883 @ 220.13	disposed
2026-08-21	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $210.01 to $210.99.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	4,528 @ 210.45	disposed
2026-08-21	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $213.07 to $214.06.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	6,821 @ 213.81	disposed
2026-08-21	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $211.06 to $212.04.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	7,151 @ 211.54	disposed
2026-08-21	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $217.07 to $218.05.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	8,187 @ 217.84	disposed
2026-08-21	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $218.07 to $219.06.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	86,825 @ 218.6	disposed
2026-08-21	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $215.07 to $216.06.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	9,365 @ 215.61	disposed
2026-08-20	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $207.01 to $207.91.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	1,132 @ 207.65	disposed
2026-08-20	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $216.14 to $217.13.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	15,263 @ 216.88	disposed
2026-08-20	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $215.14 to $216.13.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	18,405 @ 215.62	disposed
2026-08-20	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $217.14 to $218.13.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	21,147 @ 217.72	disposed
2026-08-20	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $210.11 to $211.09.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	23,638 @ 210.66	disposed
2026-08-20	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $212.14 to $213.12.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	29,805 @ 212.83	disposed
2026-08-20	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $211.14 to $212.13.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	34,009 @ 211.9	disposed
2026-08-20	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $208.02 to $209.01.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	3,563 @ 208.55	disposed
2026-08-20	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $214.14 to $215.11.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	42,218 @ 214.57	disposed
2026-08-20	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $218.14 to $219.13.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	5,693 @ 218.46	disposed
2026-08-20	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $213.14 to $214.13.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	71,939 @ 213.36	disposed
2026-08-20	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $209.11 to $210.10.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	9,078 @ 209.68	disposed
2026-08-20	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $219.15 to $220.00.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	9,348 @ 219.82	disposed
2026-08-19	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $204.72 to $205.11.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	12,813 @ 205	disposed
2026-08-19	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $201.59 to $202.58. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3)-(30) to this Form 4.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	19,884 @ 202.37	disposed
2026-08-19	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $203.65 to $204.61.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	4,759 @ 204.16	disposed
2026-08-19	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $202.59 to $203.58.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	57,544 @ 203.16	disposed
2026-08-05	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $201.60 to $202.58.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	11,372 @ 201.8	disposed
2026-08-05	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $199.60 to $200.59.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	118,753 @ 199.87	disposed
2026-08-05	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $202.60 to $203.50.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	2,450 @ 203.28	disposed
2026-08-05	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $200.60 to $201.59.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	30,398 @ 201.37	disposed
2026-08-05	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $197.60 to $198.59.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	52,249 @ 198.18	disposed
2026-08-05	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $198.60 to $199.59.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	68,047 @ 198.97	disposed
2026-08-04	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $198.00 to $198.98.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	166,501 @ 198.24	disposed
2026-08-04	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $197.00 to $197.99.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	27,854 @ 197.48	disposed
2026-08-04	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $199.00 to $199.96.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	35,160 @ 199.51	disposed
2026-08-04	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $200.00 to $200.99.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	37,242 @ 200.65	disposed
2026-08-04	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $202.00 to $202.99.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	48,186 @ 202.43	disposed
2026-08-04	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $201.00 to $201.99.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	67,725 @ 201.44	disposed
2026-08-04	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $203.00 to $203.44.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	67,988 @ 203.09	disposed
2026-08-04	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $196.00 to $196.99. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) and (5) to (17) to this Form 4.Our Section 16 filings inadvertently reported that the reporting person indirectly owned 100 fewer shares of common stock. The correct number of shares indirectly owned prior to the sales reported on this filing was 2,830,552 shares of common stock. The amount reported in Column 5 reflects such correction.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	7,202 @ 196.74	disposed
2026-06-30	grant or awardMr. Meister elected to receive 100% of his 2026 board and committee cash retainer fees in Illumina stock. The number of shares issued in lieu of cash is based on the quotient of (i) the cash compensation otherwise payable for the immediately completed quarter divided by (ii) the volume weighted average closing price per share during the immediately completed quarter, calculated by reference to each trading day during such quarter. The amount reported on this Form represents Mr. Meister's 2nd quarter 2026 retainer fees.	142 @ 149.1868	acquired
2026-06-01	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $165.00 to $165.95.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	15,472 @ 165.5	disposed
2026-06-01	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $163.00 to $163.99.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	61,613 @ 163.56	disposed
2026-06-01	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $162.00 to $162.99.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	70,262 @ 162.41	disposed
2026-06-01	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $164.00 to $164.99.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	87,653 @ 164.34	disposed
2026-05-29	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $159.05 to $160.04.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	11,760 @ 159.57	disposed
2026-05-29	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $165.20 to $165.43.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	1,961 @ 165.3	disposed
2026-05-29	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $163.13 to $164.09.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	19,832 @ 163.57	disposed
2026-05-29	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $162.05 to $162.98.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	2,225 @ 162.44	disposed
2026-05-29	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $160.05 to $161.03.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	4,579 @ 160.5	disposed
2026-05-29	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $161.05 to $162.03.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	5,256 @ 161.64	disposed
2026-05-29	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $163.19 to $164.18.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	6,198 @ 163.97	disposed
2026-05-29	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $162.19 to $163.16.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	63,020 @ 162.86	disposed
2026-05-29	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $164.14 to $165.09.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	6,888 @ 164.75	disposed
2026-05-29	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $164.19 to $165.18.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	92,877 @ 164.56	disposed
2026-05-28	other acquisition or dispositionThese securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	24,562 @ 156.4	disposed
2026-05-28	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $157.85 to $158.77.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	110,424 @ 147.5	disposed
2026-05-28	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $155.85 to $156.84. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (5)-(21) to this Form 4.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	37,590 @ 156.5	disposed
2026-05-28	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $156.85 to $157.84.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	71,986 @ 157.38	disposed
2026-05-28	exercise of an in- or at-the-money derivativeThese securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	24,562 @ 102.82	acquired
2026-05-28	exercise of an in- or at-the-money derivativeEquity Swap (right to buy) → 24,562 Common Stock · exercisable at 102.82 · expires 2028-02-11As previously reported, the Corvex Funds had entered into equity swaps that represented an aggregate economic long-side exposure comparable to a notional interest in 368,744 shares of common stock of the Issuer. Under the terms of the swaps, the value to be received or paid upon termination of a swap will be determined by the difference in the market price per notional share of common stock on the date of termination as compared to the cost of such notional share of common stock at the time of entry into the swap. On May 28, 2026, upon final termination of the swaps as reported in Table II above, the swaps counterparty paid to the Corvex Funds $3,841,496.80, representing $156.40 per share for each of the 24,562 notional shares subject to the termination (the market price of the common stock on the date of the partial termination), offset by $2,525,464.84, representing $102.82 for each of such 24,562 notional shares.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	24,562	disposed
2026-05-21	grant or awardGrant of restricted stock units. 100% of the shares subject to the restricted stock unit award shall vest the date prior to the annual meeting of the company's stockholders in the year of the award, provided, in each case, that the awardee continues to serve as a director on such date.	2,072 @ 144.83	acquired
2026-05-14	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $143.50 to $144.49.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	12,309 @ 144.13	disposed
2026-05-14	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $146.50 to $147.49.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	13,776 @ 146.96	disposed
2026-05-14	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $147.50 to $148.06.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	180 @ 147.8	disposed
2026-05-14	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $145.50 to $146.49.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	25,352 @ 146.15	disposed
2026-05-14	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $144.50 to $145.49.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	52,776 @ 144.8	disposed
2026-05-13	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $144.75 to $145.73. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (5)-(13) to this Form 4.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	159,623 @ 145.26	disposed
2026-05-13	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $148 to $148.49.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	5,310 @ 148.14	disposed
2026-05-13	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $145.75 to $146.74.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	53,610 @ 145.94	disposed
2026-05-13	open-market or private saleThe price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions within the range of $147 to $147.98.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	6,524 @ 147.5	disposed
2026-05-12	other acquisition or dispositionThese securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	255,378 @ 144.66	disposed
2026-05-12	exercise of an in- or at-the-money derivativeThese securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	255,378 @ 102.82	acquired
2026-05-12	exercise of an in- or at-the-money derivativeEquity Swap (right to buy) → 255,378 Common Stock · exercisable at 102.82 · expires 2028-02-11As previously reported, the Corvex Funds had entered into equity swaps that represented an aggregate economic long-side exposure comparable to a notional interest in 368,744 shares of common stock of the Issuer. Under the terms of the swaps, the value to be received or paid upon termination of a swap will be determined by the difference in the market price per notional share of common stock on the date of termination as compared to the cost of such notional share of common stock at the time of entry into the swap. On May 12, 2026, upon partial termination of the swaps as reported in Table II above, the swaps counterparty paid to the Corvex Funds $36,942,981.48, representing $144.66 per share for each of the 255,378 notional shares subject to the termination (the market price of the common stock on the date of the partial termination), offset by $26,257,965.96, representing $102.82 for each of such 255,378 notional shares.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	255,378	disposed
2026-05-11	other acquisition or dispositionThese securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	79,568 @ 143.45	disposed
2026-05-11	exercise of an in- or at-the-money derivativeThese securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	79,568 @ 102.82	acquired
2026-05-11	exercise of an in- or at-the-money derivativeEquity Swap (right to buy) → 79,568 Common Stock · exercisable at 102.82 · expires 2028-02-11As previously reported, the Corvex Funds had entered into equity swaps that represented an aggregate economic long-side exposure comparable to a notional interest in 368,744 shares of common stock of the Issuer. Under the terms of the swaps, the value to be received or paid upon termination of a swap will be determined by the difference in the market price per notional share of common stock on the date of termination as compared to the cost of such notional share of common stock at the time of entry into the swap. On May 7, 2026, upon partial termination of the swaps as reported in Table II above, the swaps counterparty paid to the Corvex Funds $1,295,349, representing $140.25 per share for each of the 9,236 notional shares subject to the termination (the market price of the common stock on the date of the partial termination), offset by $949,645.52, representing $102.82 for each of such 9,236 notional shares.In addition, on May 11, 2026, upon partial termination of the swaps as reported in Table II above, the swaps counterparty paid to the Corvex Funds $11,414,029.60, representing $143.45 per share for each of the 79,568 notional shares subject to the termination (the market price of the common stock on the date of the partial termination), offset by $8,181,181.76, representing $102.82 for each of such 79,568 notional shares.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	79,568	disposed
2026-05-07	other acquisition or dispositionThese securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	9,236 @ 140.25	disposed
2026-05-07	exercise of an in- or at-the-money derivativeThese securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	9,236 @ 102.82	acquired
2026-05-07	exercise of an in- or at-the-money derivativeEquity Swap (right to buy) → 9,236 Common Stock · exercisable at 102.82 · expires 2028-02-11As previously reported, the Corvex Funds had entered into equity swaps that represented an aggregate economic long-side exposure comparable to a notional interest in 368,744 shares of common stock of the Issuer. Under the terms of the swaps, the value to be received or paid upon termination of a swap will be determined by the difference in the market price per notional share of common stock on the date of termination as compared to the cost of such notional share of common stock at the time of entry into the swap. On May 7, 2026, upon partial termination of the swaps as reported in Table II above, the swaps counterparty paid to the Corvex Funds $1,295,349, representing $140.25 per share for each of the 9,236 notional shares subject to the termination (the market price of the common stock on the date of the partial termination), offset by $949,645.52, representing $102.82 for each of such 9,236 notional shares.These securities of Illumina, Inc. (the "Issuer") are held for the accounts of certain private investment funds (collectively, the "Corvex Funds") for which Corvex Management LP ("Corvex") acts as investment adviser, including Corvex Master Fund LP and Corvex Select Equity Master Fund LP. The general partner of Corvex is controlled by Keith Meister.For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.	9,236	disposed
2026-03-31	grant or awardMr. Meister elected to receive 100% of his 2026 board and committee cash retainer fees in Illumina stock. The number of shares issued in lieu of cash is based on the quotient of (i) the cash compensation otherwise payable for the immediately completed quarter divided by (ii) the volume weighted average closing price per share during the immediately completed quarter, calculated by reference to each trading day during such quarter. The amount reported on this Form represents Mr. Meister's 1st quarter 2026 retainer fees.	161 @ 131.5473	acquired

About ILLUMINA, INC., the SEC registrant the site links

Published by a third-party source

Observed via: https://www.sec.gov/Archives/edgar/data/1110803/000111080326000181/form4.xml → https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About: ILLUMINA, INC., the SEC registrant the site links
Read from: https://www.sec.gov

Gottlieb Scott

director

SEC insider of ILLUMINA, INC.

Holds: 14,795 Common Stock
SEC CIK: 1411359

Show 3 reported transactions

2026-05-21	grant or awardGrant of restricted stock units. 100% of the shares subject to the restricted stock unit award shall vest the date prior to the annual meeting of the company's stockholders in the year of the award, provided, in each case, that the awardee continues to serve as a director on such date.	2,072 @ 144.83	acquired
2026-02-09	open-market or private purchase	200 @ 117.81	acquired
2025-11-03	open-market or private purchase	500 @ 122.13	acquired

About ILLUMINA, INC., the SEC registrant the site links

Published by a third-party source

Observed via: https://www.sec.gov/Archives/edgar/data/1110803/000111080326000115/form4.xml → https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About: ILLUMINA, INC., the SEC registrant the site links
Read from: https://www.sec.gov

Ullem Scott B.

director

SEC insider of ILLUMINA, INC.

Holds: 11,143 Common Stock
SEC CIK: 1446989

Show 5 reported transactions

2026-09-30	grant or awardMr. Ullem elected to receive 100% of his 2026 board and committee cash retainer fees in Illumina stock. The number of shares issued in lieu of cash is based on the quotient of (i) the cash compensation otherwise payable for the immediately completed quarter divided by (ii) the volume weighted average closing price per share during the immediately completed quarter, calculated by reference to each trading day during such quarter. The amount reported on this Form represents Mr. Ullem's 3rd quarter 2026 retainer fees.	113 @ 219.8037	acquired
2026-06-30	grant or awardMr. Ullem elected to receive 100% of his 2026 board and committee cash retainer fees in Illumina stock. The number of shares issued in lieu of cash is based on the quotient of (i) the cash compensation otherwise payable for the immediately completed quarter divided by (ii) the volume weighted average closing price per share during the immediately completed quarter, calculated by reference to each trading day during such quarter. The amount reported on this Form represents Mr. Ullem's 2nd quarter 2026 retainer fees.	167 @ 149.1868	acquired
2026-05-21	grant or awardGrant of restricted stock units. 100% of the shares subject to the restricted stock unit award shall vest on the earlier of (i) the one year anniversary of the date of grant of the award and (ii) the date immediately preceding the date of the annual meeting of the company's stockholders for the year following the year of grant of the award, provided, in each case, that the awardee continues to serve as a director on such date.	2,072 @ 144.83	acquired
2026-03-31	grant or awardMr. Ullem elected to receive 100% of his 2026 board and committee cash retainer fees in Illumina stock. The number of shares issued in lieu of cash is based on the quotient of (i) the cash compensation otherwise payable for the immediately completed quarter divided by (ii) the volume weighted average closing price per share during the immediately completed quarter, calculated by reference to each trading day during such quarter. The amount reported on this Form represents Mr. Ullem's 1st quarter 2026 retainer fees.	190 @ 131.5473	acquired
2025-12-31	grant or awardMr. Ullem elected to receive 100% of his 2025 board and committee cash retainer fees in Illumina stock. The number of shares issued in lieu of cash is based on the quotient of (i) the cash compensation otherwise payable for the immediately completed quarter divided by (ii) the volume weighted average closing price per share during the immediately completed quarter, calculated by reference to each trading day during such quarter. The amount reported on this Form represents Mr. Ullem's 4th quarter 2025 retainer fees.	212 @ 117.6298	acquired

About ILLUMINA, INC., the SEC registrant the site links

Published by a third-party source

Observed via: https://www.sec.gov/Archives/edgar/data/1110803/000111080326000180/form4.xml → https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About: ILLUMINA, INC., the SEC registrant the site links
Read from: https://www.sec.gov

Thaysen Jacob

Chief Executive Officer · officer · director

SEC insider of ILLUMINA, INC.

Holds: 107,770 Common Stock
Pay, year to 2025-12-28: 11,018,895 reported total · 12,832,816 actually paid
Pay, year to 2024-12-29: 14,802,924 reported total · 17,689,413 actually paid
Pay, year to 2023-12-31: 4,691,233 reported total · 4,439,576 actually paid
Pay, year to 2023-01-01: 0 reported total · 0 actually paid
Pay, year to 2022-01-02: 0 reported total · 0 actually paid
SEC CIK: 1625263

Show 7 reported transactions

2026-10-05	shares withheld for exercise price or tax	1,303 @ 293.69	disposed
2026-03-05	grant or awardGrant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of February 15, 2027, February 15, 2028, February 15, 2029, and February 15, 2030, subject to awardee's continuing status as a service provider on such dates.	25,734 @ 128.24	acquired
2026-03-05	grant or awardPerformance Shares → 30,022 Common Stock · expires 2028-12-31Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's three-year average consolidated non-GAAP earnings per share growth for fiscal years 2026-2028 with vesting on December 31, 2028. The number of shares issued will range from 0% to 250% of the amount specified above, based on the Company's actual three-year average consolidated non-GAAP earnings per share growth for fiscal years 2026-2028, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates.	30,022 @ 128.24	acquired
2026-02-15	shares withheld for exercise price or tax	6,544 @ 116.51	disposed
2026-02-12	shares withheld for exercise price or tax	5,470 @ 114.44	disposed
2026-02-12	exercise or conversion of a derivativeRepresents shares of stock awarded as a result of the Company achieving at least 74% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on October 5, 2023.	13,264	acquired
2026-02-12	exercise or conversion of a derivativePerformance Shares → 13,264 Common Stock · expires 2025-12-28Represents shares of stock awarded as a result of the Company achieving at least 74% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on October 5, 2023.	13,264	disposed

About ILLUMINA, INC., the SEC registrant the site links

Published by a third-party source

Observed via: https://www.sec.gov/Archives/edgar/data/1110803/000111080326000183/form4.xml → https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About: ILLUMINA, INC., the SEC registrant the site links
Read from: https://www.sec.gov

Skovronsky Daniel

director

SEC insider of ILLUMINA, INC.

Holds: 1,674 Common Stock
SEC CIK: 1741474

Show 1 reported transaction

2026-06-16

grant or awardGrant of restricted stock units. 100% of the shares subject to the restricted stock unit award shall vest on the earlier of (i) the one year anniversary of the date of grant of the award and (ii) the date immediately preceding the date of the annual meeting of the company's stockholders for the year following the year of grant of the award, provided, in each case, that the awardee continues to serve as a director on such date.

1,674 @ 164.28

acquired

About ILLUMINA, INC., the SEC registrant the site links

Published by a third-party source

Observed via: https://www.sec.gov/Archives/edgar/data/1110803/000111080326000142/form4.xml → https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About: ILLUMINA, INC., the SEC registrant the site links
Read from: https://www.sec.gov

Coletti Julie Ann

Chief Legal Officer · officer

SEC insider of ILLUMINA, INC.

Holds: 18,763 Common Stock
Holds: 5,307 Performance Shares (a claim on shares, not shares)
SEC CIK: 1777603

Show 4 reported transactions

2026-09-08	grant or awardGrant of restricted stock units shall vest as follows: 33.3% of the shares subject to the award shall vest on each of September 5, 2027, September 5, 2028, and September 5, 2029, subject to the awardee's continuing status as a service provider on such dates.	14,214	acquired
2026-09-08	grant or awardGrant of restricted stock units with 25% of the shares subject to the award vesting on each of the first, second, third and fourth anniversaries of the date of grant, subject to the awardee's continuing to be a service provider on such dates.	4,549	acquired
2026-09-08	grant or awardPerformance Shares → 5,307 Common Stock · expires 2028-12-31Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's three-year average consolidated non-GAAP earnings per share growth for fiscal years 2026-2028 with vesting on December 31, 2028. The number of shares issued will range from 0% to 250% of the amount specified above, based on the Company's actual three-year average consolidated non-GAAP earnings per share growth for fiscal years 2026-2028, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates.	5,307	acquired
2026-09-08	grant or awardPerformance Shares → 5,307 Common Stock · expires 2028-12-31Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's relative total shareholder return for the fiscal year ending December 31, 2028. The number of shares issued will range from 0% to 250% of the amount specified above, based on the company's relative total shareholder return for the fiscal year ending December 31, 2028, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates.	5,307	acquired

About ILLUMINA, INC., the SEC registrant the site links

Published by a third-party source

Observed via: https://www.sec.gov/Archives/edgar/data/1110803/000111080326000177/form4.xml → https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About: ILLUMINA, INC., the SEC registrant the site links
Read from: https://www.sec.gov

Dhingra Ankur

SVP, Chief Financial Officer · officer

SEC insider of ILLUMINA, INC.

Holds: 34,264 Common Stock
Holds: 10,918 Performance Shares (a claim on shares, not shares)
SEC CIK: 1849682

Show 3 reported transactions

2026-03-05	grant or awardGrant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of February 15, 2027, February 15, 2028, February 15, 2029, and February 15, 2030, subject to awardee's continuing status as a service provider on such dates.	9,358 @ 128.24	acquired
2026-03-05	grant or awardPerformance Shares → 10,918 Common Stock · expires 2028-12-31Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's three-year average consolidated non-GAAP earnings per share growth for fiscal years 2026-2028 with vesting on December 31, 2028. The number of shares issued will range from 0% to 250% of the amount specified above, based on the Company's actual three-year average consolidated non-GAAP earnings per share growth for fiscal years 2026-2028, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates.	10,918 @ 128.24	acquired
2026-03-05	grant or awardPerformance Shares → 10,918 Common Stock · expires 2028-12-31Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's relative total shareholder return for the fiscal year ending December 31, 2028. The number of shares issued will range from 0% to 250% of the amount specified above, based on the company's relative total shareholder return for the fiscal year ending December 31, 2028, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates.	10,918 @ 128.24	acquired

About ILLUMINA, INC., the SEC registrant the site links

Published by a third-party source

Observed via: https://www.sec.gov/Archives/edgar/data/1110803/000111080326000072/form4.xml → https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About: ILLUMINA, INC., the SEC registrant the site links
Read from: https://www.sec.gov

Pegels Kevin Carl

Chief of Global Operations · officer

SEC insider of ILLUMINA, INC.

Holds: 29,038 Common Stock
Holds: 7,369 Performance Shares (a claim on shares, not shares)
SEC CIK: 1892104

Show 8 reported transactions

2026-03-05	grant or awardGrant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of February 15, 2027, February 15, 2028, February 15, 2029, and February 15, 2030, subject to awardee's continuing status as a service provider on such dates.	6,317 @ 128.24	acquired
2026-03-05	grant or awardPerformance Shares → 7,369 Common Stock · expires 2028-12-31Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's three-year average consolidated non-GAAP earnings per share growth for fiscal years 2026-2028 with vesting on December 31, 2028. The number of shares issued will range from 0% to 250% of the amount specified above, based on the Company's actual three-year average consolidated non-GAAP earnings per share growth for fiscal years 2026-2028, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates.	7,369 @ 128.24	acquired
2026-03-05	grant or awardPerformance Shares → 7,369 Common Stock · expires 2028-12-31Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's relative total shareholder return for the fiscal year ending December 31, 2028. The number of shares issued will range from 0% to 250% of the amount specified above, based on the company's relative total shareholder return for the fiscal year ending December 31, 2028, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates.	7,369 @ 128.24	acquired
2026-02-15	shares withheld for exercise price or tax	1,164 @ 116.51	disposed
2026-02-12	shares withheld for exercise price or tax	874 @ 114.44	disposed
2026-02-12	exercise or conversion of a derivativeRepresents shares of stock awarded as a result of the Company achieving at least 74% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on March 1, 2023.	2,283	acquired
2026-02-12	exercise or conversion of a derivativePerformance Shares → 2,283 Common Stock · expires 2025-12-28Represents shares of stock awarded as a result of the Company achieving at least 74% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on March 1, 2023.	2,283	disposed
2025-11-05	shares withheld for exercise price or tax	599 @ 122.44	disposed

About ILLUMINA, INC., the SEC registrant the site links

Published by a third-party source

Observed via: https://www.sec.gov/Archives/edgar/data/1110803/000111080326000069/form4.xml → https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About: ILLUMINA, INC., the SEC registrant the site links
Read from: https://www.sec.gov

Ericksen Scott D

VP, Chief Accounting Officer · officer

SEC insider of ILLUMINA, INC.

Holds: 14,446 Common Stock
SEC CIK: 1950482

Show 2 notices of intent to sell

Intends to sell 500 Common, worth 79,350 when filed, on or about 2026-05-29held as Employee Stock Purchase Plan · through Morgan Stanley Smith Barney LLC Executive Financial Servicesalready sold 1,500 on 2026-05-28 for 225,150 gross
Intends to sell 1,500 Common, worth 225,255 when filed, on or about 2026-05-28held as Restricted Stock Units · through Morgan Stanley Smith Barney LLC Executive Financial Services

Show 9 reported transactions

2026-05-29	open-market or private sale	500 @ 160	disposed
2026-05-28	open-market or private sale	1,500 @ 150.1	disposed
2026-03-05	grant or awardGrant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of February 15, 2027, February 15, 2028, February 15, 2029, and February 15, 2030, subject to awardee's continuing status as a service provider on such dates.	3,217 @ 128.24	acquired
2026-03-05	grant or awardPerformance Shares → 1,609 Common Stock · expires 2028-12-31Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's three-year average consolidated non-GAAP earnings per share growth for fiscal years 2026-2028 with vesting on December 31, 2028. The number of shares issued will range from 0% to 250% of the amount specified above, based on the Company's actual three-year average consolidated non-GAAP earnings per share growth for fiscal years 2026-2028, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates.	1,609 @ 128.24	acquired
2026-02-15	shares withheld for exercise price or tax	694 @ 116.51	disposed
2026-02-12	shares withheld for exercise price or tax	306 @ 114.44	disposed
2026-02-12	exercise or conversion of a derivativeRepresents shares of stock awarded as a result of the Company achieving at least 74% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on March 1, 2023.	743	acquired
2026-02-12	exercise or conversion of a derivativePerformance Shares → 743 Common Stock · expires 2025-12-28Represents shares of stock awarded as a result of the Company achieving at least 74% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on March 1, 2023.	743	disposed
2025-11-05	shares withheld for exercise price or tax	206 @ 122.44	disposed

About ILLUMINA, INC., the SEC registrant the site links

Published by a third-party source

Observed via: https://www.sec.gov/Archives/edgar/data/1110803/000111080326000129/form4.xml → https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About: ILLUMINA, INC., the SEC registrant the site links
Read from: https://www.sec.gov

Barnard Steven

SVP, Chief Technology Officer · officer

SEC insider of ILLUMINA, INC.

Holds: 40,927 Common Stock
SEC CIK: 1990125

Show 11 reported transactions

2026-09-05	shares withheld for exercise price or tax	408 @ 211.06	disposed
2026-03-05	grant or awardGrant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of February 15, 2027, February 15, 2028, February 15, 2029, and February 15, 2030, subject to awardee's continuing status as a service provider on such dates.Balance includes 297 shares acquired through Employee Stock Purchase Plan.	7,603 @ 128.24	acquired
2026-03-05	grant or awardPerformance Shares → 8,871 Common Stock · expires 2028-12-31Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's three-year average consolidated non-GAAP earnings per share growth for fiscal years 2026-2028 with vesting on December 31, 2028. The number of shares issued will range from 0% to 250% of the amount specified above, based on the Company's actual three-year average consolidated non-GAAP earnings per share growth for fiscal years 2026-2028, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates.	8,871 @ 128.24	acquired
2026-03-05	grant or awardPerformance Shares → 8,871 Common Stock · expires 2028-12-31Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's relative total shareholder return for the fiscal year ending December 31, 2028. The number of shares issued will range from 0% to 250% of the amount specified above, based on the company's relative total shareholder return for the fiscal year ending December 31, 2028, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates.	8,871 @ 128.74	acquired
2026-02-15	shares withheld for exercise price or tax	1,259 @ 116.51	disposed
2026-02-12	shares withheld for exercise price or tax	1,014 @ 114.44	disposed
2026-02-12	exercise or conversion of a derivativeRepresents shares of stock awarded as a result of the Company achieving at least 74% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on March 1, 2023.	1,256	acquired
2026-02-12	exercise or conversion of a derivativeRepresents shares of stock awarded as a result of the Company achieving at least 74% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on September 5, 2023.	1,421	acquired
2026-02-12	exercise or conversion of a derivativePerformance Shares → 1,256 Common Stock · expires 2025-12-28Represents shares of stock awarded as a result of the Company achieving at least 74% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on March 1, 2023.	1,256	disposed
2026-02-12	exercise or conversion of a derivativePerformance Shares → 1,421 Common Stock · expires 2025-12-28Represents shares of stock awarded as a result of the Company achieving at least 74% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on September 5, 2023.	1,421	disposed
2025-11-05	shares withheld for exercise price or tax	515 @ 122.44	disposed

About ILLUMINA, INC., the SEC registrant the site links

Published by a third-party source

Observed via: https://www.sec.gov/Archives/edgar/data/1110803/000111080326000175/form4.xml → https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About: ILLUMINA, INC., the SEC registrant the site links
Read from: https://www.sec.gov

Leckman Patricia

SVP, Chief People Officer · officer

SEC insider of ILLUMINA, INC.

Holds: 21,259 Common Stock
SEC CIK: 2015062

Show 3 notices of intent to sell

Intends to sell 783 Common, worth 131,215.14 when filed, on or about 2026-06-05held as PSU · through UBS Financial Services Inc.already sold 784 on 2026-06-02 for 127,067.43 gross
Intends to sell 784 Common, worth 127,067.43 when filed, on or about 2026-06-02held as PSU · through UBS Financial Services Inc.
Intends to sell 2,370 Common, worth 275,346.6 when filed, on or about 2026-02-18held as Restricted Stock · through Morgan Stanley Smith Barney LLC Executive Financial Services

Show 16 reported transactions

2026-06-05	open-market or private sale	2 @ 167.88	disposed
2026-06-05	open-market or private saleWeighted average sale price representing 290 shares sold ranging from $161.30 to $162.19 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.	290 @ 161.79	disposed
2026-06-05	open-market or private saleWeighted average sale price representing 374 shares sold ranging from $162.31 to $163.25 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.	374 @ 162.78	disposed
2026-06-05	open-market or private sale	39 @ 164.82	disposed
2026-06-05	open-market or private saleWeighted average sale price representing 78 shares sold ranging from $163.35 to $163.36 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.	78 @ 163.36	disposed
2026-06-02	open-market or private saleWeighted average sale price representing 176 shares sold ranging from $160.30 to $161.24 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.	176 @ 160.66	disposed
2026-06-02	open-market or private saleWeighted average sale price representing 290 shares sold ranging from $162.66 to $163.33 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.	290 @ 163.02	disposed
2026-06-02	open-market or private saleWeighted average sale price representing 318 shares sold ranging from $161.65 to $162.26 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.	318 @ 162	disposed
2026-03-05	grant or awardGrant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of February 15, 2027, February 15, 2028, February 15, 2029, and February 15, 2030, subject to awardee's continuing status as a service provider on such dates.Balance includes 188 shares acquired through Employee Stock Purchase Plan.	6,317 @ 128.24	acquired
2026-03-05	grant or awardPerformance Shares → 7,369 Common Stock · expires 2028-12-31Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's three-year average consolidated non-GAAP earnings per share growth for fiscal years 2026-2028 with vesting on December 31, 2028. The number of shares issued will range from 0% to 250% of the amount specified above, based on the Company's actual three-year average consolidated non-GAAP earnings per share growth for fiscal years 2026-2028, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates.	7,369 @ 128.24	acquired
2026-02-18	open-market or private sale	2,370 @ 116.18	disposed
2026-02-15	shares withheld for exercise price or tax	1,304 @ 116.51	disposed
2026-02-12	shares withheld for exercise price or tax	424 @ 114.44	disposed
2026-02-12	exercise or conversion of a derivativeRepresents shares of stock awarded as a result of the Company achieving at least 74% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on March 1, 2023.	1,028	acquired
2026-02-12	exercise or conversion of a derivativePerformance Shares → 1,028 Common Stock · expires 2025-12-28Represents shares of stock awarded as a result of the Company achieving at least 74% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on March 1, 2023.	1,028	disposed
2025-11-05	shares withheld for exercise price or tax	296 @ 122.44	disposed

About ILLUMINA, INC., the SEC registrant the site links

Published by a third-party source

Observed via: https://www.sec.gov/Archives/edgar/data/1110803/000111080326000134/form4.xml → https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About: ILLUMINA, INC., the SEC registrant the site links
Read from: https://www.sec.gov

Wedel Christensen Jakob

SVP, Strategy/Corp Development · officer

SEC insider of ILLUMINA, INC.

Holds: 14,023 Common Stock
SEC CIK: 2020721

Show 3 notices of intent to sell

Intends to sell 1,033 Common, worth 199,508.46 when filed, on or about 2026-08-18held as Restricted Stock Units · through Morgan Stanley Smith Barney LLC Executive Financial Services
Intends to sell 700 Common, worth 97,328 when filed, on or about 2026-05-06held as Restricted Stock · through Morgan Stanley Smith Barney LLC Executive Financial Services
Intends to sell 549 Common, worth 70,969.23 when filed, on or about 2025-12-08held as Restricted Stock · through Morgan Stanley Smith Barney LLC Executive Financial Services

Show 8 reported transactions

2026-08-18	open-market or private sale	1,033 @ 191.52	disposed
2026-05-06	open-market or private sale	700 @ 139.04	disposed
2026-05-05	shares withheld for exercise price or tax	233 @ 139.07	disposed
2026-03-05	grant or awardGrant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of February 15, 2027, February 15, 2028, February 15, 2029, and February 15, 2030, subject to awardee's continuing status as a service provider on such dates.	5,615 @ 128.24	acquired
2026-03-05	grant or awardPerformance Shares → 6,551 Common Stock · expires 2028-12-31Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's three-year average consolidated non-GAAP earnings per share growth for fiscal years 2026-2028 with vesting on December 31, 2028. The number of shares issued will range from 0% to 250% of the amount specified above, based on the Company's actual three-year average consolidated non-GAAP earnings per share growth for fiscal years 2026-2028, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates.	6,551 @ 128.24	acquired
2026-02-15	shares withheld for exercise price or tax	578 @ 116.51	disposed
2025-12-08	open-market or private sale	549 @ 129.27	disposed
2025-12-05	shares withheld for exercise price or tax	307 @ 128.96	disposed

About ILLUMINA, INC., the SEC registrant the site links

Published by a third-party source

Observed via: https://www.sec.gov/Archives/edgar/data/1110803/000111080326000173/form4.xml → https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About: ILLUMINA, INC., the SEC registrant the site links
Read from: https://www.sec.gov

Davies Scott M

Chief Legal Officer · officer

SEC insider of ILLUMINA, INC.

Holds: 20,338 Common Stock
SEC CIK: 2040663

Show 6 notices of intent to sell

Intends to sell 615 Common, worth 119,814.3 when filed, on or about 2026-07-30held as Restricted Stock Units · through Morgan Stanley Smith Barney LLC Executive Financial Servicesalready sold 615 on 2026-06-25 for 110,700 grossalready sold 615 on 2026-05-29 for 98,400 gross
Intends to sell 615 Common, worth 107,680.35 when filed, on or about 2026-06-25held as Performance Stock Units & Restricted Stock Units · through Morgan Stanley Smith Barney LLC Executive Financial Servicesalready sold 615 on 2026-05-29 for 98,400 gross
Intends to sell 615 Common, worth 97,600.5 when filed, on or about 2026-05-29held as Performance Stock Units & Restricted Stock Units · through Morgan Stanley Smith Barney LLC Executive Financial Services
Intends to sell 1,336 Common, worth 160,320 when filed, on or about 2026-02-20held as Performance Stock Units · through Morgan Stanley Smith Barney LLC Executive Financial Servicesalready sold 323 on 2025-12-12 for 43,957.07 gross
Intends to sell 323 Common, worth 43,957.07 when filed, on or about 2025-12-12held as Restricted Stock · through Morgan Stanley Smith Barney LLC Executive Financial Servicesalready sold 323 on 2025-11-12 for 39,661.17 gross
Intends to sell 323 Common, worth 39,661.17 when filed, on or about 2025-11-12held as Performance Shares · through Morgan Stanley Smith Barney LLC Executive Financial Services

Show 13 reported transactions

2026-07-30	open-market or private sale	615 @ 200	disposed
2026-06-25	open-market or private sale	615 @ 180	disposed
2026-05-29	open-market or private sale	615 @ 160	disposed
2026-03-05	grant or awardGrant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of February 15, 2027, February 15, 2028, February 15, 2029, and February 15, 2030, subject to awardee's continuing status as a service provider on such dates.	5,849 @ 128.24	acquired
2026-03-05	grant or awardPerformance Shares → 6,824 Common Stock · expires 2028-12-31Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's three-year average consolidated non-GAAP earnings per share growth for fiscal years 2026-2028 with vesting on December 31, 2028. The number of shares issued will range from 0% to 250% of the amount specified above, based on the Company's actual three-year average consolidated non-GAAP earnings per share growth for fiscal years 2026-2028, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates.	6,824 @ 128.24	acquired
2026-02-20	open-market or private sale	1,336 @ 116.18	disposed
2026-02-15	shares withheld for exercise price or tax	1,037 @ 116.51	disposed
2026-02-12	shares withheld for exercise price or tax	550 @ 114.44	disposed
2026-02-12	exercise or conversion of a derivativeRepresents shares of stock awarded as a result of the Company achieving at least 74% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on March 1, 2023.	1,370	acquired
2026-02-12	exercise or conversion of a derivativePerformance Shares → 1,370 Common Stock · expires 2025-12-28Represents shares of stock awarded as a result of the Company achieving at least 74% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on March 1, 2023.	1,370	disposed
2025-12-12	open-market or private sale	323 @ 136.09	disposed
2025-11-12	disposition to the issuer	323 @ 122.79	disposed
2025-11-05	shares withheld for exercise price or tax	398 @ 122.44	disposed

About ILLUMINA, INC., the SEC registrant the site links

Published by a third-party source

Observed via: https://www.sec.gov/Archives/edgar/data/1110803/000111080326000161/form4.xml → https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About: ILLUMINA, INC., the SEC registrant the site links
Read from: https://www.sec.gov

Sullivan Michael C

Chief Commercial Officer · officer

SEC insider of ILLUMINA, INC.

Holds: 4,503 Common Stock
Holds: 5,254 Performance Shares (a claim on shares, not shares)
SEC CIK: 2147356

Show 3 reported transactions

2026-08-05	grant or awardGrant of restricted stock units with 25% of the shares subject to the award vesting on each of the first, second, third and fourth anniversaries of the date of grant, subject to the awardee's continuing to be a service provider on such dates.	4,503 @ 199.87	acquired
2026-08-05	grant or awardPerformance Shares → 5,254 Common Stock · expires 2028-12-31Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's three-year average consolidated non-GAAP earnings per share growth for fiscal years 2026-2028 with vesting on December 31, 2028. The number of shares issued will range from 0% to 250% of the amount specified above, based on the Company's actual three-year average consolidated non-GAAP earnings per share growth for fiscal years 2026-2028, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates.	5,254	acquired
2026-08-05	grant or awardPerformance Shares → 5,254 Common Stock · expires 2028-12-31Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's relative total shareholder return for the fiscal year ending December 31, 2028. The number of shares issued will range from 0% to 250% of the amount specified above, based on the company's relative total shareholder return for the fiscal year ending December 31, 2028, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates.	5,254	acquired

About ILLUMINA, INC., the SEC registrant the site links

Published by a third-party source

Observed via: https://www.sec.gov/Archives/edgar/data/1110803/000111080326000169/form4.xml → https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About: ILLUMINA, INC., the SEC registrant the site links
Read from: https://www.sec.gov

Other named executive officers, average
average of the named executive officers other than the chief executive
Pay, year to 2025-12-28
3,706,336 reported total · 4,562,844 actually paid
Pay, year to 2024-12-29
5,426,941 reported total · 6,362,249 actually paid
Pay, year to 2023-12-31
4,495,352 reported total · 692,244 actually paid
Pay, year to 2023-01-01
5,772,066 reported total · (3,358,918) actually paid
Pay, year to 2022-01-02
8,019,825 reported total · 8,297,373 actually paid
About ILLUMINA, INC., the SEC registrant the site links
Published by a third-party source
Observed via
https://www.sec.gov/Archives/edgar/data/1110803/000119312526149669/R2.htm → https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://www.sec.gov
Francis deSouza
principal executive officer
Pay, year to 2025-12-28
0 reported total · 0 actually paid
Pay, year to 2024-12-29
0 reported total · 0 actually paid
Pay, year to 2023-12-31
14,494,506 reported total · (8,142,898) actually paid
Pay, year to 2023-01-01
26,752,197 reported total · (10,053,847) actually paid
Pay, year to 2022-01-02
14,333,634 reported total · 36,737,462 actually paid
About ILLUMINA, INC., the SEC registrant the site links
Published by a third-party source
Observed via
https://www.sec.gov/Archives/edgar/data/1110803/000119312526149669/R2.htm → https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://www.sec.gov
Charles Dadswell
principal executive officer
Pay, year to 2025-12-28
0 reported total · 0 actually paid
Pay, year to 2024-12-29
0 reported total · 0 actually paid
Pay, year to 2023-12-31
4,139,866 reported total · 1,840,569 actually paid
Pay, year to 2023-01-01
0 reported total · 0 actually paid
Pay, year to 2022-01-02
0 reported total · 0 actually paid
About ILLUMINA, INC., the SEC registrant the site links
Published by a third-party source
Observed via
https://www.sec.gov/Archives/edgar/data/1110803/000119312526149669/R2.htm → https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://www.sec.gov
Corvex Management LP
Affiliate of Director (1)
Show 8 notices of intent to sell
Intends to sell 150,000 Common Stock, par value $0.01 per share, worth 31,987,500 when filed, on or about 2026-09-04held as Purchases of shares of Common Stock in the open market (2) · through Goldman Sachs & Co. LLCalready sold 457,858 on 2026-08-04 for 91,616,949.73 grossalready sold 283,269 on 2026-08-05 for 56,542,873.94 grossalready sold 95,000 on 2026-08-19 for 19,312,857.7 grossalready sold 285,238 on 2026-08-20 for 60,999,944.21 grossalready sold 299,336 on 2026-08-21 for 65,242,566.35 grossalready sold 131,019 on 2026-08-25 for 29,546,278.62 grossalready sold 106,543 on 2026-08-26 for 24,021,480.44 grossalready sold 138,379 on 2026-08-27 for 31,673,634.84 grossalready sold 68,108 on 2026-09-02 for 14,526,262.57 grossalready sold 75,951 on 2026-09-03 for 16,574,471.06 gross
Intends to sell 200,000 Common Stock, par value $0.01 per share, worth 44,968,000 when filed, on or about 2026-08-27held as Purchases of shares of Common Stock in the open market (2) · through Goldman Sachs & Co. LLCalready sold 220,000 on 2026-05-28 for 34,686,783.32 grossalready sold 214,596 on 2026-05-29 for 35,088,672.43 grossalready sold 235,000 on 2026-06-01 for 38,454,606.87 grossalready sold 457,858 on 2026-08-04 for 91,616,949.73 grossalready sold 283,269 on 2026-08-05 for 56,542,873.94 grossalready sold 95,000 on 2026-08-19 for 19,312,857.7 grossalready sold 285,238 on 2026-08-20 for 60,999,944.21 grossalready sold 299,336 on 2026-08-21 for 65,242,566.35 grossalready sold 131,019 on 2026-08-25 for 29,546,278.62 grossalready sold 106,543 on 2026-08-26 for 24,021,480.44 grossalready sold 82,438 on 2026-08-27 for 18,901,434.68 gross
Intends to sell 300,000 Common Stock, par value $0.01 per share, worth 66,966,000 when filed, on or about 2026-08-25held as Purchases of shares of Common Stock in the open market (2) · through Goldman Sachs & Co. LLCalready sold 220,000 on 2026-05-28 for 34,686,783.32 grossalready sold 214,596 on 2026-05-29 for 35,088,672.43 grossalready sold 235,000 on 2026-06-01 for 38,454,606.87 grossalready sold 457,858 on 2026-08-04 for 91,616,949.73 grossalready sold 283,269 on 2026-08-05 for 56,542,873.94 grossalready sold 95,000 on 2026-08-19 for 19,312,857.7 grossalready sold 285,238 on 2026-08-20 for 60,999,944.21 grossalready sold 299,336 on 2026-08-21 for 65,242,566.35 grossalready sold 20,000 on 2026-08-25 for 4,517,623.21 gross
Intends to sell 250,000 Common Stock, par value $0.01 per share, worth 53,310,000 when filed, on or about 2026-08-21held as Purchases of shares of Common Stock in the open market (2) · through Goldman Sachs & Co. LLCalready sold 220,000 on 2026-05-28 for 34,686,783.32 grossalready sold 214,596 on 2026-05-29 for 35,088,672.43 grossalready sold 235,000 on 2026-06-01 for 38,454,606.87 grossalready sold 457,858 on 2026-08-04 for 91,616,949.73 grossalready sold 283,269 on 2026-08-05 for 56,542,873.94 grossalready sold 95,000 on 2026-08-19 for 19,312,857.7 grossalready sold 285,238 on 2026-08-20 for 60,999,944.21 grossalready sold 69,762 on 2026-08-21 for 14,940,550 gross
Intends to sell 355,000 Common Stock, par value $0.01 per share, worth 72,775,000 when filed, on or about 2026-08-20held as Purchases of shares of Common Stock in the open market (2) · through Goldman Sachs & Co. LLCalready sold 220,000 on 2026-05-28 for 34,686,783.32 grossalready sold 214,596 on 2026-05-29 for 35,088,672.43 grossalready sold 235,000 on 2026-06-01 for 38,454,606.87 grossalready sold 457,858 on 2026-08-04 for 91,616,949.73 grossalready sold 283,269 on 2026-08-05 for 56,542,873.94 grossalready sold 95,000 on 2026-08-19 for 19,312,857.7 gross
Intends to sell 840,000 Common Stock, par value $0.01 per share, worth 166,454,400 when filed, on or about 2026-08-04held as Purchases of shares of Common Stock in the open market (2) · through Goldman Sachs & Co. LLCalready sold 225,067 on 2026-05-13 for 32,760,165.38 grossalready sold 104,393 on 2026-05-14 for 15,172,549.18 grossalready sold 220,000 on 2026-05-28 for 34,686,783.32 grossalready sold 214,596 on 2026-05-29 for 35,088,672.43 grossalready sold 235,000 on 2026-06-01 for 38,454,606.87 gross
Intends to sell 400,000 Common Stock, par value $0.01 per share, worth 63,480,000 when filed, on or about 2026-05-29held as Purchases of shares of Common stock in the open market (2) · through Goldman Sachs & Co. LLCalready sold 225,067 on 2026-05-13 for 32,760,165.38 grossalready sold 104,393 on 2026-05-14 for 15,172,549.18 grossalready sold 220,000 on 2026-05-28 for 34,686,783.32 grossalready sold 50,540 on 2026-05-29 for 8,201,109.48 gross
Intends to sell 600,000 Common Stock, par value $0.01 per share, worth 87,420,000 when filed, on or about 2026-05-13held as Purchases of shares of Common Stock in the open market (2) · through Goldman Sachs & Co. LLC
About ILLUMINA, INC., the SEC registrant the site links
Published by a third-party source
Observed via
https://www.sec.gov/Archives/edgar/data/1110803/000131586326000630/primary_doc.xml → https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://www.sec.gov
FRANCES ARNOLD
Former Director
Show 3 notices of intent to sell
Intends to sell 2,000 Common, worth 362,980 when filed, on or about 2026-06-25held as Restricted Stock Vesting Under a Registered Plan · through Morgan Stanley Smith Barney LLC Executive Financial Servicesalready sold 3,000 on 2026-06-02 for 484,571.7 grossalready sold 5,000 on 2026-05-28 for 780,650 grossalready sold 3,000 on 2026-05-22 for 435,076.08 grossalready sold 1,000 on 2026-05-22 for 145,072.06 gross
Intends to sell 3,000 Common, worth 484,571.7 when filed, on or about 2026-06-02held as Restricted stock vesting under a registered plan · through Morgan Stanley Smith Barney LLC Executive Financial Servicesalready sold 5,000 on 2026-05-28 for 780,650 grossalready sold 3,000 on 2026-05-22 for 435,076.08 grossalready sold 1,000 on 2026-05-22 for 145,072.06 gross
Intends to sell 5,000 Common, worth 780,650 when filed, on or about 2026-05-28held as Restricted stock vesting under a registered plan · through Morgan Stanley Smith Barney LLC Executive Financial Servicesalready sold 3,000 on 2026-05-22 for 435,076.08 grossalready sold 1,000 on 2026-05-22 for 145,072.06 gross
About ILLUMINA, INC., the SEC registrant the site links
Published by a third-party source
Observed via
https://www.sec.gov/Archives/edgar/data/1110803/000195004726006486/primary_doc.xml → https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://www.sec.gov

Shareholder return and performance

	2025-12-28	2024-12-29	2023-12-31	2023-01-01	2022-01-02
Value of $100 invested in this company	36.47	36.56	37.63	54.65	102.82
Value of $100 invested in the peer group	122.07	91.53	91.84	88.53	99.37
Net income	850,000,000	(1,223,000,000)	(1,161,000,000)	(4,404,000,000)	762,000,000
Illumina Revenue, the measure this company selected	4,343,000,000	4,332,000,000	4,438,000,000	4,553,000,000	4,519,000,000

About ILLUMINA, INC., the SEC registrant the site links

Published by a third-party source

Observed via: https://www.sec.gov/Archives/edgar/data/1110803/000119312526149669/R2.htm → https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About: ILLUMINA, INC., the SEC registrant the site links
Read from: https://www.sec.gov

Material events reported in the last year
- 2026-10-13 entered a material agreement · took on a direct financial obligation
- 2026-08-17 reported another event it considers material
- 2026-08-13 entered a material agreement · terminated a material agreement · took on a direct financial obligation
- 2026-08-12 reported another event it considers material
- 2026-08-07 reported another event it considers material
- 2026-07-30 reported results of operations and financial condition
- 2026-06-23 changed its directors or principal officers
- 2026-05-26 reported the results of a shareholder vote
- 2026-04-30 reported results of operations and financial condition · reported another event it considers material
- 2026-04-02 changed its directors or principal officers · made a Regulation FD disclosure
- 2026-02-05 reported results of operations and financial condition
- 2026-01-30 completed an acquisition or disposal of assets · reported another event it considers material
Show the remaining 5
2026-01-13 reported results of operations and financial condition
2026-01-08 changed its directors or principal officers · made a Regulation FD disclosure
2025-11-25 reported another event it considers material
2025-11-12 reported another event it considers material
2025-10-30 reported results of operations and financial condition
About ILLUMINA, INC., the SEC registrant the site links
Published by a third-party source
Observed via
https://www.sec.gov/Archives/edgar/data/1110803/000111080326000195/0001110803-26-000195-index.html → https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://www.sec.gov
Latest annual report10-K filed 2026-02-12 · for the year ending 2025-12-28
About ILLUMINA, INC., the SEC registrant the site links
Published by a third-party source
Observed via
https://www.sec.gov/Archives/edgar/data/1110803/000111080326000024/0001110803-26-000024-index.html → https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://www.sec.gov

Litigation

Illumina, Inc. v. BillionToOne, Inc. District Court, D. Delaware · Filed May 7, 2026
Docket
1:26-cv-00531
Filed
May 7, 2026
Jurisdiction
Federal Question
Matched party
Illumina, Inc.
Searched name
ILLUMINA, INC.
Nature Of Suit
830 Patent
Cause
35:1 Patent Infringement
Exact party-name match in CourtListener; not an independently resolved legal identity, finding of wrongdoing or litigation outcome.
View court docket
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://www.courtlistener.com/api/rest/v4/search/?order_by=dateFiled+desc&q=party%3A%22ILLUMINA%2C+INC.%22&type=d → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://www.courtlistener.com
Interpreted by rule
court-dockets-v2
Evidence ID
courtlistener:2625984c5d24502bd1784b42
All published fields
Source URL
https://www.courtlistener.com/docket/73311191/illumina-inc-v-billiontoone-inc/
Cause
35:1 Patent Infringement
Court
District Court, D. Delaware
Court ID
ded
Case Name
Illumina, Inc. v. BillionToOne, Inc.
Docket ID
73311191
Date Filed
2026-05-07
Match scope
Exact party-name match in CourtListener; not an independently resolved legal identity, finding of wrongdoing or litigation outcome.
Docket number
1:26-cv-00531
Nature Of Suit
830 Patent
Other Parties
BillionToOne, Inc.
Jurisdiction Type
Federal Question
Matched Party Name
Illumina, Inc.
Queried Legal Name
ILLUMINA, INC.
Other Parties Scope
Each is a party to the case, as the docket search names it: no side is stated for any party, no relation to this company is inferred, and none was searched in turn.
10X Genomics, Inc. v. Illumina, Inc. District Court, D. Delaware · Filed Oct 21, 2025
Docket
1:25-cv-01286
Filed
Oct 21, 2025
Jurisdiction
Federal Question
Matched party
Illumina, Inc.
Searched name
ILLUMINA, INC.
Nature Of Suit
830 Patent
Cause
35:271 Patent Infringement
Exact party-name match in CourtListener; not an independently resolved legal identity, finding of wrongdoing or litigation outcome.
View court docket
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://www.courtlistener.com/api/rest/v4/search/?order_by=dateFiled+desc&q=party%3A%22ILLUMINA%2C+INC.%22&type=d → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://www.courtlistener.com
Interpreted by rule
court-dockets-v2
Evidence ID
courtlistener:a03692adca2f2bc8efa7774c
All published fields
Source URL
https://www.courtlistener.com/docket/71708640/10x-genomics-inc-v-illumina-inc/
Cause
35:271 Patent Infringement
Court
District Court, D. Delaware
Court ID
ded
Case Name
10X Genomics, Inc. v. Illumina, Inc.
Docket ID
71708640
Date Filed
2025-10-21
Match scope
Exact party-name match in CourtListener; not an independently resolved legal identity, finding of wrongdoing or litigation outcome.
Docket number
1:25-cv-01286
Nature Of Suit
830 Patent
Other Parties
10X Genomics, Inc., Prognosys Biosciences, Inc.
Jurisdiction Type
Federal Question
Matched Party Name
Illumina, Inc.
Queried Legal Name
ILLUMINA, INC.
Other Parties Scope
Each is a party to the case, as the docket search names it: no side is stated for any party, no relation to this company is inferred, and none was searched in turn.
10X Genomics, Inc. v. Illumina, Inc. District Court, D. Delaware · Filed Oct 21, 2025
Docket
1:25-cv-01287
Filed
Oct 21, 2025
Jurisdiction
Federal Question
Matched party
Illumina, Inc.
Searched name
ILLUMINA, INC.
Nature Of Suit
830 Patent
Cause
35:271 Patent Infringement
Exact party-name match in CourtListener; not an independently resolved legal identity, finding of wrongdoing or litigation outcome.
View court docket
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://www.courtlistener.com/api/rest/v4/search/?order_by=dateFiled+desc&q=party%3A%22ILLUMINA%2C+INC.%22&type=d → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://www.courtlistener.com
Interpreted by rule
court-dockets-v2
Evidence ID
courtlistener:6d85d5ecf11581a72783306d
All published fields
Source URL
https://www.courtlistener.com/docket/71709671/10x-genomics-inc-v-illumina-inc/
Cause
35:271 Patent Infringement
Court
District Court, D. Delaware
Court ID
ded
Case Name
10X Genomics, Inc. v. Illumina, Inc.
Docket ID
71709671
Date Filed
2025-10-21
Match scope
Exact party-name match in CourtListener; not an independently resolved legal identity, finding of wrongdoing or litigation outcome.
Docket number
1:25-cv-01287
Nature Of Suit
830 Patent
Other Parties
Roche Sequencing Solutions, Inc., 10X Genomics, Inc.
Jurisdiction Type
Federal Question
Matched Party Name
Illumina, Inc.
Queried Legal Name
ILLUMINA, INC.
Other Parties Scope
Each is a party to the case, as the docket search names it: no side is stated for any party, no relation to this company is inferred, and none was searched in turn.
Element Biosciences, Inc. v. Illumina, Inc. District Court, N.D. California · Filed Sep 22, 2025
Docket
5:25-cv-08026
Filed
Sep 22, 2025
Jurisdiction
Federal Question
Matched party
Illumina, Inc.
Searched name
ILLUMINA, INC.
Nature Of Suit
410 Anti-Trust
Cause
15:1 Antitrust Litigation
Exact party-name match in CourtListener; not an independently resolved legal identity, finding of wrongdoing or litigation outcome.
View court docket
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://www.courtlistener.com/api/rest/v4/search/?order_by=dateFiled+desc&q=party%3A%22ILLUMINA%2C+INC.%22&type=d → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://www.courtlistener.com
Interpreted by rule
court-dockets-v2
Evidence ID
courtlistener:6a134bf34df85dde26db3225
All published fields
Source URL
https://www.courtlistener.com/docket/71417961/element-biosciences-inc-v-illumina-inc/
Cause
15:1 Antitrust Litigation
Court
District Court, N.D. California
Court ID
cand
Case Name
Element Biosciences, Inc. v. Illumina, Inc.
Docket ID
71417961
Date Filed
2025-09-22
Match scope
Exact party-name match in CourtListener; not an independently resolved legal identity, finding of wrongdoing or litigation outcome.
Docket number
5:25-cv-08026
Nature Of Suit
410 Anti-Trust
Other Parties
Illumina Cambridge Ltd., Element Biosciences, Inc.
Jurisdiction Type
Federal Question
Matched Party Name
Illumina, Inc.
Queried Legal Name
ILLUMINA, INC.
Other Parties Scope
Each is a party to the case, as the docket search names it: no side is stated for any party, no relation to this company is inferred, and none was searched in turn.
Element Biosciences, Inc. v. Illumina, Inc. District Court, D. Delaware · Filed Sep 22, 2025
Docket
1:25-cv-01175
Filed
Sep 22, 2025
Jurisdiction
Federal Question
Matched party
Illumina, Inc.
Searched name
ILLUMINA, INC.
Nature Of Suit
830 Patent
Cause
35:1 Patent Infringement
Exact party-name match in CourtListener; not an independently resolved legal identity, finding of wrongdoing or litigation outcome.
View court docket
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://www.courtlistener.com/api/rest/v4/search/?order_by=dateFiled+desc&q=party%3A%22ILLUMINA%2C+INC.%22&type=d → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://www.courtlistener.com
Interpreted by rule
court-dockets-v2
Evidence ID
courtlistener:afde21b250aa2fc21f127c17
All published fields
Source URL
https://www.courtlistener.com/docket/71419119/element-biosciences-inc-v-illumina-inc/
Cause
35:1 Patent Infringement
Court
District Court, D. Delaware
Court ID
ded
Case Name
Element Biosciences, Inc. v. Illumina, Inc.
Docket ID
71419119
Date Filed
2025-09-22
Match scope
Exact party-name match in CourtListener; not an independently resolved legal identity, finding of wrongdoing or litigation outcome.
Docket number
1:25-cv-01175
Nature Of Suit
830 Patent
Other Parties
Element Biosciences, Inc.
Jurisdiction Type
Federal Question
Matched Party Name
Illumina, Inc.
Queried Legal Name
ILLUMINA, INC.
Other Parties Scope
Each is a party to the case, as the docket search names it: no side is stated for any party, no relation to this company is inferred, and none was searched in turn.
The Research Institute at Nationwide Children's Hospital v. Illumina, Inc. District Court, D. Delaware · Filed Jun 3, 2025
Docket
1:25-cv-00683
Filed
Jun 3, 2025
Jurisdiction
Federal Question
Matched party
Illumina, Inc.
Searched name
ILLUMINA, INC.
Nature Of Suit
830 Patent
Cause
35:271 Patent Infringement
Exact party-name match in CourtListener; not an independently resolved legal identity, finding of wrongdoing or litigation outcome.
View court docket
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://www.courtlistener.com/api/rest/v4/search/?order_by=dateFiled+desc&q=party%3A%22ILLUMINA%2C+INC.%22&type=d → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://www.courtlistener.com
Interpreted by rule
court-dockets-v2
Evidence ID
courtlistener:c8a2e4f70f23fd1c44be63f3
All published fields
Source URL
https://www.courtlistener.com/docket/70448243/the-research-institute-at-nationwide-childrens-hospital-v-illumina-inc/
Cause
35:271 Patent Infringement
Court
District Court, D. Delaware
Court ID
ded
Case Name
The Research Institute at Nationwide Children's Hospital v. Illumina, Inc.
Docket ID
70448243
Date Filed
2025-06-03
Match scope
Exact party-name match in CourtListener; not an independently resolved legal identity, finding of wrongdoing or litigation outcome.
Docket number
1:25-cv-00683
Nature Of Suit
830 Patent
Other Parties
The Research Institute at Nationwide Children's Hospital
Jurisdiction Type
Federal Question
Matched Party Name
Illumina, Inc.
Queried Legal Name
ILLUMINA, INC.
Other Parties Scope
Each is a party to the case, as the docket search names it: no side is stated for any party, no relation to this company is inferred, and none was searched in turn.
Illumina, Inc. v. Element Biosciences, Inc. District Court, D. Delaware · Filed May 15, 2025
Docket
1:25-cv-00602
Filed
May 15, 2025
Jurisdiction
Federal Question
Matched party
Illumina, Inc.
Searched name
ILLUMINA, INC.
Nature Of Suit
830 Patent
Cause
35:271 Patent Infringement
Exact party-name match in CourtListener; not an independently resolved legal identity, finding of wrongdoing or litigation outcome.
View court docket
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://www.courtlistener.com/api/rest/v4/search/?order_by=dateFiled+desc&q=party%3A%22ILLUMINA%2C+INC.%22&type=d → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://www.courtlistener.com
Interpreted by rule
court-dockets-v2
Evidence ID
courtlistener:9bd3604bc8cf4a00b7651d60
All published fields
Source URL
https://www.courtlistener.com/docket/70272259/illumina-inc-v-element-biosciences-inc/
Cause
35:271 Patent Infringement
Court
District Court, D. Delaware
Court ID
ded
Case Name
Illumina, Inc. v. Element Biosciences, Inc.
Docket ID
70272259
Date Filed
2025-05-15
Match scope
Exact party-name match in CourtListener; not an independently resolved legal identity, finding of wrongdoing or litigation outcome.
Docket number
1:25-cv-00602
Nature Of Suit
830 Patent
Other Parties
Illumina Cambridge, Ltd., Element Biosciences, Inc.
Jurisdiction Type
Federal Question
Matched Party Name
Illumina, Inc.
Queried Legal Name
ILLUMINA, INC.
Other Parties Scope
Each is a party to the case, as the docket search names it: no side is stated for any party, no relation to this company is inferred, and none was searched in turn.
Illumina, Inc. v. Molecular Loop Biosciences, Inc. District Court, D. Delaware · Filed Aug 2, 2024
Docket
1:24-cv-00911
Filed
Aug 2, 2024
Terminated
Aug 30, 2024
Jurisdiction
Federal Question
Matched party
Illumina Inc.
Searched name
ILLUMINA, INC.
Nature Of Suit
830 Patent
Cause
28:2201 Declaratory Judgment
Exact party-name match in CourtListener; not an independently resolved legal identity, finding of wrongdoing or litigation outcome.
View court docket
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://www.courtlistener.com/api/rest/v4/search/?order_by=dateFiled+desc&q=party%3A%22ILLUMINA%2C+INC.%22&type=d → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://www.courtlistener.com
Interpreted by rule
court-dockets-v2
Evidence ID
courtlistener:bc3d0fcf45532937ebac0d74
All published fields
Source URL
https://www.courtlistener.com/docket/69011112/illumina-inc-v-molecular-loop-biosciences-inc/
Cause
28:2201 Declaratory Judgment
Court
District Court, D. Delaware
Court ID
ded
Case Name
Illumina, Inc. v. Molecular Loop Biosciences, Inc.
Docket ID
69011112
Date Filed
2024-08-02
Match scope
Exact party-name match in CourtListener; not an independently resolved legal identity, finding of wrongdoing or litigation outcome.
Docket number
1:24-cv-00911
Nature Of Suit
830 Patent
Other Parties
Verinata Health, Inc., Molecular Loop Biosciences, Inc.
Date Terminated
2024-08-30
Jurisdiction Type
Federal Question
Matched Party Name
Illumina Inc.
Queried Legal Name
ILLUMINA, INC.
Other Parties Scope
Each is a party to the case, as the docket search names it: no side is stated for any party, no relation to this company is inferred, and none was searched in turn.
Molecular Loop Biosciences, Inc. v. Illumina, Inc. District Court, D. Delaware · Filed Jun 10, 2024
Docket
1:24-cv-00680
Filed
Jun 10, 2024
Terminated
Feb 6, 2025
Jurisdiction
Federal Question
Matched party
Illumina, Inc.
Searched name
ILLUMINA, INC.
Nature Of Suit
830 Patent
Cause
35:271 Patent Infringement
Exact party-name match in CourtListener; not an independently resolved legal identity, finding of wrongdoing or litigation outcome.
View court docket
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://www.courtlistener.com/api/rest/v4/search/?order_by=dateFiled+desc&q=party%3A%22ILLUMINA%2C+INC.%22&type=d → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://www.courtlistener.com
Interpreted by rule
court-dockets-v2
Evidence ID
courtlistener:0bcd6d868f16f3ce6d70c218
All published fields
Source URL
https://www.courtlistener.com/docket/68840730/molecular-loop-biosciences-inc-v-illumina-inc/
Cause
35:271 Patent Infringement
Court
District Court, D. Delaware
Court ID
ded
Case Name
Molecular Loop Biosciences, Inc. v. Illumina, Inc.
Docket ID
68840730
Date Filed
2024-06-10
Match scope
Exact party-name match in CourtListener; not an independently resolved legal identity, finding of wrongdoing or litigation outcome.
Docket number
1:24-cv-00680
Nature Of Suit
830 Patent
Other Parties
Molecular Loop Biosciences, Inc., Verinata Health, Inc.
Date Terminated
2025-02-06
Jurisdiction Type
Federal Question
Matched Party Name
Illumina, Inc.
Queried Legal Name
ILLUMINA, INC.
Other Parties Scope
Each is a party to the case, as the docket search names it: no side is stated for any party, no relation to this company is inferred, and none was searched in turn.
Warner v. Desouza District Court, D. Delaware · Filed Apr 8, 2024
Docket
1:24-cv-00442
Filed
Apr 8, 2024
Terminated
May 1, 2024
Jurisdiction
Federal Question
Matched party
Illumina, Inc.
Searched name
ILLUMINA, INC.
Nature Of Suit
160 Stockholders Suits
Cause
15:0078ma
Exact party-name match in CourtListener; not an independently resolved legal identity, finding of wrongdoing or litigation outcome.
View court docket
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://www.courtlistener.com/api/rest/v4/search/?order_by=dateFiled+desc&q=party%3A%22ILLUMINA%2C+INC.%22&type=d → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://www.courtlistener.com
Interpreted by rule
court-dockets-v2
Evidence ID
courtlistener:b3276b9ed79cbe88cd250649
All published fields
Source URL
https://www.courtlistener.com/docket/68418806/warner-v-desouza/
Cause
15:0078ma
Court
District Court, D. Delaware
Court ID
ded
Case Name
Warner v. Desouza
Docket ID
68418806
Date Filed
2024-04-08
Match scope
Exact party-name match in CourtListener; not an independently resolved legal identity, finding of wrongdoing or litigation outcome.
Docket number
1:24-cv-00442
Nature Of Suit
160 Stockholders Suits
Other Parties
Michael Warner, Sam A. Samad, Scott B. Ullem, Gary S. Guthart, Philip Schiller, Andrew Teno, John Thompson, Frances Arnold, Francis A. Desouza, Robert S. Epstein, Caroline Dorsa, Scott Gottlieb, Sue Siegel
Date Terminated
2024-05-01
Jurisdiction Type
Federal Question
Matched Party Name
Illumina, Inc.
Queried Legal Name
ILLUMINA, INC.
Other Parties Scope
Each is a party to the case, as the docket search names it: no side is stated for any party, no relation to this company is inferred, and none was searched in turn.
Warner v. Desouza District Court, S.D. California · Filed Mar 8, 2024
Docket
3:24-cv-00464
Filed
Mar 8, 2024
Terminated
Mar 29, 2024
Jurisdiction
Federal Question
Matched party
Illumina, Inc.
Searched name
ILLUMINA, INC.
Nature Of Suit
160 Stockholders Suits
Cause
15:0078m(a) Securities Exchange Act
Exact party-name match in CourtListener; not an independently resolved legal identity, finding of wrongdoing or litigation outcome.
View court docket
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://www.courtlistener.com/api/rest/v4/search/?order_by=dateFiled+desc&q=party%3A%22ILLUMINA%2C+INC.%22&type=d → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://www.courtlistener.com
Interpreted by rule
court-dockets-v2
Evidence ID
courtlistener:cdd5aa271b3e51c0c8493a27
All published fields
Source URL
https://www.courtlistener.com/docket/68325371/warner-v-desouza/
Cause
15:0078m(a) Securities Exchange Act
Court
District Court, S.D. California
Court ID
casd
Case Name
Warner v. Desouza
Docket ID
68325371
Date Filed
2024-03-08
Match scope
Exact party-name match in CourtListener; not an independently resolved legal identity, finding of wrongdoing or litigation outcome.
Docket number
3:24-cv-00464
Nature Of Suit
160 Stockholders Suits
Other Parties
Michael Warner, Sam A. Samad, Scott B. Ullem, Gary S. Guthart, Philip Schiller, Andrew Teno, John Thompson, Frances Arnold, Francis A. Desouza, Robert S. Epstein, Caroline Dorsa, Scott Gottlieb, Sue Siegel
Date Terminated
2024-03-29
Jurisdiction Type
Federal Question
Matched Party Name
Illumina, Inc.
Queried Legal Name
ILLUMINA, INC.
Other Parties Scope
Each is a party to the case, as the docket search names it: no side is stated for any party, no relation to this company is inferred, and none was searched in turn.
Wang v. deSouza District Court, D. Delaware · Filed Feb 21, 2024
Docket
1:24-cv-00232
Filed
Feb 21, 2024
Terminated
Apr 29, 2024
Jurisdiction
Federal Question
Matched party
Illumina, Inc.
Searched name
ILLUMINA, INC.
Nature Of Suit
160 Stockholders Suits
Cause
15:78m(a) Securities Exchange Act
Exact party-name match in CourtListener; not an independently resolved legal identity, finding of wrongdoing or litigation outcome.
View court docket
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://www.courtlistener.com/api/rest/v4/search/?order_by=dateFiled+desc&q=party%3A%22ILLUMINA%2C+INC.%22&type=d → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://www.courtlistener.com
Interpreted by rule
court-dockets-v2
Evidence ID
courtlistener:94936e34b408c26f6ead90ea
All published fields
Source URL
https://www.courtlistener.com/docket/68271973/wang-v-desouza/
Cause
15:78m(a) Securities Exchange Act
Court
District Court, D. Delaware
Court ID
ded
Case Name
Wang v. deSouza
Docket ID
68271973
Date Filed
2024-02-21
Match scope
Exact party-name match in CourtListener; not an independently resolved legal identity, finding of wrongdoing or litigation outcome.
Docket number
1:24-cv-00232
Nature Of Suit
160 Stockholders Suits
Other Parties
Caroline Dorsa, Sue Siegel, Scott B. Ulleme, John Thompson, Scott Gottlieb, Andrew Teno, Gary S. Guthart, Francis A. deSouza, Elaine Wang, Jacob Thaysen, Frances Arnold, Philip Schiller, Sam A. Samad, Jay Flatley, Joydeep Goswami, Stephen P. MacMillan, Robert S. Epstein
Date Terminated
2024-04-29
Jurisdiction Type
Federal Question
Matched Party Name
Illumina, Inc.
Queried Legal Name
ILLUMINA, INC.
Other Parties Scope
Each is a party to the case, as the docket search names it: no side is stated for any party, no relation to this company is inferred, and none was searched in turn.
Roy v. Illumina, Inc. District Court, S.D. California · Filed Dec 21, 2023
Docket
3:23-cv-02327
Filed
Dec 21, 2023
Jurisdiction
Federal Question
Matched party
Illumina, Inc.
Searched name
ILLUMINA, INC.
Nature Of Suit
850 Securities/Commodities
Cause
15:0719i(c ) Civil actions re violations or inj involving Gas
Exact party-name match in CourtListener; not an independently resolved legal identity, finding of wrongdoing or litigation outcome.
View court docket
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://www.courtlistener.com/api/rest/v4/search/?order_by=dateFiled+desc&q=party%3A%22ILLUMINA%2C+INC.%22&type=d → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://www.courtlistener.com
Interpreted by rule
court-dockets-v2
Evidence ID
courtlistener:53886407a4e3062e2865365b
All published fields
Source URL
https://www.courtlistener.com/docket/68110539/roy-v-illumina-inc/
Cause
15:0719i(c ) Civil actions re violations or inj involving Gas
Court
District Court, S.D. California
Court ID
casd
Case Name
Roy v. Illumina, Inc.
Docket ID
68110539
Date Filed
2023-12-21
Match scope
Exact party-name match in CourtListener; not an independently resolved legal identity, finding of wrongdoing or litigation outcome.
Docket number
3:23-cv-02327
Nature Of Suit
850 Securities/Commodities
Other Parties
Anand Roy, John Thompson, Francis A. Desouza
Jurisdiction Type
Federal Question
Matched Party Name
Illumina, Inc.
Queried Legal Name
ILLUMINA, INC.
Other Parties Scope
Each is a party to the case, as the docket search names it: no side is stated for any party, no relation to this company is inferred, and none was searched in turn.
Louisiana Sheriffs' Pension & Relief Fund v. Illumina, Inc. District Court, S.D. California · Filed Dec 21, 2023
Docket
3:23-cv-02328
Filed
Dec 21, 2023
Jurisdiction
Federal Question
Matched party
Illumina, Inc.
Searched name
ILLUMINA, INC.
Nature Of Suit
850 Securities/Commodities
Cause
15:0078m(a) Securities Exchange Act
Exact party-name match in CourtListener; not an independently resolved legal identity, finding of wrongdoing or litigation outcome.
View court docket
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://www.courtlistener.com/api/rest/v4/search/?order_by=dateFiled+desc&q=party%3A%22ILLUMINA%2C+INC.%22&type=d → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://www.courtlistener.com
Interpreted by rule
court-dockets-v2
Evidence ID
courtlistener:48633fd57821940d68b6e019
All published fields
Source URL
https://www.courtlistener.com/docket/68112456/louisiana-sheriffs-pension-relief-fund-v-illumina-inc/
Cause
15:0078m(a) Securities Exchange Act
Court
District Court, S.D. California
Court ID
casd
Case Name
Louisiana Sheriffs' Pension & Relief Fund v. Illumina, Inc.
Docket ID
68112456
Date Filed
2023-12-21
Match scope
Exact party-name match in CourtListener; not an independently resolved legal identity, finding of wrongdoing or litigation outcome.
Docket number
3:23-cv-02328
Nature Of Suit
850 Securities/Commodities
Other Parties
Joydeep Goswami, Louisiana Sheriffs' Pension & Relief Fund, John Thompson, Francis A. Desouza, Sam A. Samad
Jurisdiction Type
Federal Question
Matched Party Name
Illumina, Inc.
Queried Legal Name
ILLUMINA, INC.
Other Parties Scope
Each is a party to the case, as the docket search names it: no side is stated for any party, no relation to this company is inferred, and none was searched in turn.
Kangas v. Illumina, Inc. District Court, S.D. California · Filed Nov 10, 2023
Docket
3:23-cv-02082
Filed
Nov 10, 2023
Jurisdiction
Federal Question
Matched party
Illumina, Inc.
Searched name
ILLUMINA, INC.
Nature Of Suit
850 Securities/Commodities
Cause
15:0078m(a) Securities Exchange Act
Exact party-name match in CourtListener; not an independently resolved legal identity, finding of wrongdoing or litigation outcome.
View court docket
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://www.courtlistener.com/api/rest/v4/search/?cursor=cz0xMzM3OTIxMzAwMDAwMC4wJnM9NjgxMTA1MzkmdD1kJmQ9MjAyNi0xMC0yMyZwPTI%3D&order_by=dateFiled+desc&q=party%3A%22ILLUMINA%2C+INC.%22&type=d → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://www.courtlistener.com
Interpreted by rule
court-dockets-v2
Evidence ID
courtlistener:c67c3c0d0e7b360cd753e336
All published fields
Source URL
https://www.courtlistener.com/docket/67999601/kangas-v-illumina-inc/
Cause
15:0078m(a) Securities Exchange Act
Court
District Court, S.D. California
Court ID
casd
Case Name
Kangas v. Illumina, Inc.
Docket ID
67999601
Date Filed
2023-11-10
Match scope
Exact party-name match in CourtListener; not an independently resolved legal identity, finding of wrongdoing or litigation outcome.
Docket number
3:23-cv-02082
Nature Of Suit
850 Securities/Commodities
Other Parties
UI BVK Kapitalverwaltungsgesellschaft mbH, GRAIL, LLC, Francis A. Desouza, Sam A. Samad, John Thompson, Wayne County Employees' Retirement System, Leslie Kangas, Alexander M. Aravanis, Joshua J. Ofman, Richard D. Klausner, Macomb County Retiree Health Care Fund, Hans Bishop, KBC Asset Management NV, Universal-Investment-Gesellschaft mbH, Jackson County Employees' Retirement System, ACATIS Investment Kapitalverwaltungsgesellschaft mbH, Phillip G. Febbo, Macomb County Employees' Retirement System, Macomb County Intermediate Retirees Medical Benefits Trust, Camelot Event Driven Fund, A Series of Frank Funds Trust
Jurisdiction Type
Federal Question
Matched Party Name
Illumina, Inc.
Queried Legal Name
ILLUMINA, INC.
Other Parties Scope
Each is a party to the case, as the docket search names it: no side is stated for any party, no relation to this company is inferred, and none was searched in turn.
Gold v. Illumina, Inc. District Court, N.D. California · Filed Sep 5, 2022
Docket
4:22-cv-05036
Filed
Sep 5, 2022
Terminated
Jul 27, 2023
Jurisdiction
Diversity
Matched party
Illumina, Inc.
Searched name
ILLUMINA, INC.
Nature Of Suit
Labor: Other
Cause
05:704 Labor Litigation
Exact party-name match in CourtListener; not an independently resolved legal identity, finding of wrongdoing or litigation outcome.
View court docket
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://www.courtlistener.com/api/rest/v4/search/?cursor=cz0xMzM3OTIxMzAwMDAwMC4wJnM9NjgxMTA1MzkmdD1kJmQ9MjAyNi0xMC0yMyZwPTI%3D&order_by=dateFiled+desc&q=party%3A%22ILLUMINA%2C+INC.%22&type=d → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://www.courtlistener.com
Interpreted by rule
court-dockets-v2
Evidence ID
courtlistener:bfad2b9d1b938f2774cb6dba
All published fields
Source URL
https://www.courtlistener.com/docket/64948875/gold-v-illumina-inc/
Cause
05:704 Labor Litigation
Court
District Court, N.D. California
Court ID
cand
Case Name
Gold v. Illumina, Inc.
Docket ID
64948875
Date Filed
2022-09-05
Match scope
Exact party-name match in CourtListener; not an independently resolved legal identity, finding of wrongdoing or litigation outcome.
Docket number
4:22-cv-05036
Nature Of Suit
Labor: Other
Other Parties
Albert Mark Gold, Verinata Health, Inc.
Date Terminated
2023-07-27
Jurisdiction Type
Diversity
Matched Party Name
Illumina, Inc.
Queried Legal Name
ILLUMINA, INC.
Other Parties Scope
Each is a party to the case, as the docket search names it: no side is stated for any party, no relation to this company is inferred, and none was searched in turn.
Illumina, Inc. v. Guardant Health, Inc. District Court, D. Delaware · Filed Mar 17, 2022
Docket
1:22-cv-00334
Filed
Mar 17, 2022
Terminated
Aug 2, 2023
Jurisdiction
Federal Question
Matched party
Illumina, Inc.
Searched name
ILLUMINA, INC.
Nature Of Suit
830 Patent
Cause
35:1 Patent Infringement
Exact party-name match in CourtListener; not an independently resolved legal identity, finding of wrongdoing or litigation outcome.
View court docket
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://www.courtlistener.com/api/rest/v4/search/?cursor=cz0xMzM3OTIxMzAwMDAwMC4wJnM9NjgxMTA1MzkmdD1kJmQ9MjAyNi0xMC0yMyZwPTI%3D&order_by=dateFiled+desc&q=party%3A%22ILLUMINA%2C+INC.%22&type=d → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://www.courtlistener.com
Interpreted by rule
court-dockets-v2
Evidence ID
courtlistener:79bc2f22e40309e0257eda3e
All published fields
Source URL
https://www.courtlistener.com/docket/63165906/illumina-inc-v-guardant-health-inc/
Cause
35:1 Patent Infringement
Court
District Court, D. Delaware
Court ID
ded
Case Name
Illumina, Inc. v. Guardant Health, Inc.
Docket ID
63165906
Date Filed
2022-03-17
Match scope
Exact party-name match in CourtListener; not an independently resolved legal identity, finding of wrongdoing or litigation outcome.
Docket number
1:22-cv-00334
Nature Of Suit
830 Patent
Other Parties
Guardant Health, Inc., Helmy Eltoukhy, AmirAli Talasaz
Date Terminated
2023-08-02
Jurisdiction Type
Federal Question
Matched Party Name
Illumina, Inc.
Queried Legal Name
ILLUMINA, INC.
Other Parties Scope
Each is a party to the case, as the docket search names it: no side is stated for any party, no relation to this company is inferred, and none was searched in turn.
Federal Trade Commission v. Illumina Inc. District Court, S.D. California · Filed Apr 23, 2021
Docket
3:21-cv-00800
Filed
Apr 23, 2021
Terminated
Jun 1, 2021
Jurisdiction
U.S. Government Plaintiff
Matched party
Illumina Inc.
Searched name
ILLUMINA, INC.
Nature Of Suit
410 Anti-Trust
Cause
15:0053 Federal Trade Commission Act
Exact party-name match in CourtListener; not an independently resolved legal identity, finding of wrongdoing or litigation outcome.
View court docket
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://www.courtlistener.com/api/rest/v4/search/?cursor=cz0xMzM3OTIxMzAwMDAwMC4wJnM9NjgxMTA1MzkmdD1kJmQ9MjAyNi0xMC0yMyZwPTI%3D&order_by=dateFiled+desc&q=party%3A%22ILLUMINA%2C+INC.%22&type=d → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://www.courtlistener.com
Interpreted by rule
court-dockets-v2
Evidence ID
courtlistener:aba5cc3b76acb2ae44976167
All published fields
Source URL
https://www.courtlistener.com/docket/59848562/federal-trade-commission-v-illumina-inc/
Cause
15:0053 Federal Trade Commission Act
Court
District Court, S.D. California
Court ID
casd
Case Name
Federal Trade Commission v. Illumina Inc.
Docket ID
59848562
Date Filed
2021-04-23
Match scope
Exact party-name match in CourtListener; not an independently resolved legal identity, finding of wrongdoing or litigation outcome.
Docket number
3:21-cv-00800
Nature Of Suit
410 Anti-Trust
Other Parties
Federal Trade Commission, GRAIL, INC.
Date Terminated
2021-06-01
Jurisdiction Type
U.S. Government Plaintiff
Matched Party Name
Illumina Inc.
Queried Legal Name
ILLUMINA, INC.
Other Parties Scope
Each is a party to the case, as the docket search names it: no side is stated for any party, no relation to this company is inferred, and none was searched in turn.
Complete Genomics, Inc. v. Illumina, Inc. District Court, N.D. California · Filed Jan 11, 2021
Docket
3:21-cv-00217
Filed
Jan 11, 2021
Terminated
Jul 28, 2022
Jurisdiction
Federal Question
Matched party
Illumina, Inc.
Searched name
ILLUMINA, INC.
Nature Of Suit
410 Anti-Trust
Cause
15:2 Antitrust Litigation
Exact party-name match in CourtListener; not an independently resolved legal identity, finding of wrongdoing or litigation outcome.
View court docket
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://www.courtlistener.com/api/rest/v4/search/?cursor=cz0xMzM3OTIxMzAwMDAwMC4wJnM9NjgxMTA1MzkmdD1kJmQ9MjAyNi0xMC0yMyZwPTI%3D&order_by=dateFiled+desc&q=party%3A%22ILLUMINA%2C+INC.%22&type=d → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://www.courtlistener.com
Interpreted by rule
court-dockets-v2
Evidence ID
courtlistener:19cf288841bd1b4f9817d3e0
All published fields
Source URL
https://www.courtlistener.com/docket/29094871/complete-genomics-inc-v-illumina-inc/
Cause
15:2 Antitrust Litigation
Court
District Court, N.D. California
Court ID
cand
Case Name
Complete Genomics, Inc. v. Illumina, Inc.
Docket ID
29094871
Date Filed
2021-01-11
Match scope
Exact party-name match in CourtListener; not an independently resolved legal identity, finding of wrongdoing or litigation outcome.
Docket number
3:21-cv-00217
Nature Of Suit
410 Anti-Trust
Other Parties
Illumina Cambridge Ltd., Complete Genomics, Inc., MGI Americas, Inc., BGI Americas Corp.
Date Terminated
2022-07-28
Jurisdiction Type
Federal Question
Matched Party Name
Illumina, Inc.
Queried Legal Name
ILLUMINA, INC.
Other Parties Scope
Each is a party to the case, as the docket search names it: no side is stated for any party, no relation to this company is inferred, and none was searched in turn.
Ravgen, Inc. v. Illumina, Inc. District Court, D. Delaware · Filed Dec 3, 2020
Docket
1:20-cv-01644
Filed
Dec 3, 2020
Terminated
Apr 14, 2023
Jurisdiction
Federal Question
Matched party
Illumina, Inc.
Searched name
ILLUMINA, INC.
Nature Of Suit
830 Patent
Cause
35:1 Patent Infringement
Exact party-name match in CourtListener; not an independently resolved legal identity, finding of wrongdoing or litigation outcome.
View court docket
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://www.courtlistener.com/api/rest/v4/search/?cursor=cz0xMzM3OTIxMzAwMDAwMC4wJnM9NjgxMTA1MzkmdD1kJmQ9MjAyNi0xMC0yMyZwPTI%3D&order_by=dateFiled+desc&q=party%3A%22ILLUMINA%2C+INC.%22&type=d → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://www.courtlistener.com
Interpreted by rule
court-dockets-v2
Evidence ID
courtlistener:cb1406fc61e6153e967ef6a3
All published fields
Source URL
https://www.courtlistener.com/docket/18710965/ravgen-inc-v-illumina-inc/
Cause
35:1 Patent Infringement
Court
District Court, D. Delaware
Court ID
ded
Case Name
Ravgen, Inc. v. Illumina, Inc.
Docket ID
18710965
Date Filed
2020-12-03
Match scope
Exact party-name match in CourtListener; not an independently resolved legal identity, finding of wrongdoing or litigation outcome.
Docket number
1:20-cv-01644
Nature Of Suit
830 Patent
Other Parties
Verinata Health, Inc., Ravgen, Inc.
Date Terminated
2023-04-14
Jurisdiction Type
Federal Question
Matched Party Name
Illumina, Inc.
Queried Legal Name
ILLUMINA, INC.
Other Parties Scope
Each is a party to the case, as the docket search names it: no side is stated for any party, no relation to this company is inferred, and none was searched in turn.
in re Application of Latvia MGI Tech SIA District Court, N.D. California · Filed Sep 8, 2020
Docket
3:20-mc-80152
Filed
Sep 8, 2020
Jurisdiction
U.S. Government Plaintiff
Matched party
Illumina Inc.
Searched name
ILLUMINA, INC.
Nature Of Suit
Other Statutory Actions
Cause
Civil Miscellaneous Case
Exact party-name match in CourtListener; not an independently resolved legal identity, finding of wrongdoing or litigation outcome.
View court docket
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://www.courtlistener.com/api/rest/v4/search/?cursor=cz0xMzM3OTIxMzAwMDAwMC4wJnM9NjgxMTA1MzkmdD1kJmQ9MjAyNi0xMC0yMyZwPTI%3D&order_by=dateFiled+desc&q=party%3A%22ILLUMINA%2C+INC.%22&type=d → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://www.courtlistener.com
Interpreted by rule
court-dockets-v2
Evidence ID
courtlistener:5fe36d00e9f8ad538e8efba2
All published fields
Source URL
https://www.courtlistener.com/docket/18424187/in-re-application-of-latvia-mgi-tech-sia/
Cause
Civil Miscellaneous Case
Court
District Court, N.D. California
Court ID
cand
Case Name
in re Application of Latvia MGI Tech SIA
Docket ID
18424187
Date Filed
2020-09-08
Match scope
Exact party-name match in CourtListener; not an independently resolved legal identity, finding of wrongdoing or litigation outcome.
Docket number
3:20-mc-80152
Nature Of Suit
Other Statutory Actions
Other Parties
in re Application of Latvia MGI Tech SIA et al
Jurisdiction Type
U.S. Government Plaintiff
Matched Party Name
Illumina Inc.
Queried Legal Name
ILLUMINA, INC.
Other Parties Scope
Each is a party to the case, as the docket search names it: no side is stated for any party, no relation to this company is inferred, and none was searched in turn.
Rakuten Medical, Inc. v. Illumina, Inc. District Court, N.D. California · Filed Aug 5, 2020
Docket
5:20-cv-05430
Filed
Aug 5, 2020
Terminated
Dec 23, 2021
Jurisdiction
Federal Question
Matched party
Illumina, Inc.
Searched name
ILLUMINA, INC.
Nature Of Suit
840 Trademark
Cause
15:1125 Trademark Infringement (Lanham Act)
Exact party-name match in CourtListener; not an independently resolved legal identity, finding of wrongdoing or litigation outcome.
View court docket
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://www.courtlistener.com/api/rest/v4/search/?cursor=cz0xMzM3OTIxMzAwMDAwMC4wJnM9NjgxMTA1MzkmdD1kJmQ9MjAyNi0xMC0yMyZwPTI%3D&order_by=dateFiled+desc&q=party%3A%22ILLUMINA%2C+INC.%22&type=d → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://www.courtlistener.com
Interpreted by rule
court-dockets-v2
Evidence ID
courtlistener:e11f8f28ba49193c968897de
All published fields
Source URL
https://www.courtlistener.com/docket/17419141/rakuten-medical-inc-v-illumina-inc/
Cause
15:1125 Trademark Infringement (Lanham Act)
Court
District Court, N.D. California
Court ID
cand
Case Name
Rakuten Medical, Inc. v. Illumina, Inc.
Docket ID
17419141
Date Filed
2020-08-05
Match scope
Exact party-name match in CourtListener; not an independently resolved legal identity, finding of wrongdoing or litigation outcome.
Docket number
5:20-cv-05430
Nature Of Suit
840 Trademark
Other Parties
Rakuten Medical, Inc.
Date Terminated
2021-12-23
Jurisdiction Type
Federal Question
Matched Party Name
Illumina, Inc.
Queried Legal Name
ILLUMINA, INC.
Other Parties Scope
Each is a party to the case, as the docket search names it: no side is stated for any party, no relation to this company is inferred, and none was searched in turn.
Illumina Inc. v. BGI Genomics Co., Ltd. District Court, N.D. California · Filed Feb 27, 2020
Docket
3:20-cv-01465
Filed
Feb 27, 2020
Terminated
May 10, 2022
Jurisdiction
Federal Question
Matched party
Illumina Inc.
Searched name
ILLUMINA, INC.
Nature Of Suit
830 Patent
Cause
28:1331 Fed. Question
Exact party-name match in CourtListener; not an independently resolved legal identity, finding of wrongdoing or litigation outcome.
View court docket
Published by a third-party source · confirmed Oct 23, 2026, 10:59 AM UTC
Observed via
https://www.courtlistener.com/api/rest/v4/search/?cursor=cz0xMzM3OTIxMzAwMDAwMC4wJnM9NjgxMTA1MzkmdD1kJmQ9MjAyNi0xMC0yMyZwPTI%3D&order_by=dateFiled+desc&q=party%3A%22ILLUMINA%2C+INC.%22&type=d → SEC registrant ILLUMINA, INC. on https://www.sec.gov/ix?doc=/Archives/edgar/data/0001110803/000119312524087264/d534824ddef14a.htm
About
ILLUMINA, INC., the SEC registrant the site links
Read from
https://www.courtlistener.com
Interpreted by rule
court-dockets-v2
Evidence ID
courtlistener:9460d4f8f0efda18707e3f61
All published fields
Source URL
https://www.courtlistener.com/docket/16899654/illumina-inc-v-bgi-genomics-co-ltd/
Cause
28:1331 Fed. Question
Court
District Court, N.D. California
Court ID
cand
Case Name
Illumina Inc. v. BGI Genomics Co., Ltd.
Docket ID
16899654
Date Filed
2020-02-27
Match scope
Exact party-name match in CourtListener; not an independently resolved legal identity, finding of wrongdoing or litigation outcome.
Docket number
3:20-cv-01465
Nature Of Suit
830 Patent
Other Parties
Illumina Cambridge Ltd., MGI Tech Co., Ltd., BGI Genomics Co., Ltd., Complete Genomics Inc., BGI Americas Corp., MGI Americas, Inc.
Date Terminated
2022-05-10
Jurisdiction Type
Federal Question
Matched Party Name
Illumina Inc.
Queried Legal Name
ILLUMINA, INC.
Other Parties Scope
Each is a party to the case, as the docket search names it: no side is stated for any party, no relation to this company is inferred, and none was searched in turn.

San Diego Union-Tribune Employees & Ownership

Aaron CrosslandOwnerslast seen

Stated by 1 source

https://www.sandiegouniontribune.com/things-to-do/restaurants-food-drink/page/9/ · Published person (named with a role or their own mailbox on the site) · Owners

Published by a third-party source · confirmed Oct 23, 2026, 10:56 AM UTC

First observed: Oct 23, 2026, 10:56 AM UTC

Accursio Lotageneral managerlast seen 2025

Stated by 1 source

https://www.sandiegouniontribune.com/things-to-do/restaurants-food-drink/page/5/ · Published person (named with a role or their own mailbox on the site) · general manager · published 2025

Published by a third-party source · confirmed Oct 23, 2026, 10:56 AM UTC

First observed: Oct 23, 2026, 10:56 AM UTC

Adam Glickcheflast seen

Stated by 1 source

https://www.sandiegouniontribune.com/things-to-do/restaurants-food-drink/page/10/ · Published person (named with a role or their own mailbox on the site) · chef

Published by a third-party source · confirmed Oct 23, 2026, 10:56 AM UTC

First observed: Oct 23, 2026, 10:56 AM UTC

Alan Penticoexecutive directorlast seen

Stated by 1 source

https://www.sandiegouniontribune.com/business/real-estate/ · Published person (named with a role or their own mailbox on the site) · executive director

Published by a third-party source · confirmed Oct 23, 2026, 10:56 AM UTC

First observed: Oct 23, 2026, 10:56 AM UTC

Alexander HarvardCo Founderlast seen

Stated by 1 source

https://mediakit.sandiegouniontribune.com/team/ · Published person (named with a role or their own mailbox on the site) · Co Founder

Published by a third-party source · confirmed Oct 23, 2026, 10:58 AM UTC

First observed: Oct 23, 2026, 10:58 AM UTC

Alex Klinneroperationslast seen 2025

Stated by 1 source

https://www.sandiegouniontribune.com/tag/military/ · Published person (named with a role or their own mailbox on the site) · operations · published 2025

Published by a third-party source · confirmed Oct 23, 2026, 10:56 AM UTC

First observed: Oct 23, 2026, 10:56 AM UTC

Alton Brownculinarylast seen

Stated by 1 source

https://www.sandiegouniontribune.com/things-to-do/restaurants-food-drink/page/18/ · Published person (named with a role or their own mailbox on the site) · culinary

Published by a third-party source · confirmed Oct 23, 2026, 10:56 AM UTC

First observed: Oct 23, 2026, 10:56 AM UTC

Amanda Sarichgeneral managerlast seen

Stated by 1 source

https://www.sandiegouniontribune.com/things-to-do/restaurants-food-drink/page/3/ · Published person (named with a role or their own mailbox on the site) · general manager

Published by a third-party source · confirmed Oct 23, 2026, 10:56 AM UTC

First observed: Oct 23, 2026, 10:56 AM UTC

Andrew BachelierChefslast seen

Stated by 1 source

https://www.sandiegouniontribune.com/things-to-do/restaurants-food-drink/page/10/ · Published person (named with a role or their own mailbox on the site) · Chefs

Published by a third-party source · confirmed Oct 23, 2026, 10:56 AM UTC

First observed: Oct 23, 2026, 10:56 AM UTC

Anna Heldfounderlast seen

Roles

founder · foundinghttps://www.sandiegouniontribune.com/la-jolla-light/

Stated by 1 source

https://www.sandiegouniontribune.com/la-jolla-light/ · Published person (named with a role or their own mailbox on the site) · founder

Published by a third-party source · confirmed Oct 23, 2026, 10:56 AM UTC

First observed: Oct 23, 2026, 10:56 AM UTC

Anthony Tallmanownerlast seen

As printed “The Oasis started as a trial run, but it blossomed into something more than we ever imagined because of the community and their reception to our products and service,” says co-founder and head brewer Anthony Tallman, who worked at Stone prior to starting his own business.
Published by a third-party source · confirmed Oct 23, 2026, 10:55 AM UTC
Observed via
https://www.sandiegouniontribune.com/2026/10/21/escondidos-beer-scene-beyond-stone-brewing/ → Published person (named with a role or their own mailbox on the site)

Stated by 1 source

https://www.sandiegouniontribune.com/2026/10/21/escondidos-beer-scene-beyond-stone-brewing/ · Published person (named with a role or their own mailbox on the site) · owner

Published by a third-party source · confirmed Oct 23, 2026, 10:55 AM UTC

First observed: Oct 23, 2026, 10:55 AM UTC

Arely ChavezHead Pastry Cheflast seen 2025

Stated by 1 source

https://www.sandiegouniontribune.com/things-to-do/restaurants-food-drink/page/6/ · Published person (named with a role or their own mailbox on the site) · Head Pastry Chef · published 2025

Published by a third-party source · confirmed Oct 23, 2026, 10:56 AM UTC

First observed: Oct 23, 2026, 10:56 AM UTC

1 person not confirmed

The latest people collection is incomplete. Previously confirmed people remain available with their original dates.

Lisa Deaderick
mailbox_without_role: a mailbox spells the name, and no role or contact purpose is printed beside it
Source not recorded · confirmed Oct 23, 2026, 10:56 AM UTC
Observed via
https://www.sandiegouniontribune.com/author/lisa-deaderick/ → Person candidate named on the business's own site page (no admission chain accepted it)

Job Postings

36 job listings

Recruiting platformworkday
Directly observed · confirmed Oct 23, 2026, 10:58 AM UTC
Observed via
publisher careers link → resolved board identity → https://myworkdaycenter.wd5.myworkdayjobs.com/wday/cxs/myworkdaycenter/MNG/jobs
Read from
https://myworkdaycenter.wd5.myworkdayjobs.com
Boardmyworkdaycenter.wd5/MNG
Directly observed · confirmed Oct 23, 2026, 10:58 AM UTC
Observed via
publisher careers link → resolved board identity → https://myworkdaycenter.wd5.myworkdayjobs.com/wday/cxs/myworkdaycenter/MNG/jobs
Read from
https://myworkdaycenter.wd5.myworkdayjobs.com
Open roles36
Directly observed · confirmed Oct 23, 2026, 10:58 AM UTC
Observed via
publisher careers link → resolved board identity → https://myworkdaycenter.wd5.myworkdayjobs.com/wday/cxs/myworkdaycenter/MNG/jobs
Read from
https://myworkdaycenter.wd5.myworkdayjobs.com

Account Executive San Jose, California · ID R2862
Recruiting platform
workday
Directly observed · confirmed Oct 23, 2026, 10:58 AM UTC
Observed via
https://myworkdaycenter.wd5.myworkdayjobs.com/wday/cxs/myworkdaycenter/MNG/jobs
Read from
https://myworkdaycenter.wd5.myworkdayjobs.com
All published fields
Title
Account Executive
Identifier
R2862
Recruiting platform
workday
Published location
San Jose, California
Account Manager St. Paul, Minnesota · ID R2834
Recruiting platform
workday
Directly observed · confirmed Oct 23, 2026, 10:58 AM UTC
Observed via
https://myworkdaycenter.wd5.myworkdayjobs.com/wday/cxs/myworkdaycenter/MNG/jobs
Read from
https://myworkdaycenter.wd5.myworkdayjobs.com
All published fields
Title
Account Manager
Identifier
R2834
Recruiting platform
workday
Published location
St. Paul, Minnesota
Accountability Reporter San Jose, California · ID R2904
Recruiting platform
workday
Directly observed · confirmed Oct 23, 2026, 10:58 AM UTC
Observed via
https://myworkdaycenter.wd5.myworkdayjobs.com/wday/cxs/myworkdaycenter/MNG/jobs
Read from
https://myworkdaycenter.wd5.myworkdayjobs.com
All published fields
Title
Accountability Reporter
Identifier
R2904
Recruiting platform
workday
Published location
San Jose, California
Accounts Payable Clerk Willoughby, Ohio · ID R2905
Recruiting platform
workday
Directly observed · confirmed Oct 23, 2026, 10:58 AM UTC
Observed via
https://myworkdaycenter.wd5.myworkdayjobs.com/wday/cxs/myworkdaycenter/MNG/jobs
Read from
https://myworkdaycenter.wd5.myworkdayjobs.com
All published fields
Title
Accounts Payable Clerk
Identifier
R2905
Recruiting platform
workday
Published location
Willoughby, Ohio
Accounts Receivable Specialist 2 Locations · ID R2894
Recruiting platform
workday
Directly observed · confirmed Oct 23, 2026, 10:58 AM UTC
Observed via
https://myworkdaycenter.wd5.myworkdayjobs.com/wday/cxs/myworkdaycenter/MNG/jobs
Read from
https://myworkdaycenter.wd5.myworkdayjobs.com
All published fields
Title
Accounts Receivable Specialist
Identifier
R2894
Recruiting platform
workday
Published location
2 Locations
Advertising Operations Specialist San Diego, California · ID R2908
Recruiting platform
workday
Directly observed · confirmed Oct 23, 2026, 10:58 AM UTC
Observed via
https://myworkdaycenter.wd5.myworkdayjobs.com/wday/cxs/myworkdaycenter/MNG/jobs
Read from
https://myworkdaycenter.wd5.myworkdayjobs.com
All published fields
Title
Advertising Operations Specialist
Identifier
R2908
Recruiting platform
workday
Published location
San Diego, California

Billing Specialist II 2 Locations · ID R2891
Recruiting platform
workday
Directly observed · confirmed Oct 23, 2026, 10:58 AM UTC
Observed via
https://myworkdaycenter.wd5.myworkdayjobs.com/wday/cxs/myworkdaycenter/MNG/jobs
Read from
https://myworkdaycenter.wd5.myworkdayjobs.com
All published fields
Title
Billing Specialist II
Identifier
R2891
Recruiting platform
workday
Published location
2 Locations
Breaking News Reporter San Jose, California · ID R2903-1
Recruiting platform
workday
Directly observed · confirmed Oct 23, 2026, 10:58 AM UTC
Observed via
https://myworkdaycenter.wd5.myworkdayjobs.com/wday/cxs/myworkdaycenter/MNG/jobs
Read from
https://myworkdaycenter.wd5.myworkdayjobs.com
All published fields
Title
Breaking News Reporter
Identifier
R2903-1
Recruiting platform
workday
Published location
San Jose, California
Business Development Executive Irvine, California · ID R2747
Recruiting platform
workday
Directly observed · confirmed Oct 23, 2026, 10:58 AM UTC
Observed via
https://myworkdaycenter.wd5.myworkdayjobs.com/wday/cxs/myworkdaycenter/MNG/jobs
Read from
https://myworkdaycenter.wd5.myworkdayjobs.com
All published fields
Title
Business Development Executive
Identifier
R2747
Recruiting platform
workday
Published location
Irvine, California
Business Operations Coordinator San Diego, California · ID R2888
Recruiting platform
workday
Directly observed · confirmed Oct 23, 2026, 10:58 AM UTC
Observed via
https://myworkdaycenter.wd5.myworkdayjobs.com/wday/cxs/myworkdaycenter/MNG/jobs
Read from
https://myworkdaycenter.wd5.myworkdayjobs.com
All published fields
Title
Business Operations Coordinator
Identifier
R2888
Recruiting platform
workday
Published location
San Diego, California
Director, Finance Business Systems 9 Locations · ID R2886
Recruiting platform
workday
Directly observed · confirmed Oct 23, 2026, 10:58 AM UTC
Observed via
https://myworkdaycenter.wd5.myworkdayjobs.com/wday/cxs/myworkdaycenter/MNG/jobs
Read from
https://myworkdaycenter.wd5.myworkdayjobs.com
All published fields
Title
Director, Finance Business Systems
Identifier
R2886
Recruiting platform
workday
Published location
9 Locations
General Assignment Reporter Pottsville, Pennsylvania · ID R2822
Recruiting platform
workday
Directly observed · confirmed Oct 23, 2026, 10:58 AM UTC
Observed via
https://myworkdaycenter.wd5.myworkdayjobs.com/wday/cxs/myworkdaycenter/MNG/jobs
Read from
https://myworkdaycenter.wd5.myworkdayjobs.com
All published fields
Title
General Assignment Reporter
Identifier
R2822
Recruiting platform
workday
Published location
Pottsville, Pennsylvania

Contact Information

Phones

(858) 263-7475

The Local: The Local in Pacific Beach is the home to Sooners football. The bar has tons of TVs throughout the venue and will feature Oklahoma-themed drinks with other food and drink deals during games

Directly observed · confirmed Oct 23, 2026, 10:56 AM UTC

Observed via: https://www.sandiegouniontribune.com/2024/08/26/where-to-watch-your-favorite-college-football-team-at-san-diego-restaurants-and-bars/ → printed in page text, not marked up
First observed: Oct 23, 2026, 10:56 AM UTC

619-269-8906

E-mail: david.garrick@sduniontribune.com | Phone: 619-269-8906

Directly observed · confirmed Oct 23, 2026, 10:56 AM UTC

Observed via: https://www.sandiegouniontribune.com/contact-newsroom/ → printed in page text, not marked up
First observed: Oct 23, 2026, 10:56 AM UTC

(619) 293-1350

E-mail: karen.kucher@sduniontribune.com | Phone: (619) 293-1350

Directly observed · confirmed Oct 23, 2026, 10:56 AM UTC

Observed via: https://www.sandiegouniontribune.com/contact-newsroom/ → printed in page text, not marked up
First observed: Oct 23, 2026, 10:56 AM UTC

(760) 519-2952

E-mail: pam.kragen@sduniontribune.com | Phone: (760) 519-2952

Directly observed · confirmed Oct 23, 2026, 10:56 AM UTC

Observed via: https://www.sandiegouniontribune.com/contact-newsroom/ → printed in page text, not marked up
First observed: Oct 23, 2026, 10:56 AM UTC

(760) 529-4923

E-mail: tarcy.connors@sduniontribune.com | Phone: (760) 529-4923

Directly observed · confirmed Oct 23, 2026, 10:56 AM UTC

Observed via: https://www.sandiegouniontribune.com/contact-newsroom/ → printed in page text, not marked up
First observed: Oct 23, 2026, 10:56 AM UTC

(619) 293-1729

E-mail: adrian.vore@sduniontribune.com | Phone: (619) 293-1729

Directly observed · confirmed Oct 23, 2026, 10:56 AM UTC

Observed via: https://www.sandiegouniontribune.com/contact-newsroom/ → printed in page text, not marked up
First observed: Oct 23, 2026, 10:56 AM UTC

External references

Emails

gary.robbins@sduniontribune.com

Published by the company · confirmed Oct 23, 2026, 10:56 AM UTC

Observed via: https://www.sandiegouniontribune.com/contact-newsroom/ → address on another registrable domain — referenced, not the subject's contact point → printed beside it: "E-mail: gary.robbins@sduniontribune.com | Phone: (619) 293-1228"
First observed: Oct 23, 2026, 10:56 AM UTC

sam.schulz@sduniontribune.com

Published by the company · confirmed Oct 23, 2026, 10:56 AM UTC

Observed via: https://www.sandiegouniontribune.com/contact-newsroom/ → address on another registrable domain — referenced, not the subject's contact point → printed beside it: "E-mail: sam.schulz@sduniontribune.com"
First observed: Oct 23, 2026, 10:56 AM UTC

eddie.brown@sduniontribune.com

Published by the company · confirmed Oct 23, 2026, 10:56 AM UTC

Observed via: https://www.sandiegouniontribune.com/contact-newsroom/ → address on another registrable domain — referenced, not the subject's contact point → printed beside it: "E-mail: eddie.brown@sduniontribune.com"
First observed: Oct 23, 2026, 10:56 AM UTC

michael.smolens@sduniontribune.com

Published by the company · confirmed Oct 23, 2026, 10:56 AM UTC

Observed via: https://www.sandiegouniontribune.com/contact-newsroom/ → address on another registrable domain — referenced, not the subject's contact point → printed beside it: "E-mail: michael.smolens@sduniontribune.com | Phone: (619) 246-8514"
First observed: Oct 23, 2026, 10:56 AM UTC

lisa.deaderick@sduniontribune.com

Published by the company · confirmed Oct 23, 2026, 10:56 AM UTC

Observed via: https://www.sandiegouniontribune.com/2022/05/29/for-the-founder-of-san-diego-nonprofit-healthy-day-partners-increasing-equity-in-our-food-system-is-priority-no-1-2/ → address on another registrable domain — referenced, not the subject's contact point → printed beside it: "By Lisa Deaderick | lisa.deaderick@sduniontribune.com"
First observed: Oct 23, 2026, 10:56 AM UTC

linda.mcintosh@sduniontribune.com

Published by the company · confirmed Oct 23, 2026, 10:56 AM UTC

Observed via: https://www.sandiegouniontribune.com/contact-newsroom/ → address on another registrable domain — referenced, not the subject's contact point → printed beside it: "E-mail: linda.mcintosh@sduniontribune.com | Phone: (760) 529-4967"
First observed: Oct 23, 2026, 10:56 AM UTC

More contact information (136)

Contact forms

https://mediakit.sandiegouniontribune.com/fsg?pageId=807c6d79-3e85-49cd-a5a1-886a9ad57f1e&variant=a

Directly observed · confirmed Oct 23, 2026, 10:59 AM UTC

Observed via: https://mediakit.sandiegouniontribune.com/advertise-with-us/ → submits to https://mediakit.sandiegouniontribune.com/fsg?pageId=807c6d79-3e85-49cd-a5a1-886a9ad57f1e&variant=a → purpose: contact (a field to write or be reached through)
First observed: Oct 23, 2026, 10:59 AM UTC

Full contact-form data (JSON)

1 known location

Loading location map…

San DiegoNA, CA

Location evidence

The latest location collection is incomplete.

View location data

Menu & Online Ordering

Menu at San Diego Union-Tribune

5 menu items, including This upscale Carlsbad movie theater is closing on Oct, Friday, October and Thursday, October.

Menu & price evidence

Channel presence at San Diego Union-Tribune, NA
San Diego Union-Tribune, NA · the accepted location carrying the most storefront identities (0), with 0 of 27 platform menus read
the site's own menu: 13 items (5 priced)
- Toastnot declared · 0/1 locations
- Grubhubnot_searched · 0/1 locations
- Uber Eatsnot_searched · 0/1 locations
- DoorDashnot declared · 0/1 locations
- ChowNownot declared · 0/1 locations
- Olonot declared · 0/1 locations
- SkyTabnot declared · 0/1 locations
- Clovernot declared · 0/1 locations
- Slicenot declared · 0/1 locations
- KwickMenunot declared · 0/1 locations
- Restolabs (onlineordering.io)not declared · 0/1 locations
- CHOMPnot declared · 0/1 locations
- OrderSave (Owner.com)not declared · 0/1 locations
- SpotOnnot declared · 0/1 locations
- TouchBistronot declared · 0/1 locations
- Square Onlinenot declared · 0/1 locations
- MenuSifunot declared · 0/1 locations
- Menufynot declared · 0/1 locations
- Dylishnot declared · 0/1 locations
- getsaucenot declared · 0/1 locations
- DoorDash Storefront (order.online)not declared · 0/1 locations
- SpotHoppernot_searched · 0/1 locations
- ezCaternot declared · 0/1 locations
- OpenTablenot declared · 0/1 locations
One representative location per record: the accepted location carrying the most channel menus. Channel menus come from each provider's own store object for that store; prices are as each channel lists them, in the channel's currency; comparisons are projected from the resolved catalog -- one row per dish, portion-aware identity, prices kept as scoped offers -- and a pair the policy refuses is counted and explained rather than dropped.
Derived from observations
Observed via
no channel menu was read for this location
Interpreted by rule
channel-pricing/1
Evidence ID
channel-pricing:c276854e9cc039d416783eec

Resolved for San Diego Union-Tribune. 5 priced lines across 1 surface.

Compared against 🍺 Escondido’s beer scene — the site's own menu, resolved to this location.

🍺 Escondido’s beer scene

More From Our Newsroom

Thursday, OctoberWhether ‘stringing’ or ‘looping,’ tobacco is the tie that binds many North Carolina farm families$22.00

More From Our Newsroom

Wednesday, OctoberSouthern California’s first Sierra discount sporting store is heading to San Diego County$21.00

More From Our Newsroom

Tuesday, October10 new retailers are debuting at Fashion Valley$20.00

More From Our Newsroom

Friday, October6 San Diego County ZIP codes make list of the nation’s priciest$16.00

More From Our Newsroom

This upscale Carlsbad movie theater is closing on Oct$29.00

More From Our Newsroom

Website & Digital Technology

signonsandiego.com was first registered on April 22, 1997. Its registrar is MarkMonitor Inc..

Protocols: TLS 1.2.

HTTPS certificate: GoDaddy.com, Inc., expires January 4, 2025. The nosniff security header is enabled.

DNSSEC was not enabled when observed.

View technology, DNS, network and security evidence

Email & Mail Infrastructure

SPF authorizes sosdmail.com.

SPF is configured with a hard fail (-all).

View mail records and evidence

More website details

Apps, Loyalty & Guest Technology

View apps, provider accounts and technical evidence

App store details: Nothing observed in this category.

Publisher files

Nothing observed in this category.

Feeds

Nothing observed in this category.

GitHub

Nothing observed in this category.

Additional site intelligence

Useful site-graph evidence is available on demand instead of being pre-rendered into every company profile.